fv4za
As filed
with the Securities and Exchange Commission on June, 22,
2011
Registration
No. 333-173144-16
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
Amendment No. 1
to
Form F-4
REGISTRATION
STATEMENT
UNDER
THE SECURITIES ACT OF
1933
ELAN FINANCE PUBLIC LIMITED
COMPANY
(Exact name of registrant as
specified in its charter)
|
|
|
|
|
Ireland
|
|
2834
|
|
98-0573539
|
(State or other jurisdiction
of
incorporation or organization)
|
|
(Primary Standard Industrial
Classification Code Number)
|
|
(I.R.S. Employer
Identification Number)
|
ELAN FINANCE CORP.
(Exact name of registrant as
specified in its charter)
|
|
|
|
|
Delaware
|
|
2834
|
|
20-2143397
|
(State or other jurisdiction
of
incorporation or organization)
|
|
(Primary Standard Industrial
Classification Code Number)
|
|
(I.R.S. Employer
Identification Number)
|
Treasury Building, Lower Grand Canal Street
Dublin 2, Ireland
011-353-1-709-4000
(Address, including zip code,
and telephone number, including area code, of Registrants
principal executive offices)
(See Table of Additional Registrants)
National Registered Agents, Inc.
875 Avenue of the Americas, Suite 501
New York, New York
10001
(800) 767-1553
(Name, address, including zip
code, and telephone number, including area code, of agent for
service)
Copy to:
Christopher T. Cox, Esq.
Cahill Gordon & Reindel LLP
80 Pine Street
New York, New York 10005
(212) 701-3000
Approximate date of commencement of proposed issuance of the
securities to the public: As soon as practicable
after this Registration Statement becomes effective.
If this Form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act,
check the following box and list the Securities Act registration
statement number of the earlier effective registration statement
for the same
offering. o
If this Form is a post-effective amendment filed pursuant to
Rule 462(d) under the Securities Act, check the following
box and list the Securities Act registration statement number of
the earlier effective registration statement for the same
offering. o
If applicable, place an X in the box to designate the
appropriate rule provision relied upon in conducting this
transaction:
Exchange Act
Rule 13e-4(i)
(Cross-Border Issuer Tender
Offer) o
Exchange Act
Rule 14d-1(d)
(Cross-Border Third-Party Tender
Offer) o
The Registrants hereby amend this Registration Statement on
such date or dates as may be necessary to delay its effective
date until the Registrants shall file a further amendment which
specifically states that this Registration Statement shall
thereafter become effective in accordance with Section 8(a)
of the Securities Act or until the Registration Statement shall
become effective on such date as the Securities and Exchange
Commission, acting pursuant to said Section 8(a), may
determine.
Additional
Registrants
|
|
|
|
|
|
|
|
|
|
|
State or Other
|
|
|
|
|
|
|
|
Jurisdiction of
|
|
Primary Standard
|
|
|
|
Exact Name of Registrant as
|
|
Incorporation
|
|
Industrial Classification
|
|
|
I.R.S. Employer
|
Specified in its Charter
|
|
or Organization
|
|
Code Number
|
|
|
Identification No.
|
|
Elan Corporation, plc
|
|
Ireland
|
|
|
2834
|
|
|
98-0487435
|
Elan Holdings Limited
|
|
Ireland
|
|
|
2834
|
|
|
98-0112748
|
Elan Management Limited
|
|
Ireland
|
|
|
2834
|
|
|
98-0464854
|
Elan Pharma International Limited
|
|
Ireland
|
|
|
2834
|
|
|
98-0551187
|
Elan Science Four Limited
|
|
Ireland
|
|
|
2834
|
|
|
Not Applicable
|
Elan Transdermal Limited
|
|
Ireland
|
|
|
2834
|
|
|
Not Applicable
|
The Institute of Biopharmaceutics, Limited
|
|
Ireland
|
|
|
2834
|
|
|
Not Applicable
|
Keavy Finance Limited
|
|
Ireland
|
|
|
2834
|
|
|
Not Applicable
|
Crimagua Limited
|
|
Ireland
|
|
|
2834
|
|
|
Not Applicable
|
Orchardbrook Limited
|
|
Ireland
|
|
|
2834
|
|
|
Not Applicable
|
Elan Pharma Limited
|
|
United Kingdom
|
|
|
2834
|
|
|
Not Applicable
|
Meadway Pharmaceuticals Ltd.
|
|
United Kingdom
|
|
|
2834
|
|
|
Not Applicable
|
The Liposome Company Limited
|
|
United Kingdom
|
|
|
2834
|
|
|
Not Applicable
|
Monksland Holdings B.V.
|
|
The Netherlands
|
|
|
2834
|
|
|
Not Applicable
|
Elan International Insurance Ltd.
|
|
Bermuda
|
|
|
2834
|
|
|
Not Applicable
|
Elan International Services Ltd.
|
|
Bermuda
|
|
|
2834
|
|
|
Not Applicable
|
Neuralab Limited
|
|
Bermuda
|
|
|
2834
|
|
|
Not Applicable
|
Athena Neurosciences, Inc.
|
|
Delaware
|
|
|
2834
|
|
|
33-0204761
|
Elan Drug Delivery, Inc.
|
|
Delaware
|
|
|
2834
|
|
|
75-2971178
|
Elan Holdings, Inc.
|
|
Massachusetts
|
|
|
2834
|
|
|
04-2903487
|
Elan Pharmaceuticals, Inc.
|
|
Delaware
|
|
|
2834
|
|
|
77-0128552
|
The address and telephone number of the other registrants is
c/o Elan
Corporation, plc, Treasury Building, Lower Grand Canal Street,
Dublin 2, Ireland,
011-353-1-709-4000.
The
information in this prospectus is not complete and may be
changed. We may not consummate the exchange offer until the
registration statement filed with the Securities and Exchange
Commission is effective. This prospectus is not an offer to sell
these securities and is not soliciting an offer to acquire these
securities in any state where the offer or sale is not
permitted.
|
SUBJECT TO COMPLETION DATED
JUNE 22, 2011
PROSPECTUS
Elan Finance public limited
company
and
Elan Finance Corp.
Offer to Exchange
up to
$200,000,000 Aggregate
Principal Amount of our outstanding
8.75% Senior Notes due
2016 (CUSIP Nos. 284138AL8 and G29543AF5)
Fully and Unconditionally
Guaranteed by
Elan Corporation, plc and
certain of its subsidiaries
for up to
$200,000,000 Aggregate
Principal Amount of 8.75% Senior Notes due 2016
Fully and Unconditionally
Guaranteed by
Elan Corporation, plc and
certain of its subsidiaries
and
Registered Under the Securities
Act of 1933, as amended.
We are conducting the exchange offer in order to provide you
with an opportunity to exchange your unregistered notes for
freely tradable notes that have been registered under the
Securities Act.
Material
Terms of Exchange Offer:
|
|
|
|
|
Expires 5:00 p.m., New York City time,
on ,
2011, unless extended.
|
|
|
|
Subject to certain customary conditions which may be waived by
us.
|
|
|
|
Any outstanding Notes not validly tendered will remain subject
to existing transfer restrictions.
|
|
|
|
All outstanding Notes that are validly tendered and not
withdrawn will be exchanged.
|
|
|
|
Tenders of outstanding Notes may be withdrawn any time prior to
the expiration of this exchange offer.
|
|
|
|
The exchange of the outstanding Notes will not be a taxable
exchange for U.S. tax purposes or for the purposes of Irish
tax on capital gains.
|
|
|
|
We will not receive any cash proceeds from the exchange offer.
|
|
|
|
The terms of the exchange Notes and guarantees to be issued in
exchange for the outstanding Notes and guarantees are
substantially identical to the outstanding Notes and guarantees,
except for certain transfer restrictions and registration rights
relating to the outstanding Notes.
|
See Risk Factors, beginning on page 8, for a
discussion of certain factors that should be considered by
holders before tendering their outstanding Notes in the exchange
offer.
There has not previously been any public market for the Notes
that will be issued in the exchange offer. We do not intend to
list the exchange Notes on any securities exchange or for
inclusion of the exchange Notes in any automated quotation
system. There can be no assurance that an active market for such
exchange Notes will develop.
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these
securities or passed upon the adequacy or accuracy of this
prospectus. Any representation to the contrary is a criminal
offense.
The date of this prospectus
is ,
2011.
This prospectus incorporates important business and financial
information that is not delivered with this prospectus. These
documents are available without charge to each person to whom
this prospectus is delivered upon the written or oral request of
such person to: Elan Corporation, plc, Treasury Building, Lower
Grand Canal Street, Dublin 2, Ireland,
011-353-1-709-400,
Attention: Company Secretary. In order to ensure timely delivery
of these documents, please make your request as soon as
practicable and, in any event, no later than five business days
prior to the expiration date of the exchange offer.
TABLE OF
CONTENTS
THIS PROSPECTUS DOES NOT CONSTITUTE AN OFFER TO SELL, OR A
SOLICITATION OF AN OFFER TO BUY OR EXCHANGE, ANY SECURITIES
OFFERED HEREBY, BY ANY PERSON IN ANY JURISDICTION IN WHICH IT IS
UNLAWFUL FOR SUCH PERSON TO MAKE SUCH AN OFFER OR SOLICITATION.
NEITHER THE DELIVERY OF THIS PROSPECTUS NOR ANY SALE MADE
HEREUNDER SHALL UNDER ANY CIRCUMSTANCES IMPLY THAT THERE HAS
BEEN NO CHANGE IN OUR AFFAIRS OR THE AFFAIRS OF ELAN OR ITS
OTHER SUBSIDIARIES OR THAT THE INFORMATION SET FORTH HEREIN IS
CORRECT AS OF ANY DATE SUBSEQUENT TO THE DATE HEREOF, REGARDLESS
OF THE TIME OF DELIVERY OF THIS PROSPECTUS OR OF ANY SALE OF THE
SECURITIES.
You should rely only on the information contained or
incorporated in this prospectus. Neither we nor Elan or its
other subsidiaries have authorized anyone to provide you with
information different from that contained or incorporated in
this prospectus. This document may only be used where it is
legal to sell these securities. The information in this document
may only be accurate on the date of this document.
Any broker-dealer that resells exchange Notes that were
received by it for its own account pursuant to the exchange
offer and any broker or dealer that participates in a
distribution of such exchange Notes may be deemed to be an
underwriter within the meaning of the Securities
Act. Any broker-dealer that receives exchange Notes for its own
account pursuant to the exchange offer must acknowledge that it
will deliver a prospectus in connection with any resale of such
exchange Notes. In addition, any profit of any such resale of
exchange Notes and any commissions or concessions received by
any such persons may be deemed to be underwriting compensation
under the Securities Act. The letter of transmittal
i
states that, by acknowledging that it will deliver and by
delivering a prospectus, a broker-dealer will not be deemed to
admit that it is an underwriter within the meaning
of the Securities Act. By acceptance of the exchange offer, each
broker-dealer that receives exchange Notes pursuant to the
exchange offer hereby agrees to notify us prior to using this
prospectus in connection with the sale or transfer of exchange
Notes, and acknowledges and agrees that, upon receipt of notice
from us of the happening of any event which makes any statement
in this prospectus untrue in any material respect or which
requires the making of any changes in this prospectus in order
to make the statements herein not misleading (which notice we
agree to deliver promptly to such broker-dealer), such
broker-dealer will suspend use of this prospectus until we have
amended or supplemented the prospectus to correct such
misstatement or omission and have furnished copies of the
amended or supplemented prospectus to such broker-dealer. See
Plan of Distribution.
ii
INCORPORATION
OF CERTAIN INFORMATION BY REFERENCE
The Securities and Exchange Commission (the
Commission or the SEC) allows us to
incorporate by reference the information we file with them,
which means that we can disclose important information to you by
referring to those documents. The information incorporated by
reference is considered to be part of this prospectus. The
following documents filed by Elan with the Commission are
incorporated herein by reference and shall be deemed to be a
part of this prospectus:
|
|
|
|
|
Elan Corporation, plcs Annual Report on
Form 20-F
for the year ended December 31, 2010, filed with the
Commission on February 24, 2011;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on February 3, 2011;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on February 8, 2011;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on February 9, 2011;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on February 10, 2011;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on February 23, 2011 relating
to Elans presentation at the Cowen and Company
31st Annual Health Care Conference;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on February 23, 2011 relating
to Elans global business relationship with PPD in drug
development;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on February 25, 2011 relating
to the
ABRAXANE®
settlement;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on February 25, 2011 relating
to the filing of Elans Annual Report on
Form 20-F
for year ended December 31, 2010;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on February 28, 2011;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on March 1, 2011;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission furnished on March 10, 2011;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on March 15, 2011;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on March 25, 2011, relating to
Elans Annual Report for the year ended December 31,
2010;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on March 25, 2011 relating to
Elans filing its Annual Report for year ended
December 31, 2010;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on April 6, 2011;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on April 18, 2011;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on April 19, 2011;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on April 20, 2011;
|
iii
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on April 28, 2011;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K furnished to the Commission on May 9, 2011;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on May 25, 2011;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on June 2, 2011 relating to
Elans presentation at Jefferies 2011 Global Healthcare
Conference;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on June 2, 2011 relating to the
appointment of principal accounting officer;
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on June 7, 2011; and
|
|
|
|
|
|
Elan Corporation, plcs Report of Foreign Private Issuer on
Form 6-K
furnished to the Commission on June 22, 2011.
|
All documents and reports filed by Elan with, or furnished by
Elan to, the Commission pursuant to Section 13(a), 13(c),
or 15(d) of the Securities Exchange Act of 1934, as amended (the
Exchange Act) after the date of this prospectus and
prior to the termination of this exchange offer shall be deemed
incorporated herein by reference and shall be deemed to be a
part hereof from the date of filing of such documents and
reports; provided that, with respect to any Report of
Foreign Private Issuer on
Form 6-K,
only those reports that are expressly designated therein as
being incorporated by reference into this prospectus shall be
deemed incorporated by reference herein. Any statement contained
in a document incorporated or deemed to be incorporated by
reference in this prospectus shall be deemed to be modified or
superseded for purposes of this document to the extent that a
statement contained herein or in any subsequently filed document
or report that also is or is deemed to be incorporated by
reference herein modifies or supersedes such statement. Any such
statement so modified or superseded shall not be deemed, except
as so modified or superseded, to constitute a part of this
document.
FORWARD-LOOKING
STATEMENTS
This prospectus contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
These statements relate to, among other things, our and
Elans financial condition, results of operations and
business prospects and the products in research that involve
substantial risks and uncertainties.
These forward-looking statements are identified by their use of
terms and phrases such as anticipate,
believe, could, estimate,
expect, intend, may,
plan, predict, project,
target, will and similar terms and
phrases, including references to assumptions. These statements
are contained in sections entitled Summary,
Risk Factors, and other sections of documents and
reports contained or incorporated in this prospectus.
These forward-looking statements involve known and unknown
risks, uncertainties and other factors that may cause actual
results to be materially different from those expected,
estimated or projected. Factors that could cause actual results
to differ materially from those expressed or implied in such
forward-looking statements include, but are not limited to:
|
|
|
|
|
the risks and uncertainties described in the Risk
Factors section of this prospectus;
|
|
|
|
any negative developments relating to
Tysabri®
(natalizumab), such as safety or efficacy issues
(including deaths and cases of progressive multifocal
leukoencephalopathy (PML)), the introduction or
greater acceptance of competing products, including biosimilars,
or adverse regulatory or legislative developments may reduce our
revenues and adversely affect our results of operations;
|
|
|
|
the potential for the successful development and
commercialization of additional products;
|
|
|
|
the effects of settlement with the U.S. government relating
to marketing practices with respect to our former
Zonegran®
(zonisamide) product, which required us to pay
$203.5 million in fines and to take other actions that
could have a material adverse effect on Elan;
|
iv
|
|
|
|
|
our ability to maintain financial flexibility and sufficient
cash, cash equivalents, and investments and other assets capable
of being monetized to meet our liquidity requirements;
|
|
|
|
whether restrictive covenants in our debt obligations will
adversely affect us;
|
|
|
|
our dependence on Johnson & Johnson and Pfizer Inc.
(Pfizer) for the development and potential commercialization,
and the funding potentially required from us for such
development and potential commercialization, of bapineuzumab and
any other potential products in the Alzheimers
Immunotherapy Program (AIP);
|
|
|
|
the success of our research and development (R&D)
activities and R&D activities in which we retain an
interest, including, in particular, whether the Phase 3 clinical
trials for bapineuzumab (AAB-001) are successful, and the speed
with which regulatory authorizations and product launches may be
achieved;
|
|
|
|
Johnson & Johnson is our largest shareholder with an
18.3% interest in our outstanding ordinary shares and is largely
in control of our remaining interest in the AIP;
Johnson & Johnsons interest in Elan and the AIP
may discourage others from seeking to work with or acquire us;
|
|
|
|
competitive developments, including the introduction of generic
or biosimilar competition following the loss of patent
protection or marketing exclusivity for a product; in particular
several of the products from which we derive manufacturing or
royalty revenues are under patent challenge by potential generic
competitors;
|
|
|
|
our ability to protect our patents and other intellectual
property;
|
|
|
|
difficulties or delays in manufacturing Tysabri (we are
dependent on Biogen Idec, Inc. for the manufacture of
Tysabri);
|
|
|
|
pricing pressures and uncertainties regarding healthcare
reimbursement and reform;
|
|
|
|
failure to comply with anti-kickback, bribery and false claims
laws in the United States and elsewhere;
|
|
|
|
extensive government regulation;
|
|
|
|
risks from potential environmental liabilities;
|
|
|
|
failure to comply with our reporting and payment obligations
under Medicaid or other government programs;
|
|
|
|
legislation affecting pharmaceutical pricing and reimbursement,
both in the United States and Europe;
|
|
|
|
exposure to product liability risks;
|
|
|
|
an adverse effect that could result from the putative class
action lawsuits alleging we disseminated false and misleading
statements related to bapineuzumab and the outcome of our other
pending or future litigation;
|
|
|
|
the volatility of our stock price;
|
|
|
|
some of our agreements that may discourage or prevent others
from acquiring us;
|
|
|
|
governmental laws and regulations affecting domestic and foreign
operations, including tax obligations;
|
|
|
|
general changes in U.S. generally accepted accounting
principles and IFRS; and
|
|
|
|
the impact of acquisitions, divestitures, restructurings,
product withdrawals and other unusual items.
|
A further list and description of these risks, uncertainties and
other matters can be found in Elans Annual Report on
Form 20-F
for the year ended December 31, 2010 incorporated by
reference herein. Neither we nor Elan assumes any obligation to
update any forward-looking statements, whether as a result of
new information, future events or otherwise.
If one or more of these risks or uncertainties materialize, or
if underlying assumptions prove incorrect, Elans and our
actual results may vary materially from those expected,
estimated or projected.
The information contained in this prospectus is a statement of
Elans and our present intention, beliefs or expectations
and is based upon, among other things, the existing regulatory
environment, industry conditions, market conditions and prices,
the economy in general and their and our assumptions. We or Elan
may change our or their intention, belief or expectation, at any
time and without notice, based upon any changes in such factors,
in our or their assumptions or otherwise. We do not undertake to
update the forward-looking statements or risk factors contained
or incorporated in this prospectus to reflect future events or
circumstances.
v
The cautionary statements contained in this prospectus should be
considered in connection with any subsequent written or oral
forward-looking statements that we, Elan or persons acting on
our or its behalf may issue. Neither we nor Elan or any of our
or its affiliates undertakes any obligation to review or confirm
analysts expectations or estimates or to release publicly
any revisions to any forward-looking statements to reflect
events or circumstances after the date hereof or to reflect the
occurrence of unanticipated events.
BASIS OF
PRESENTATION
Unless we indicate otherwise or the context otherwise requires,
in this prospectus when we refer to:
|
|
|
|
|
Elan, we are referring to Elan Corporation, plc and
its consolidated subsidiaries and their predecessors;
|
|
|
|
the Issuers, the Co-Issuers,
we, our and us, we are
referring to Elan Finance public limited company and Elan
Finance Corp., collectively, as the co-issuers of the Notes;
|
|
|
|
the outstanding Notes, we mean the outstanding
8.75% Senior Notes due 2016, which were issued in a private
offering on August 17, 2010;
|
|
|
|
the exchange Notes in this prospectus we mean the
new Notes we intend to issue to you if you exchange your
outstanding Notes;
|
|
|
|
the Notes, we mean, before the consummation of the
exchange offer, the outstanding Notes, and, after the
consummation of the exchange offer, the exchange Notes.
|
NOTICE
REGARDING SERVICE OF PROCESS AND ENFORCEMENT OF
JUDGMENTS
A MAJORITY OF THE DIRECTORS AND EXECUTIVE OFFICERS OF THE
ISSUERS, ELAN AND THE SUBSIDIARY GUARANTORS ARE NON-RESIDENTS OF
THE UNITED STATES. ALL OR A SUBSTANTIAL PORTION OF THE ASSETS OF
SUCH NON-RESIDENT PERSONS AND OF THE ISSUERS, ELAN AND THE
SUBSIDIARY GUARANTORS ARE LOCATED OUTSIDE THE UNITED STATES. AS
A RESULT, IT MAY NOT BE POSSIBLE FOR INVESTORS TO EFFECT SERVICE
OF PROCESS WITHIN THE UNITED STATES UPON SUCH PERSONS OR THE
ISSUERS, ELAN AND THE SUBSIDIARY GUARANTORS, OR TO ENFORCE
AGAINST THEM IN U.S. COURTS JUDGMENTS OBTAINED IN SUCH
COURTS PREDICATED UPON THE CIVIL LIABILITY PROVISIONS OF THE
FEDERAL SECURITIES LAWS OF THE UNITED STATES. THE ISSUERS, ELAN
AND THE SUBSIDIARY GUARANTORS HAVE BEEN ADVISED BY COUNSEL THAT
THERE IS DOUBT AS TO THE ENFORCEABILITY IN IRELAND IN ORIGINAL
ACTIONS OR IN ACTIONS FOR ENFORCEMENT OF JUDGMENTS OF
U.S. COURTS, OF LIABILITIES PREDICATED SOLELY UPON THE
SECURITIES LAWS OF THE UNITED STATES.
WHERE YOU
CAN FIND MORE INFORMATION
Elan is required to file annual and current reports, proxy
statements and other information with the Commission, which are
available to the public over the Internet at the
Commissions website at
http://www.sec.gov.
You may also read and copy any document Elan files at the
Commissions public reference room at
100 F Street, N.E., Washington, D.C. 20549. You
may call the Commission at
1-800-SEC-0330
for further information on the public reference room.
You may request a copy of these filings and other reports
furnished to the Commission at no cost, by writing or
telephoning Elan at:
Elan
Corporation, plc
Treasury Building
Lower Grand Canal Street
Dublin 2, Ireland
Attention: Investor Relations
Tel:
353-1-709-4000
vi
SUMMARY
The following summary highlights selected information from
this prospectus and may not contain all of the information that
is important to you. We urge you to read carefully this entire
prospectus and the other documents incorporated by reference in
this prospectus to understand fully the terms of the exchange
offer.
Elan
For a description of Elan, please read the information set forth
in Item 4 Information on the
Company in Elans Annual Report on
Form 20-F
for the year ended December 31, 2010.
The
Co-Issuers
Elan Finance public limited company was formed on
October 19, 2004 as a public limited company organized
under the laws of Ireland and is a wholly owned subsidiary of
Elan. Elan Finance public limited company received the net
proceeds from the original sale of the outstanding Notes and
will make all payments of principal and interest on the Notes.
Elan Finance Corp. was formed on October 25, 2004 as a
Delaware corporation, is a wholly owned subsidiary of Elan
Finance public limited company, has only nominal assets, does
not currently conduct any operations, did not receive any
proceeds from the sale of the outstanding Notes and was formed
solely to act as a co-issuer in connection with our prior note
issuances, including the outstanding Notes and the exchange
Notes offered hereby.
1
SUMMARY
OF THE EXCHANGE OFFER
|
|
|
Registration Rights; Effect of Not Exchanging |
|
You are entitled to exchange your outstanding Notes for freely
tradeable exchange Notes with substantially identical terms. The
exchange offer is intended to satisfy your exchange rights.
After the exchange offer is complete, you will no longer be
entitled to any exchange or registration rights with respect to
your outstanding Notes. Accordingly, if you do not exchange your
outstanding Notes, you will not be able to reoffer, resell or
otherwise dispose of your outstanding Notes unless you comply
with the registration and prospectus delivery requirements of
the Securities Act, or there is an exemption available. |
|
The Exchange Offer |
|
We are offering to exchange $1,000 principal amount of each of
our new 8.75% Senior Notes due 2016, all of which have been
registered under the Securities Act, for $1,000 principal amount
of our outstanding restricted unregistered 8.75% Senior
Notes due 2016, which were issued in a private offering on
August 17, 2010. As of the date of this prospectus, there
are $200.0 million aggregate principal amount at maturity
of outstanding Notes. We will issue exchange Notes promptly
after the expiration of the exchange offer. |
|
Resales |
|
We believe that the exchange Notes issued in the exchange offer
may be offered for resale, resold or otherwise transferred by
you without compliance with the registration and prospectus
delivery requirements of the Securities Act, provided
that: |
|
|
|
you are acquiring the exchange Notes in the ordinary
course of your business;
|
|
|
|
you are not participating, do not intend to
participate and have no arrangement or understanding with any
person to participate in a distribution of the exchange Notes;
|
|
|
|
you are not an Affiliate, as defined in
Rule 405 of the Securities Act, of ours or any guarantor of
the Notes; and
|
|
|
|
you are not a broker-dealer tendering outstanding
Notes that you acquired directly from us for your own account.
|
|
|
|
If you do not meet any of the above criteria you will have to
comply with the registration and prospectus delivery
requirements of the Securities Act in connection with any
reoffer, resale or other disposition of your exchange Notes. |
|
|
|
Each broker or dealer that receives exchange Notes for its own
account in exchange for outstanding Notes that were acquired as
a result of market-making or other trading activities must
acknowledge that it will deliver this prospectus in connection
with any sale of exchange Notes. |
|
Expiration Date |
|
5:00 p.m., New York City time,
on ,
2011, unless we extend the expiration date. |
|
Conditions to the Exchange Offer |
|
The exchange offer is subject to certain customary conditions,
which may be waived by us. The exchange offer is not conditioned
upon any minimum principal amount of outstanding Notes being |
2
|
|
|
|
|
tendered. See The Exchange Offer Conditions to
the Exchange Offer. |
|
Procedures for Tendering Outstanding Notes |
|
If you wish to tender outstanding Notes, you must
(i) complete, sign and date the letter of transmittal, or a
facsimile of it, in accordance with its instructions and
transmit the letter of transmittal, together with your Notes to
be exchanged and any other required documentation, to The Bank
of New York Mellon, who is the exchange agent, at the address
set forth in the letter of transmittal to arrive by
5:00 p.m., New York City time, on the expiration date or
(ii) arrange for The Depository Trust Company
(DTC) to transmit certain required information,
including an agents message forming part of a book-entry
transfer in which you agree to be bound by the terms of the
letter of transmittal, to the exchange agent in connection with
a book-entry transfer. See The Exchange Offer
Procedures for Tendering Outstanding Notes. By executing
the letter of transmittal or making arrangements with DTC as
described above, you will represent to us that, among other
things: |
|
|
|
any exchange Note you receive will be acquired
in the ordinary course of your business;
|
|
|
|
you are not engaged in, and do not intend to
engage in, a distribution of the exchange Notes;
|
|
|
|
you have no arrangement or understanding with
any person to participate in the distribution of the exchange
Notes; and
|
|
|
|
you are not an Affiliate, as
defined in Rule 405 of the Securities Act, of ours or of
any of the guarantors of the Notes, or if you are an affiliate,
you will comply with the registration and prospectus delivery
requirements of the Securities Act to the extent applicable. If
you are a broker-dealer that will receive exchange Notes for
your own account, you must:
|
|
|
|
represent that you have no arrangement or
understanding with the co-issuers or any of their affiliates to
distribute the exchange Notes;
|
|
|
|
represent that the outstanding Notes to be
exchanged for exchange Notes were acquired by you as a result of
market-making or other trading activities; and
|
|
|
|
acknowledge that you will deliver a prospectus
in connection with any resale of exchange Notes received in
exchange for the outstanding Notes acquired by you as a result
of market-making or other trading activities, provided
that you may use this prospectus, as it may be amended or
supplemented from time to time.
|
|
|
|
See The Exchange Offer Procedures for
Tendering Outstanding Notes. |
|
Special Procedures for Beneficial Holders |
|
If you are the beneficial holder of outstanding Notes that are
registered in the name of your broker, dealer, commercial bank,
trust company or other nominee, and you wish to tender in the
exchange |
3
|
|
|
|
|
offer, you should contact the person in whose name your
outstanding Notes are registered promptly and instruct such
person to tender on your behalf. See The Exchange
Offer Procedures for Tendering Outstanding
Notes. |
|
Guaranteed Delivery Procedures |
|
If you wish to tender your outstanding Notes, and you cannot
deliver such outstanding Notes, the letter of transmittal or any
other required documents to the exchange agent before the
expiration date or the procedures for book-entry transfer cannot
be completed on time, you may tender your outstanding Notes
according to the guaranteed delivery procedures set forth in
The Exchange Offer Guaranteed Delivery
Procedures. |
|
Withdrawal Rights |
|
Tenders may be withdrawn at any time before 5:00 p.m., New
York City time, on the expiration date. See The Exchange
Offer Withdrawal Rights. |
|
Acceptance of Outstanding Notes and Delivery of
Exchange Notes |
|
Subject to certain conditions, we will accept for exchange any
and all outstanding Notes which are properly tendered in the
exchange offer before 5:00 p.m., New York City time, on the
expiration date. The exchange Notes will be delivered promptly
after the expiration date. See The Exchange
Offer Terms of the Exchange Offer. |
|
Certain U.S. Federal Income Tax Considerations |
|
The exchange of outstanding Notes for exchange Notes will not be
a taxable event for U.S. federal income tax purposes. You will
not recognize any taxable gain or loss as a result of exchanging
outstanding Notes for exchange Notes, and you will have the same
tax basis and holding period in the exchange Notes as you had in
the outstanding Notes immediately before the exchange. See
Certain U.S. Federal Income Tax Consequences. |
|
Irish Capital Gains Tax Considerations |
|
The exchange of outstanding Notes for exchange Notes will not be
a disposal for Irish capital gains tax purposes, as the exchange
Notes represent substituted evidence of the indebtedness
originally represented by the outstanding Notes. Any holder
subject to Irish capital gains tax on any disposal of the
exchange Notes would retain the base cost and date of
acquisition of the outstanding Notes for the purposes of
calculating any gain on that subsequent disposal. |
|
Use of Proceeds |
|
We will not receive any proceeds from the issuance of the
exchange Notes. |
|
Exchange Agent |
|
The Bank of New York Mellon is serving as exchange agent in
connection with the exchange offer. The address, telephone
number and facsimile number of the exchange agent are set forth
in The Exchange Offer Exchange Agent. |
4
SUMMARY
OF THE EXCHANGE NOTES
The following summary is provided solely for your
convenience. This summary is not intended to be complete. You
should read the full text and more specific details contained
elsewhere in this prospectus. Unless we indicate otherwise or
the context otherwise requires, in this summary, the exchange
Notes are referred to as the Notes. For a more
detailed description of the Notes and definitions of some of the
terms used in this summary, see Description of the
Exchange Notes.
|
|
|
Co-Issuers |
|
Elan Finance public limited company, a public limited company
organized under the laws of Ireland and a direct wholly owned
subsidiary of Elan, and Elan Finance Corp., a Delaware
corporation and a direct wholly owned subsidiary of Elan Finance
public limited company. |
|
Guarantors |
|
Elan and each of its existing and future material restricted
subsidiaries other than the Co-Issuers will fully and
unconditionally guarantee the Notes on a senior unsecured basis.
See Description of the Exchange Notes Note
Guarantees and Risk Factors Risks
Related to the Notes and the Exchange Offer Not all
of Elans subsidiaries will guarantee the Notes and the
assets of the non-guarantor subsidiaries may not be available to
Elan for payment on its guarantee of the Notes. |
|
Securities Offered |
|
$200.0 million aggregate principal amount of
8.75% Senior Notes due 2016 which have been registered
under the Securities Act. |
|
Maturity |
|
The Notes will mature on October 15, 2016. |
|
Interest |
|
The Notes will bear interest at the rate of 8.75% per annum,
paid every six months on April 15 and October 15,
commencing
on ,
2011. With respect to the initial interest payment on the Notes,
interest on each Note will accrue from the last interest payment
date on which interest was paid on the outstanding Note
surrendered in exchange therefor or, if no interest has been
paid on such outstanding Note, from the date of the original
issuance of such outstanding Note. For subsequent interest
payments, interest will accrue from and including the most
recent interest payment date (whether or not such interest
payment date was a business day) for which interest has been
paid or provided for to but excluding the relevant interest
payment date. |
|
Denomination |
|
Notes in denominations of $100,000 and any integral multiple of
$1,000 in excess of $100,000. Notes in denominations of less
than $100,000 will not be available. |
|
Ranking |
|
The Notes will be our senior unsecured obligations and will rank
equally in right of payment with all of our existing and future
senior unsecured indebtedness and senior to our existing and
future subordinated indebtedness. The Notes will be effectively
subordinated to all of our secured indebtedness to the extent of
the value of the assets securing that indebtedness. As of
December 31, 2010, Elan had $1,285.0 million of
outstanding indebtedness (aggregate principal amount of debt
outstanding, not including trade payables). The guarantee of the
Notes by each guarantor, including Elan, will be the senior
unsecured obligation of such guarantor and will rank equally in
right of payment with all existing and future senior unsecured
indebtedness of such guarantor and senior to the existing and |
5
|
|
|
|
|
future subordinated indebtedness of Elan and the subsidiary
guarantors. The guarantee of the Notes by each guarantor will be
effectively subordinated to all secured indebtedness of such
guarantor, to the extent of the value of the assets securing
that indebtedness. |
|
Optional Redemption |
|
At any time prior to October 15, 2012, we may redeem the
Notes, in whole but not in part, at a price equal to 100% of
their principal amount plus a make-whole premium plus accrued
and unpaid interest. We may redeem the Notes, in whole or in
part, beginning on October 15, 2012 at an initial
redemption price of 108.750% of their principal amount plus
accrued and unpaid interest. |
|
|
|
At any time beginning November 30, 2011 and on or prior to
October 15, 2012, we may redeem up to 35% of the Notes
using the proceeds of certain equity offerings as described
herein under Description of the Exchange Notes
Optional Redemption. |
|
|
|
The Notes will also contain a tax redemption provision, as
further described in Description of the Exchange
Notes Optional Redemption Tax
Redemption. |
|
Mandatory Offer to Repurchase |
|
Upon the occurrence of certain change of control events
described under Description of the Exchange
Notes Change of Control, you may require us to
repurchase some or all of your Notes at 101% of their principal
amount plus accrued and unpaid interest to the date of
repurchase. The occurrence of those events may, however, be an
event of default under other debt agreements we or Elan may be a
party to at such time, and those agreements may prohibit the
repurchase. Further, neither we nor Elan can assure you that we
or Elan will have sufficient resources to satisfy the repurchase
obligation. You should read carefully the sections entitled
Risk Factors Risks Related to the Notes and
the Exchange Offer We may be unable to purchase the
Notes upon a change of control and Description of
the Exchange Notes Change of Control. In
addition, to the extent we, Elan or a restricted subsidiary
receive proceeds from the sale of certain assets and do not
apply the proceeds of any such asset sale in the manner set
forth in the indenture, we may be required to make an offer to
purchase an aggregate amount of Notes and certain other pari
passu indebtedness equal to the amount of such unapplied
proceeds. |
|
Certain Covenants |
|
The indenture governing the Notes contains covenants limiting,
subject to various exceptions, our ability and the ability of
Elan and its other restricted subsidiaries to: |
|
|
|
incur additional debt;
|
|
|
|
make certain types of investments;
|
|
|
|
make certain sales of assets or engage in sale and
leaseback transactions;
|
|
|
|
pay dividends on capital stock;
|
|
|
|
create liens;
|
|
|
|
engage in transactions with affiliates, except on an
arms-length basis; or
|
6
|
|
|
|
|
consolidate or merge with, or sell assets
substantially as an entirety to, another person.
|
|
|
|
You should read Description of the Exchange
Notes Certain Covenants for a description of
these covenants and exceptions. |
|
|
|
During the time, if any, that the Notes are rated investment
grade by both Standard & Poors Ratings Group and
Moodys Investors Service, Inc. and certain other
conditions are met, many of the restrictive covenants contained
in the indenture governing the Notes will cease to be in effect.
See Description of the Exchange Notes Certain
Covenants Covenant Suspension. |
|
Book-Entry, Form, Registration and Transfer of the Notes |
|
Notes will be represented by one or more registered global notes
without interest coupons (the Global Notes). The
Global Notes will be deposited upon issuance with the Trustee as
custodian for The Depository Trust Company
(DTC) in New York, New York and registered in the
name of DTC or its nominee for credit to an account of a direct
or indirect participant in DTC. Beneficial interests in a Global
Note (Book-Entry Interests) will be shown on, and
transfers thereof effective only through, the records maintained
in book-entry form by DTC and its participants. See
Book-Entry. |
|
|
|
Except in the limited circumstances described herein, Notes in
certificated form will not be issued in exchange for Book-Entry
Interests. See Book-Entry. |
|
Risk Factors |
|
See Risk Factors and the other information in this
prospectus for a discussion of certain factors you should
carefully consider before deciding to invest in the Notes. |
|
Original Issue Discount |
|
Because the outstanding notes were issued with original issue
discount (OID), for U.S. federal income tax
purposes, the exchange Notes will be treated as having been
issued with such OID. Holders subject to U.S. Federal Income
Tax, whether on the cash or accrual method of tax accounting,
will be required to include amounts representing OID in gross
income (as ordinary income) on a constant yield to maturity
basis for U.S. federal income tax purposes in advance of the
receipt of cash payments to which such income is attributable.
For a further discussion, see Certain U.S. Federal Income
Tax Consequences. |
|
Trustee |
|
The Bank of New York Mellon. |
7
RISK
FACTORS
You should carefully consider the risks described below and
the other information appearing elsewhere in this prospectus and
the additional factors set forth under Item 3.D Key
Information Risk Factors in Elans Annual
Report on
Form 20-F
for the year ended December 31, 2010 (incorporated herein
by reference), before making an investment decision or
exchanging your Notes in this Exchange Offer. The risks
described below and in Elans Annual Report on
Form 20-F
for the year ended December 31, 2010 are intended to
highlight risks that are specific to Elan, but are not the only
risks that Elan faces. Additional risks, including those
generally affecting the industry in which Elan operates, risks
that Elan currently deems immaterial and risks and uncertainties
generally applicable to companies that have recently undertaken
transactions similar to this offering, may also impair
Elans business, the value of your investment and our
ability to pay interest on, and repay or refinance, the Notes
and the guarantees thereon. Unless we indicate otherwise or the
context otherwise requires, the exchange Notes are referred to
herein as the Notes.
Risks
Related to the Notes and the Exchange Offer
Elan
has substantial debt. The principal and interest payment
obligations of such debt may restrict Elans future
operations and impair Elans ability to provide us with the
funding necessary to allow us to meet our obligations under the
Notes. Elans indebtedness may also restrict Elans
and the guarantor subsidiaries ability to perform under
their respective guarantees. Despite Elans current
leverage, we, Elan and its other subsidiaries may still be able
to incur substantially more debt. This could further exacerbate
these risks.
As of December 31, 2010, Elan had $1,285.0 million of
outstanding indebtedness (aggregate principal amount of debt
outstanding, not including trade payables) on its consolidated
balance sheet, none of which was secured.
Elans and its subsidiaries substantial indebtedness
could have important consequences to you. For example, it could:
|
|
|
|
|
make it more difficult for us and Elan to satisfy our and
Elans obligations with respect to the Notes and the
guarantees, respectively;
|
|
|
|
increase Elans vulnerability to general adverse economic
and industry conditions;
|
|
|
|
require Elan to dedicate a substantial portion of its cash flow
from operations to payments on its indebtedness, thereby
reducing the availability of its cash flow to fund working
capital, capital expenditures, acquisitions and investments and
other general corporate purposes;
|
|
|
|
limit Elans flexibility in planning for, or reacting to,
changes in its business and the markets in which it operates;
|
|
|
|
place Elan at a competitive disadvantage compared to its
competitors that have less debt; and
|
|
|
|
limit Elans ability to borrow additional funds.
|
Elans ability to satisfy its debt obligations and to
reduce its total debt depends on its future operating
performance and on economic, financial, competitive and other
factors, many of which are beyond its control. Elans
business may not generate sufficient cash flow, and future
financings may not be available to provide sufficient net
proceeds, to meet these obligations or to successfully execute
its business strategy.
In addition, we, Elan and its other subsidiaries may incur
substantial additional indebtedness in the future. The terms of
the indenture governing the Notes permit the incurrence of
additional debt subject to certain limitations. If new debt is
added to current debt levels, the related risks described above
could intensify. Furthermore, the terms of the indenture
governing the Notes restrict the ability of Elan and its
restricted subsidiaries to make certain investments and to pay
dividends on capital stock. See Description of the
Exchange Notes Certain Covenants
Limitation on Restricted Payments. Any amount paid as a
restricted payment may not be available to satisfy obligations
with respect to the Notes and the guarantees.
8
Not
all of Elans subsidiaries will guarantee the Notes and the
assets of the non-guarantor subsidiaries may not be available to
Elan for payment on its guarantee of the Notes.
The Notes will not be guaranteed by (a) certain
subsidiaries of Elan which, for the year ended December 31,
2010, generated approximately 2% of Elans consolidated net
loss and, at December 31, 2010, held approximately 20% of
Elans total assets, and (b) future subsidiaries
organized outside the United States or Ireland if the provision
of such guarantee would result in a material adverse tax
consequence to Elan. Non-guarantor subsidiaries have no
obligation to make payments to Elan in respect of Elans or
its other subsidiaries guarantee of the Notes. In the
event of a bankruptcy, liquidation or reorganization of any
non-guarantor subsidiary of Elan, the creditors of such
subsidiary (including trade creditors) will generally be
entitled to payment of their claims from the assets of such
subsidiary before any assets are made available for distribution
to Elan as a shareholder of such subsidiary. Elan may not have
sufficient assets to be able to make payments on its guarantee
of the Notes. As a result, the Notes and the guarantees of the
Notes by Elan and the subsidiary guarantors are effectively
junior to the obligations of Elans non-guarantor
subsidiaries.
The
Notes will be effectively subordinated to our future secured
debt and other secured obligations, and the guarantees of the
Notes will be effectively subordinated to the guarantors
future secured debt and other secured obligations.
Our obligations under the Notes, and the obligations of our
guarantors, including Elan, under their guarantees of the Notes
are unsecured, but our and each guarantors obligations
under future debt could be secured by a security interest in
substantially all of our and our guarantors tangible and
intangible assets and the assets and the stock of Elans
subsidiaries. If we or any of the guarantors, including Elan, is
declared bankrupt or insolvent, or defaults under future secured
debt obligations, the lenders thereunder could declare all of
the funds borrowed thereunder, together with accrued interest,
immediately due and payable. If we or any of the guarantors,
including Elan, are unable to repay such future secured
indebtedness, the lenders of the secured debt could foreclose on
the pledged assets to the exclusion of holders of the Notes,
even if an event of default exists at such time under the
indenture governing the Notes. Furthermore, if such lenders
foreclose and sell the pledged equity interests in any
subsidiary guarantor under the Notes, then that guarantor will
be released from its guarantee of the Notes automatically and
immediately upon such sale. In any such event, because the Notes
will not be secured by any of our or our guarantors assets
or the equity interests in Elans subsidiaries, it is
possible that there would be no assets remaining from which your
claims could be satisfied or, if any assets remained, they might
be insufficient to satisfy your claims fully.
The
indenture governing the Notes contains various covenants which
limit Elans managements discretion in the operation
of Elans business.
The indenture governing the Notes contains various provisions
that restrict Elans and its restricted subsidiaries
ability to:
|
|
|
|
|
incur additional debt;
|
|
|
|
make certain types of investments;
|
|
|
|
make certain asset sales or engage in sale and leaseback
transactions;
|
|
|
|
pay dividends on capital stock;
|
|
|
|
create liens;
|
|
|
|
engage in transactions with affiliates, except on an
arms-length basis; or
|
|
|
|
consolidate or merge with, or sell assets substantially as an
entirety to, another person.
|
Any failure to comply with the restrictions of the indenture
governing the Notes or any other existing or subsequent
financing agreements may result in an event of default under
those agreements. Such default may allow the creditors, if the
agreements so provide, to accelerate the related debt as well as
any other debt to which a cross-acceleration or cross-default
provision applies. In addition, lenders may be able to terminate
any
9
commitments they had made to supply us with further funds. Even
if Elan is able to obtain new financing, it may not be on
commercially reasonable terms or terms that are acceptable to
Elan. In addition, complying with these covenants may also cause
Elan to take actions that are not favorable to holders of the
Notes and may make it more difficult for Elan to successfully
execute its business strategies and compete against companies
that are not subject to such restrictions.
During
the time the Notes are rated investment grade, many of the
restrictive covenants will cease to be in effect.
During the time, if any, that the Notes are rated investment
grade, by both Standard & Poors Ratings Group
and Moodys Investors Service, Inc. and certain other
conditions are met, many of the restrictive covenants contained
in the indenture governing the Notes will cease to be in effect.
See Description of the Exchange Notes Certain
Covenants Covenant Suspension.
We
have nominal net worth and will depend on contributions from
Elan and its other subsidiaries to fulfill our obligations under
the Notes.
Both Elan Finance public limited company and Elan Finance Corp.
have nominal net worth. Our ability to service our debt
obligations, including our ability to pay the interest on and
principal of the Notes when due, will be dependent upon cash
dividends and distributions or other transfers from Elan and its
other subsidiaries. Payments to us by Elan and its other
subsidiaries will be contingent upon their respective earnings
and subject to any limitations on the ability of such entities
to make payments or other distributions to us. Elan and its
other subsidiaries are separate and distinct legal entities and
have no obligation, other than under inter-company loan
agreements, the guarantee of the Notes and guarantees of certain
of our other indebtedness, to make any funds available to us. In
addition, under U.S. federal and foreign bankruptcy laws
and comparable provisions of state and foreign fraudulent
transfer laws, our incurrence of joint and several liability in
respect of each others obligations under the Notes could
be voided if the circumstances described in the following risk
factor were applicable to either of us.
A
guarantee of the Notes by Elan or its subsidiaries may be
voidable, subordinated or limited in scope under laws governing
fraudulent transfers and insolvency or under laws governing
corporate authority.
Under U.S. federal and foreign bankruptcy laws and
comparable provisions of state and foreign fraudulent transfer
laws, a guarantee of the Notes by Elan or its subsidiaries could
be voided if, among other things, at the time Elan or the
subsidiary guarantor issued its guarantee, Elan or such
subsidiary guarantor:
|
|
|
|
|
intended to hinder, delay or defraud any present or future
creditor by making such guarantee; and
|
|
|
|
received less than reasonably equivalent value or fair
consideration for the incurrence of such indebtedness and:
|
|
|
|
|
|
was insolvent or rendered insolvent by reason of such incurrence;
|
|
|
|
was engaged in a business or transaction for which such
subsidiary guarantors remaining assets constituted
unreasonably small capital; or
|
|
|
|
intended to incur, or believed that it would incur, debts beyond
its ability to pay such debts as they mature.
|
The measures of insolvency for purposes of the foregoing
considerations will vary depending upon the law applied in any
proceeding with respect to the foregoing. Generally, however, an
entity in the United States would be considered insolvent if:
|
|
|
|
|
the sum of its debts, including contingent liabilities, was
greater than the saleable value of all of its assets;
|
10
|
|
|
|
|
the present fair saleable value of its assets was less than the
amount that would be required to pay its probable liabilities on
its existing debts, including contingent liabilities, as they
become absolute and mature; or
|
|
|
|
it was generally not paying or could not pay its debts as they
became due.
|
We cannot be certain as to the standards a court would use to
determine whether or not Elan or the subsidiary guarantors were
solvent at the relevant time. If the guarantees were legally
challenged, any guarantee could also be subject to the claim
that, since the guarantee was incurred for our benefit and only
indirectly for the benefit of the applicable guarantor, the
obligations of the applicable guarantor were incurred for less
than reasonably equivalent value or fair consideration. A court
could thus void the obligations under the guarantees,
subordinate them to the applicable guarantors other debt
or take other action detrimental to the holders of the Notes.
A guarantee may only be issued where the entity issuing the
guarantee receives sufficient commercial benefit for doing so.
If there is insufficient commercial benefit, the beneficiary of
the guarantee may not be able to rely on the authority of the
directors of that entity to grant the guarantee and accordingly
a court may set aside the guarantee at the request of the
entitys shareholders or a liquidator. The board of
directors of Elan and each of the subsidiary note guarantors has
passed a resolution that the entry into the guarantee is in each
of their best interests and for each of their corporate benefit.
However, no assurance can be given that a court would agree with
their conclusion in this regard.
If a court voided any guarantee or any payment under any
guarantee of the Notes as a result of a fraudulent transfer or
held it unenforceable for any other reason, the right of holders
of the Notes under the guarantee would be seriously undermined
and such holders could cease to have any claim against the
applicable guarantor under its guarantee of the Notes. Although
each guarantee will contain a provision intended to limit the
guarantors liability to the maximum amount that it could
incur without causing the incurrence of obligations under its
guarantee to be a fraudulent transfer, this provision may not be
effective to protect the guarantees from being voided under
fraudulent transfer laws. In a recent Florida bankruptcy case,
this kind of provision was found to be ineffective to protect
the guarantees.
Many of Elans subsidiaries, including many of the
subsidiary guarantors, are incorporated in jurisdictions other
than Ireland and the United States and are subject to the
insolvency, bankruptcy and corporation laws of such other
jurisdictions. The insolvency, bankruptcy and corporation laws
of these jurisdictions may differ materially from those of
Ireland and those of the United States. In addition, there can
be no assurance as to how the insolvency, bankruptcy or
corporation laws of the various jurisdictions in which Elan
operates will be applied in relation to one another.
There
may be no public market for the Notes.
The exchange Notes are new securities for which there currently
is no established public market. The outstanding Notes have been
listed on the Irish Stock Exchange, and it is intended that the
exchange Notes will replace the outstanding Notes on the Irish
Stock Exchange. We cannot assure you that the exchange Notes
will become listed on the Irish Stock Exchange or remain listed
on any exchange. In addition, we cannot assure as to:
|
|
|
|
|
the development of a public market for the exchange Notes;
|
|
|
|
the liquidity of any such market that may develop;
|
|
|
|
your ability to sell your exchange Notes; or
|
|
|
|
the price at which you would be able to sell your exchange Notes.
|
If such a market were to exist for the exchange Notes, the
exchange Notes could trade at prices that may be lower than the
principal amount or your purchase price, depending on many
factors, including prevailing interest rates, the market for
similar securities and our financial performance.
11
Enforcing
your rights under the guarantees entered into by certain of our
foreign subsidiaries across multiple jurisdictions may be
difficult.
The Co-Issuers of the Notes are a public limited company
incorporated in the Republic of Ireland and a
U.S. corporation incorporated in the State of Delaware,
respectively. The Notes are guaranteed by most of our existing
and future material subsidiaries, including subsidiaries in the
United States, Bermuda and Ireland. In the event of bankruptcy,
insolvency or a similar event, proceedings could be initiated in
any of these jurisdictions and in the jurisdiction of
organization of any future guarantor of the Notes. Your rights
under the Notes and the guarantees will thus be subject to the
laws of several jurisdictions, and you may not be able to
effectively enforce your rights in multiple bankruptcy,
insolvency and other similar proceedings. Moreover, such
multi-jurisdictional proceedings are typically complex and
costly for creditors and often result in substantial uncertainty
and delay in the enforcement of creditors rights.
We may
be unable to purchase the Notes upon a change of
control.
Upon a change of control, we may be required to offer to
purchase all of the Notes then outstanding for cash at 101% of
the principal amount thereof plus accrued and unpaid interest.
If a change of control were to occur, we may not have sufficient
funds to pay the change of control purchase price and we may be
required to obtain third-party financing in order to do so.
However, we may not be able to obtain such financing on
commercially reasonable terms, or at all. Our failure following
a change of control to make or consummate an offer to purchase
the Notes would constitute an event of default under the
indenture governing the Notes. In such an event, the trustee or
the holders of at least 25% in aggregate principal amount of the
outstanding Notes may accelerate the maturity of all of the
Notes.
The change of control provisions in the indenture governing the
Notes may not protect you in the event we consummate a highly
leveraged transaction, reorganization, restructuring, merger or
other similar transaction, unless such transaction constitutes a
change of control under the indenture governing the Notes. Such
a transaction may not involve a change in voting power or
beneficial ownership or, even if it does, may not involve a
change of the magnitude required under the definition of change
of control in the indenture governing the Notes to trigger our
obligation to offer to repurchase the Notes. Except as described
in Description of the Exchange Notes Change of
Control, the indenture governing the Notes does not
contain provisions that permit the holders of the Notes to
require us to repurchase or redeem the Notes in the event of a
takeover, recapitalization or similar transaction.
A recent Delaware Chancery Court decision raised questions about
the enforceability of repurchase obligations, which are similar
to those in the indenture, related to the triggering of a change
of control as a result of a change in the composition of a board
of directors. Accordingly, the effectiveness of the provisions
of the indenture that require us to repurchase Notes as a result
of certain changes in the composition of directors on our board
of directors may be uncertain.
The
exchange Notes will be issued with OID for U.S. federal income
tax purposes.
The exchange Notes will be treated as having OID for
U.S. federal income tax purposes because the outstanding
notes were issued with OID. Holders subject to U.S. Federal
Income Tax, whether on the cash or accrual method of tax
accounting, will be required to include amounts representing OID
in gross income (as ordinary income) on a constant yield to
maturity basis for U.S. federal income tax purposes in
advance of the receipt of cash payments to which such income is
attributable. For a further discussion, see Certain
U.S. Federal Income Tax Consequences.
If
Elan is unable to pay its debts, an examiner may be appointed
under Irish law to oversee Elans operations.
If Elan is unable, or likely to be unable, to pay its debts, an
examiner may be appointed to oversee Elans operations and
to facilitate its survival and the whole or any part of its
business by formulating proposals for a compromise or scheme of
arrangement. An examiner may be appointed even if Elan is not
insolvent. If an examiner has been appointed to Elan or any of
its subsidiaries, the examinership may be extended to Elan and
12
any of its related companies, including us, even if we are not
ourselves insolvent. There can be no assurance that we would be
exempt from an extension of the examinership.
If an examiner is appointed to Elan, a protection period,
generally not exceeding 100 days, will be imposed so that
the examiner can formulate and implement his proposals for a
compromise or scheme or arrangement. During the protection
period, any enforcement action by a creditor is prohibited. In
addition, Elan would be prohibited from paying any debts
existing at the time of the presentation of the petition to
appoint an examiner. The appointment of an examiner may restrict
the ability of Elan to make timely payments under its guarantees
and holders of the Notes may be unable to enforce their rights
under the guarantees. During the course of examinership, rights
of the holders of the Notes under the guarantees may be affected
by the examiners exercise of his powers to, for example,
repudiate a restriction or prohibition on further borrowings or
the creation of security.
Preferred
creditors under Irish law.
In an insolvency of an Irish company, the claims of certain
preferential creditors (including the Irish Revenue
Commissioners for certain unpaid taxes) will rank in priority to
claims of unsecured creditors.
If the Issuers become subject to an insolvency proceeding and
the Issuers have obligations to creditors that are treated under
Irish law as creditors that are senior relative to the holders
of the Notes, the holders of the Notes may suffer losses as a
result of their subordinated status during such insolvency
proceeding.
Your
failure to tender the outstanding Notes in the exchange offer
may affect their marketability.
If outstanding Notes are tendered for exchange Notes and
accepted in the exchange offer, the trading market, if any, for
the untendered but unaccepted outstanding Notes will be
adversely affected. Your failure to participate in the exchange
offer will substantially limit, and may effectively eliminate,
opportunities to sell your outstanding Notes in the future.
We issued the outstanding Notes in a private offering exempt
from the registration requirements of the Securities Act.
Accordingly, you may not offer, sell or otherwise transfer your
outstanding Notes except in compliance with the registration
requirements of the Securities Act and any other applicable
securities laws, or pursuant to an exemption from the securities
laws, or in a transaction not subject to the securities laws. If
you do not exchange your outstanding Notes for exchange Notes in
the exchange offer, or if you do not properly tender your
outstanding Notes in the exchange offer, your outstanding Notes
will continue to be subject to these transfer restrictions after
the completion of the exchange offer. In addition, after the
completion of the exchange offer, you will no longer be able to
obligate us to register the outstanding Notes under the
Securities Act.
Your
outstanding Notes will not be accepted for exchange if you fail
to follow the exchange offer procedures and, as a result, your
outstanding Notes will continue to be subject to the transfer
restrictions on your outstanding Notes and you may not be able
to sell your outstanding Notes.
We will not accept your outstanding Notes for exchange if you do
not follow the exchange offer procedures. We will issue you
exchange Notes as part of the exchange offer only after timely
receipt of your outstanding Notes, a properly completed and duly
executed letter of transmittal and all other required documents.
Therefore, if you want to tender your outstanding Notes, please
allow sufficient time to ensure timely delivery. If we do not
receive your outstanding Notes, letter of transmittal and other
required documents by the expiration date of the exchange offer,
we will not accept your outstanding Notes for exchange. If you
do not properly tender your outstanding Notes for exchange Notes
in the exchange offer, you will continue to be subject to the
restrictions on the transfer of your outstanding Notes. If you
do not properly tender your outstanding Notes for exchange
Notes, you may not offer, sell or otherwise transfer your
outstanding Notes except in compliance with the registration
requirements of the Securities Act and any other applicable
securities laws, or pursuant to an exemption from the securities
laws, or in a transaction not subject to the securities laws. We
are under no duty to give notification of defects or
irregularities with respect to the tenders
13
of outstanding Notes for exchange. If there are defects or
irregularities with respect to your tender of outstanding Notes,
we will not accept your outstanding Notes for exchange.
If you
are a broker-dealer, your ability to transfer the exchange Notes
may be restricted.
A broker-dealer that purchased outstanding Notes for its own
account as part of market-making or trading activities must
comply with the prospectus delivery requirements of the
Securities Act when it sells the exchange Notes. Our obligation
to make this prospectus available to broker-dealers is limited.
Consequently, we cannot guarantee that a current prospectus will
be available to broker-dealers wishing to resell their exchange
Notes.
14
USE OF
PROCEEDS
The exchange offer is intended to satisfy certain of our
obligations under the registration rights agreement. We will not
receive any cash proceeds from the exchange offer.
The net proceeds from the original sale of the outstanding Notes
were approximately $187.1 million, after deduction of
discounts and expenses payable by us in connection with the
original offering. We used the net proceeds from the sale of the
outstanding Notes for the redemption of certain debt, to pay
fees and expenses incurred in connection with the original
offering and the redemption and for general corporate purposes.
15
THE
EXCHANGE OFFER
Purpose
and Effect of the Exchange Offer
Exchange Offer Registration Statement. We
issued the outstanding Notes on August 17, 2010. The
initial purchasers of the Notes originally issued have advised
us that they subsequently resold the outstanding Notes to
qualified institutional buyers in reliance on
Rule 144A under the Securities Act and to certain persons
in offshore transactions in reliance on Regulation S under
the Securities Act. As a condition to the offering of the
outstanding Notes, we entered into a registration rights
agreement dated August 17, 2010, pursuant to which we
agreed, for the benefit of all holders of the outstanding Notes,
at our own expense, to:
|
|
|
|
|
file this registration statement of which this prospectus is a
part as soon as practicable after the date the Notes were
originally issued but in no event later than March 31, 2011
(such date of filing, the first filing date);
|
|
|
|
use our commercially reasonable efforts to cause the
registration statement to be declared effective under the
Securities Act within 150 days after the first filing date
and in any event no later than 15 business days following
notification from the Commission that the registration statement
will not be subject to review or that the Commission has no
further comments to the registration statement; and
|
|
|
|
use our commercially reasonable efforts to consummate the
registered exchange offer within 30 days after the
registration statement has been declared effective by the
Commission.
|
Further, we agreed to keep the exchange offer open not less than
20 business days after the date we mailed notice of the exchange
offer to holders of the outstanding Notes. For each outstanding
Note validly tendered pursuant to the exchange offer and not
withdrawn, the holder of the outstanding Note will receive an
exchange Note having a principal amount equal to that of the
tendered outstanding Note. Interest on each exchange Note will
accrue from the last date on which interest was paid on the
tendered outstanding Note in exchange therefor or, if no
interest was paid on such outstanding Note, from the issue date.
The following is a summary of the registration rights agreement.
It does not purport to be complete and it does not contain all
of the information you might find useful. For further
information you should read the registration rights agreement, a
copy of which has been filed as an exhibit to the registration
statement. The exchange offer is intended to satisfy certain of
our obligations under the registration rights agreement.
Transferability. We issued the outstanding
Notes on August 17, 2010 in a transaction exempt from the
registration requirements of the Securities Act and applicable
state securities laws. Accordingly, the outstanding Notes may
not be offered or sold in the United States unless registered or
pursuant to an applicable exemption under the Securities Act and
applicable state securities laws. Based on no-action letters
issued by the staff of the Commission with respect to similar
transactions, we believe that the exchange Notes issued pursuant
to the exchange offer in exchange for outstanding Notes may be
offered for resale, resold and otherwise transferred by holders
of Notes who are not our affiliates without further compliance
with the registration and prospectus delivery requirements of
the Securities Act, provided that:
(1) any exchange Notes to be received by the holder were
acquired in the ordinary course of the holders business;
(2) at the time of the commencement of the exchange offer
the holder has no arrangement or understanding with any person
to participate in the distribution (within the meaning of the
Securities Act) of the exchange Notes;
(3) the holder is not an Affiliate of Elan, as
defined in Rule 405 under the Securities Act, or, if it is
an affiliate, that it will comply with the registration and
prospectus delivery requirements of the Securities Act to the
extent applicable; and
(4) you are not a broker-dealer tendering outstanding Notes
acquired directly from us for your own account.
16
However, we have not sought a no-action letter with respect to
the exchange offer, and we cannot assure you that the staff of
the Commission would make a similar determination with respect
to the exchange offer. Any holder who tenders his outstanding
Notes in the exchange offer with any intention of participating
in a distribution of exchange Notes (1) cannot rely on the
interpretation by the staff of the Commission, (2) will not
be able to validly tender outstanding Notes in the exchange
offer and (3) must comply with the registration and
prospectus delivery requirements of the Securities Act in
connection with any secondary resale transactions.
In addition, each broker-dealer that receives exchange Notes for
its own account pursuant to the exchange offer must acknowledge
that it will deliver a prospectus in connection with any resale
of such exchange Notes. The letter of transmittal accompanying
this prospectus states that by so acknowledging and by
delivering a prospectus, a broker-dealer will not be deemed to
admit that it is acting in the capacity of an
underwriter within the meaning of Section 2(11)
of the Securities Act. This prospectus, as it may be amended or
supplemented from time to time, may be used by a broker-dealer
in connection with resales of exchange Notes received in
exchange for outstanding Notes where the outstanding Notes were
acquired by such broker-dealer as a result of market-making
activities or other trading activities. Pursuant to the
registration rights agreement, we agreed to make this prospectus
available to any such broker-dealer for use in connection with
any such resale.
Shelf Registration Statement. In the event
that we determine that we cannot effect the exchange offer or
that the exchange offer may not be consummated as soon as
practicable after the last date on which Notes are accepted for
exchange because it would violate applicable law or applicable
interpretations of the staff of the Commission, we do not
consummate the exchange offer within 180 days of the first
filing date, we do not consummate the exchange offer on or
before the date that is 30 days after the 15 business
days following notification from the Commission that the
registration statement will not be subject to review, or if the
exchange offer has been completed and in the opinion of counsel
for the initial purchasers a registration statement must be
filed and a prospectus must be delivered by the initial
purchasers in connection with any offering or sale of Notes that
constitute part of an unsold allotment, we will use
our commercially reasonable efforts to file as soon as
practicable thereafter a shelf registration statement providing
for resales of the Notes, to have such shelf registration
statement declared effective by the Commission and to keep that
shelf registration statement continuously effective until the
expiration of the period referred to in Rule 144(b)(1) with
respect to such Notes, or such shorter period that will
terminate when all Notes covered by the shelf registration
statement have been sold pursuant thereto. We will, in the event
of such a shelf registration, provide to each holder of the
Notes copies of the related prospectus or any amendment thereto,
notify each holder of the Notes when the shelf registration
statement or any amendment thereto has become effective and take
certain other actions to permit resales of the Notes. A holder
of the Notes that sells Notes under the shelf registration
statement generally will be required to make certain
representations to us (as described in the registration rights
agreement), to be named as a selling security holder in the
related prospectus and to deliver a prospectus to purchasers,
will be subject to certain of the civil liability provisions
under the Securities Act in connection with those sales and will
be bound by the provisions of the registration rights agreement
that are applicable to such a holder of the Notes (including
certain indemnification obligations).
In the case of a shelf registration statement, each holder will
be required, upon the occurrence of any event that makes any
statement made in the shelf registration statement untrue in any
material respect or which requires the making of any changes in
the shelf registration statement or related prospectus in order
to make the statements therein not misleading and following
receipt of notice from us, to stop selling Notes pursuant to the
shelf registration statement until it receives an amended
prospectus. We may also delay the effectiveness or filing of any
shelf registration statement upon the occurrence of such event.
If we provide any such notice to suspend the shelf registration
statement, we will thereafter extend the period during which the
shelf registration statement must be maintained effective by the
number of days during the period from the date such notice is
given and ending on the date when holders have received copies
of the supplemented or amended prospectus. We may give any such
notice or cause such delay only twice during any
365-day
period, any such suspension may not exceed 30 days and
there may not be more than two suspensions in effect during any
365-day
period. The period of such suspension is referred to as a
black-out period. If we fail to keep the shelf
registration statement effective at any time other than in a
black-out period, the annual interest rate
17
borne by the Notes will be increased by 1.0% per annum until
such shelf registration statement becomes and remains effective
as described above.
If the exchange offer is not completed on or before the date
that is 180 days after the first filing date or
30 days after the 15 business days following
notification from the Commission that the registration statement
will not be subject to review or, if required, the shelf
registration statement is not declared effective on or before
the date that is 180 days after the first filing date, the
annual interest rate borne by the Notes will be increased by
1.0% per annum until the exchange offer is completed or the
shelf registration, if required, is declared effective.
If we effect the exchange offer, we will be entitled to close
the exchange offer 20 business days after its commencement,
provided that we have accepted all Notes validly
surrendered in accordance with the terms of the exchange offer.
Notes not tendered in the exchange offer shall bear interest at
the rate set forth on the cover page of this prospectus and be
subject to all the terms and conditions specified in the
indenture governing the Notes, including transfer restrictions.
This summary of the provisions of the registration rights
agreement does not purport to be complete and is subject to, and
is qualified in its entirety by reference to, all the provisions
of the registration rights agreement, a copy of which is
available in the manner set forth under Where You Can Find
More Information.
Terms of
the Exchange Offer
Upon satisfaction or waiver of all the conditions of the
exchange offer, we will accept any and all outstanding Notes
properly tendered and not withdrawn prior to the expiration date
and will issue the exchange Notes promptly after acceptance of
the outstanding Notes. See Conditions to the
Exchange Offer and Procedures for
Tendering Outstanding Notes. We will issue exchange Notes
in minimum denominations of $100,000 and integral multiples of
$1000 in excess thereof in exchange for each equivalent
principal amount of outstanding Notes accepted in the exchange
offer. As of the date of this prospectus, $200,000,000 aggregate
principal amount of our 8.75% Senior Notes due 2016 issued
August 17, 2010 are outstanding. Holders may tender some or
all of their outstanding Notes pursuant to the exchange offer.
However, outstanding Notes may be tendered only in minimum
denominations of $100,000 and integral multiples of $1000 in
excess thereof.
The exchange Notes are identical to the outstanding Notes except
for the elimination of certain transfer restrictions,
registration rights, restrictions on holding Notes in
certificated form and liquidated damages provisions. The
exchange Notes will evidence the same debt as the outstanding
Notes and will be issued pursuant to, and entitled to the
benefits of, the indenture pursuant to which the outstanding
Notes were issued and will be deemed one issue of Notes,
together with the outstanding Notes.
This prospectus, together with the letter of transmittal, is
being sent to all registered holders and to others believed to
have beneficial interests in the outstanding Notes. Holders of
outstanding Notes do not have any appraisal or dissenters
rights under the indenture in connection with the exchange
offer. We intend to conduct the exchange offer in accordance
with the applicable requirements of the Securities Act, the
Exchange Act and the rules and regulations of the Commission
promulgated thereunder.
For purposes of the exchange offer, we will be deemed to have
accepted validly tendered outstanding Notes when, and if, we
have given oral or written notice thereof to the exchange agent.
The exchange agent will act as our agent for the purpose of
distributing the exchange Notes from us to the tendering
holders. If we do not accept any tendered outstanding Notes
because of an invalid tender, the occurrence of certain other
events set forth in this prospectus or otherwise, we will return
the unaccepted outstanding Notes, without expense, to the
tendering holder thereof as promptly as practicable after the
expiration date.
Holders who tender outstanding Notes in the exchange offer will
not be required to pay brokerage commissions or fees or, except
as set forth below under Transfer Taxes,
transfer taxes with respect to the exchange of outstanding Notes
pursuant to the exchange offer. We will pay all charges and
expenses, other than certain applicable taxes, in connection
with the exchange offer. See Fees and
Expenses.
18
Expiration
Date; Extensions; Amendments
The term expiration date shall mean 5:00 p.m.,
New York City time,
on ,
2011, unless we, in our sole discretion, extend the exchange
offer, in which case the term expiration date shall
mean the latest date and time to which the exchange offer is
extended. In order to extend the exchange offer, we will notify
the exchange agent by oral or written notice and each registered
holder by means of press release or other public announcement of
any extension, in each case, prior to 9:00 a.m., New York
City time, on the next business day after the previously
scheduled expiration date. We reserve the right, in our sole
discretion, (1) to delay accepting all tendered outstanding
Notes, (2) to extend the exchange offer, (3) to
terminate the exchange offer if the conditions set forth below
under Conditions to the Exchange Offer
shall not have been satisfied, or (4) to amend the terms of
the exchange offer in any manner. We will notify the exchange
agent of any delay, extension, termination or amendment by oral
or written notice and will issue a press release or other public
announcement. We will additionally issue a press release or
otherwise notify each registered holder of any amendment. We
will give to the exchange agent written confirmation of any oral
notice.
Exchange
Date
As soon as practicable after the close of the exchange offer we
will accept for exchange all outstanding Notes properly tendered
and not validly withdrawn prior to 5:00 p.m., New York City
time, on the expiration date in accordance with the terms of
this prospectus and the letter of transmittal.
Conditions
to the Exchange Offer
Notwithstanding any other provisions of the exchange offer, and
subject to our obligations under the registration rights
agreement, we (1) shall not be required to accept any
outstanding Notes for exchange, (2) shall not be required
to issue exchange Notes in exchange for any outstanding Notes
and (3) may terminate or amend the exchange offer if, at
any time before the acceptance of such Notes for exchange, any
of the following events shall occur:
(1) any injunction, order or decree shall have been issued
by any court or any governmental agency that would prohibit,
prevent or otherwise materially impair our ability to proceed
with the exchange offer;
(2) any change, or any development involving a prospective
change, in Elans or our business or financial affairs or
any of Elans or our respective subsidiaries has occurred
which, in our sole judgment, might materially impair our ability
to proceed with the exchange offer or materially impair the
contemplated benefits of the exchange offer to us;
(3) any law, statute, rule or regulation is proposed,
adopted or enacted which, in our sole judgment, might materially
impair our ability to proceed with the exchange offer or
materially impair the contemplated benefits of the exchange
offer to us;
(4) any governmental approval has not been obtained, which
approval we shall, in our sole discretion, deem necessary for
the consummation of the exchange offer as contemplated
hereby; or
(5) the exchange offer will violate any applicable law or
any applicable interpretation of the staff of the Commission.
The foregoing conditions are for our sole benefit and may be
asserted by us regardless of the circumstances giving rise to
any such condition or may be waived by us in whole or in part at
any time and from time to time in our sole discretion. Our
failure at any time to exercise any of the foregoing rights
shall not be deemed a waiver of any such right and such right
shall be deemed an ongoing right which may be asserted at any
time and from time to time.
In addition, we will not accept for exchange any outstanding
Notes tendered, and no exchange Notes will be issued in exchange
for any such outstanding Notes if at such time any stop order
shall be threatened by the Commission or be in effect with
respect to the registration statement of which this prospectus
is a part or the qualification of the indenture under the
Trust Indenture Act of 1939, as amended.
19
The exchange offer is not conditioned on any minimum aggregate
principal amount of outstanding Notes being tendered for
exchange.
Consequences
of Failure to Exchange
Any outstanding Notes not tendered pursuant to the exchange
offer will remain outstanding and continue to accrue interest.
The outstanding Notes will remain restricted
securities within the meaning of the Securities Act.
Accordingly, prior to the date that is one year after the later
of the issue date and the last date on which we or any of our
affiliates was the owner of the outstanding Notes, the
outstanding Notes may be resold only (1) to us, (2) to
a person who the seller reasonably believes is a qualified
institutional buyer purchasing for its own account or for
the account of another qualified institutional buyer
in compliance with the resale limitations of Rule 144A,
(3) pursuant to the limitations on resale provided by
Rule 144 under the Securities Act, (4) pursuant to the
resale provisions of Rule 904 of Regulation S under
the Securities Act, (5) pursuant to an effective
registration statement under the Securities Act or
(6) pursuant to any other available exemption from the
registration requirements of the Securities Act, subject in each
of the foregoing cases to compliance with applicable state
securities laws. As a result, the liquidity of the market for
non-tendered outstanding Notes could be adversely affected upon
completion of the exchange offer. The foregoing restrictions on
resale will no longer apply after the first anniversary of the
issue date of the outstanding Note or the purchase of the
outstanding Notes from us or an affiliate.
Fees and
Expenses
We will not make any payments to brokers, dealers or others
soliciting acceptances of the exchange offer. The principal
solicitation is being made by mail; however, additional
solicitations may be made in person or by telephone by our
officers and employees.
Expenses incurred in connection with the exchange offer will be
paid by us. Such expenses include, among others, the fees and
expenses of the trustee and the exchange agent, accounting and
legal fees, printing costs and other miscellaneous fees and
expenses.
Accounting
Treatment
We will not recognize any gain or loss for accounting purposes
upon the consummation of the exchange offer. We will amortize
the expenses of the exchange offer as additional interest
expense over the term of the exchange Notes.
Procedures
for Tendering Outstanding Notes
The tender of outstanding Notes pursuant to any of the
procedures set forth in this prospectus and in the letter of
transmittal will constitute a binding agreement between the
tendering holder and us in accordance with the terms and subject
to the conditions set forth in this prospectus and in the letter
of transmittal. The tender of outstanding Notes will constitute
an agreement to deliver good and marketable title to all
tendered outstanding Notes prior to the expiration date free and
clear of all liens, charges, claims, encumbrances, interests and
restrictions of any kind.
Except as provided in Guaranteed Delivery
Procedures, unless the outstanding Notes being tendered
are deposited by you with the exchange agent prior to the
expiration date and are accompanied by a properly completed and
duly executed letter of transmittal, we may, at our option,
reject the tender. Issuance of exchange Notes will be made only
against deposit of tendered outstanding Notes and delivery of
all other required documents. Notwithstanding the foregoing, DTC
participants tendering through its Automated Tender Offer
Program (ATOP) will be deemed to have made valid
delivery where the exchange agent receives an agents
message prior to the expiration date.
20
Accordingly, to properly tender outstanding Notes, the following
procedures must be followed:
Notes held through a Custodian. Each
beneficial owner holding outstanding Notes through a DTC
participant must instruct the DTC participant to cause its
outstanding Notes to be tendered in accordance with the
procedures set forth in this prospectus.
Notes held through DTC. Pursuant to an
authorization given by DTC to the DTC participants, each DTC
participant holding outstanding Notes through DTC must
(1) electronically transmit its acceptance through ATOP,
and DTC will then edit and verify the acceptance, execute a
book-entry delivery to the exchange agents account at DTC
and send an agents message to the exchange agent for its
acceptance, or (2) comply with the guaranteed delivery
procedures set forth below and in a notice of guaranteed
delivery. See Guaranteed Delivery
Procedures Notes held through DTC.
The exchange agent will (promptly after the date of this
prospectus) establish accounts at DTC for purposes of the
exchange offer with respect to outstanding Notes held through
DTC. Any financial institution that is a DTC participant may
make book-entry delivery of interests in outstanding Notes into
the exchange agents account through ATOP. However,
although delivery of interests in the outstanding Notes may be
effected through book-entry transfer into the exchange
agents account through ATOP, an agents message in
connection with such book-entry transfer, and any other required
documents, must be, in any case, transmitted to and received by
the exchange agent at its address set forth under
Exchange Agent, or the guaranteed
delivery procedures set forth below must be complied with, in
each case, prior to the expiration date. Delivery of documents
to DTC does not constitute delivery to the exchange agent. The
confirmation of a book-entry transfer into the exchange
agents account at DTC as described above is referred to
herein as a Book-Entry Confirmation.
The term agents message means a message,
transmitted by DTC to, and received by, the exchange agent and
forming a part of a book-entry confirmation, which states that
DTC has received an express acknowledgment from each tendering
DTC participant tendering through ATOP that such DTC
participants have received a letter of transmittal and agree to
be bound by the terms of the letter of transmittal and that we
may enforce such agreement against such DTC participants.
Cede & Co., as the registered owner of the global
notes, will instruct The Bank of New York Mellon, or book-entry
depositary and custodian, to tender a portion of the global
notes equal to the aggregate principal amount due at the stated
maturity for which instructions to tender are given by DTC
participants.
By tendering, each holder and each DTC participant will
represent to us that, among other things, (1) it is not our
affiliate, (2) it is not a broker-dealer tendering
outstanding Notes acquired directly from us for its own account,
(3) it is acquiring the exchange Notes in its ordinary
course of business and (4) it is not engaged in, and does
not intend to engage in, and has no arrangement or understanding
with any person to participate in, a distribution of the
exchange Notes.
We will not accept any alternative, conditional, irregular or
contingent tenders (unless waived by us). By executing a letter
of transmittal or transmitting an acceptance through ATOP, as
the case may be, each tendering holder waives any right to
receive any notice of the acceptance for purchase of its
outstanding Notes.
We will resolve all questions as to the validity, form,
eligibility (including time of receipt) and acceptance of
tendered outstanding Notes, and such determination will be final
and binding. We reserve the absolute right to reject any or all
tenders that are not in proper form or the acceptance of which
may, in the opinion of our counsel, be unlawful. We also reserve
the absolute right to waive any condition to the exchange offer
and any irregularities or conditions of tender as to particular
outstanding Notes. Our interpretation of the terms and
conditions of the exchange offer (including the instructions in
the letter of transmittal) will be final and binding. Unless
waived, any irregularities in connection with tenders must be
cured within such time as we shall determine. We, along with the
exchange agent, shall be under no duty to give notification of
defects in such tenders and shall not incur liabilities for
failure to give such notification. Tenders of outstanding Notes
will not be deemed to have been made until such irregularities
have been cured or waived. Any outstanding Notes received by the
exchange agent that are not properly tendered and as to which
the irregularities have not
21
been cured or waived will be returned by the exchange agent to
the tendering holder, unless otherwise provided in the letter of
transmittal, as soon as practicable following the expiration
date.
LETTERS OF TRANSMITTAL AND OUTSTANDING NOTES MUST BE SENT
ONLY TO THE EXCHANGE AGENT. DO NOT SEND LETTERS OF TRANSMITTAL
OR OUTSTANDING NOTES TO US OR DTC.
The method of delivery of outstanding Notes, letters of
transmittal, any required signature guaranties and all other
required documents, including delivery through DTC and any
acceptance through ATOP, is at the election and risk of the
persons tendering and delivering acceptances or letters of
transmittal and, except as otherwise provided in the applicable
letter of transmittal, delivery will be deemed made only when
actually received by the exchange agent. If delivery is by mail,
it is suggested that the holder use properly insured, registered
mail with return receipt requested, and that the mailing be made
sufficiently in advance of the expiration date to permit
delivery to the exchange agent prior to the expiration date.
Guaranteed
Delivery Procedures
Notes held through DTC. DTC participants
holding outstanding Notes through DTC who wish to cause their
outstanding Notes to be tendered, but who cannot transmit their
acceptances through ATOP prior to the expiration date, may cause
a tender to be effected if:
(1) guaranteed delivery is made by or through a firm or
other entity identified in Rule 17Ad-15 under the Exchange Act,
including:
|
|
|
|
|
a bank;
|
|
|
|
a broker, dealer, municipal securities dealer, municipal
securities broker, government securities dealer or government
securities broker;
|
|
|
|
a credit union;
|
|
|
|
a national securities exchange, registered securities
association or clearing agency; or
|
|
|
|
a savings institution that is a participant in a Securities
Transfer Association recognized program;
|
(2) prior to the expiration date, the exchange agent
receives from any of the above institutions a properly completed
and duly executed notice of guaranteed delivery (by mail, hand
delivery, facsimile transmission or overnight courier)
substantially in the form provided with this prospectus; and
(3) book-entry confirmation and an agents message in
connection therewith are received by the exchange agent within
three NYSE trading days after the date of the execution of the
notice of guaranteed delivery.
Notes held by Holders. Holders who wish to
tender their outstanding Notes but (1) whose outstanding
Notes are not immediately available and will not be available
for tendering prior to the expiration date or (2) who
cannot deliver their outstanding Notes, the letter of
transmittal, or any other required documents to the exchange
agent prior to the expiration date, may effect a tender if:
|
|
|
|
|
the tender is made by or through any of the above-listed
institutions;
|
|
|
|
prior to the expiration date, the exchange agent receives from
any above-listed institution a properly completed and duly
executed notice of guaranteed delivery, whether by mail, hand
delivery, facsimile transmission or overnight courier,
substantially in the form provided with this prospectus; and
|
|
|
|
a properly completed and executed letter of transmittal, as well
as the certificate(s) representing all tendered outstanding
Notes in proper form for transfer, and all other documents
required by the letter of transmittal, are received by the
exchange agent within three NYSE trading days after the date of
the execution of the notice of guaranteed delivery.
|
22
Withdrawal
Rights
You may withdraw tenders of outstanding Notes, or any portion of
your outstanding Notes, in integral multiples of $1,000
principal amount due at the stated maturity, at any time prior
to 5:00 p.m., New York City time, on the expiration date.
Any outstanding Notes properly withdrawn will be deemed to be
not validly tendered for purposes of the exchange offer.
Notes held through DTC. DTC participants
holding outstanding Notes who have transmitted their acceptances
through ATOP may, prior to 5:00 p.m. New York City time, on
the expiration date, withdraw the instruction given thereby with
a notice to DTC specifying the name and number of the DTC
participant and the principal amount due at the stated maturity
of outstanding Notes to which such withdrawal relates. Holders
must comply with procedures for the Notes.
Notes held by Holders. Holders may withdraw
their tender of outstanding Notes, prior to 5:00 p.m., New
York City time, on the expiration date, by delivering to the
exchange agent, at its address set forth under
Exchange Agent, a written, telegraphic
or facsimile notice of withdrawal. Any such notice of withdrawal
must (1) specify the name of the person who tendered the
outstanding Notes to be withdrawn, (2) contain a
description of the outstanding Notes to be withdrawn and
identify the certificate number or numbers shown on the
particular certificates evidencing such outstanding Notes and
the aggregate principal amount due at the stated maturity
represented by such outstanding Notes and (3) be signed by
the holder of such outstanding Notes in the same manner as the
original signature on the letter of transmittal by which such
outstanding Notes were tendered (including any required
signature guaranties), or be accompanied by (x) documents
of transfer in a form acceptable to us, in our sole discretion,
and (y) a properly completed irrevocable proxy that
authorized such person to effect such revocation on behalf of
such holder. If the outstanding Notes to be withdrawn have been
delivered or otherwise identified to the exchange agent, a
signed notice of withdrawal is effective immediately upon
written, telegraphic or facsimile notice of withdrawal even if
physical release is not yet effected.
All signatures on a notice of withdrawal must be guaranteed by a
recognized participant in the Securities Transfer Agents
Medallion Program, the New York Stock Exchange Medallion
Signature Program or the Stock Exchange Medallion Program;
provided, however, that signatures on the notice
of withdrawal need not be guaranteed if the outstanding Notes
being withdrawn are held for the account of any of the
institutions listed above under Guaranteed
Delivery Procedures.
A withdrawal of an instruction or a withdrawal of a tender must
be executed by a DTC participant or a holder of outstanding
Notes, as the case may be, in the same manner as the
persons name appears on its transmission through ATOP or
letter of transmittal, as the case may be, to which such
withdrawal relates. If a notice of withdrawal is signed by a
trustee, partner, executor, administrator, guardian,
attorney-in-fact, agent, officer of a corporation or other
person acting in a fiduciary or representative capacity, such
person must so indicate when signing and must submit with the
revocation appropriate evidence of authority to execute the
notice of withdrawal. A DTC participant or a holder may withdraw
an instruction or a tender, as the case may be, only if such
withdrawal complies with the provisions of this prospectus.
A withdrawal of a tender of outstanding Notes by a DTC
participant or a holder, as the case may be, may be rescinded
only by a new transmission of an acceptance through ATOP or
execution and delivery of a new letter of transmittal, as the
case may be, in accordance with the procedures described herein.
23
Exchange
Agent
The Bank of New York Mellon has been appointed as exchange agent
for the exchange offer. Questions, requests for assistance and
requests for additional copies of this prospectus or of the
letter of transmittal should be directed to the exchange agent
addressed as follows:
The Bank of New York Mellon
Corporate Trust Operations
Reorganization Unit
480 Washington Boulevard 27th Floor
Jersey City, New Jersey 07310
Attn: Mrs. Carolle Montreuil
Telephone:
(212) 815-5920
Facsimile:
(212) 298-1915
The exchange agent also acts as trustee under the indenture.
Transfer
Taxes
Holders of outstanding Notes who tender their outstanding Notes
for exchange Notes will not be obligated to pay any transfer
taxes in connection therewith, except that holders who instruct
us to register exchange Notes in the name of, or request that
outstanding Notes not tendered or not accepted in the exchange
offer be returned to, a person other than the registered
tendering holder will be responsible for the payment of any
applicable transfer tax thereon.
24
CAPITALIZATION
The following table sets forth Elans capitalization in
accordance with generally accepted accounting principles in the
United States as of December 31, 2010.
You should read the following table in conjunction with
Elans consolidated financial statements and related notes
thereto and the information set forth in
Item 5 Operating and Financial Review and
Prospects in its Annual Report on
Form 20-F
for the year ended December 31, 2010.
|
|
|
|
|
|
|
As of
|
|
|
|
December 31, 2010
|
|
|
|
(US GAAP)
|
|
|
|
(In millions)
|
|
|
Principal amount of debt, including current maturities:
|
|
|
|
|
8.875% Notes due 2013
|
|
$
|
449.5
|
|
Floating Rate Notes due 2013
|
|
|
10.5
|
|
8.75% Notes issued October 2009
|
|
|
625.0
|
|
8.75% Notes issued August 2010
|
|
|
200.0
|
|
|
|
|
|
|
Total principal amount of debt(1)
|
|
|
1,285.0
|
|
Shareholders equity
|
|
|
194.3
|
|
|
|
|
|
|
Total liabilities and shareholders equity
|
|
$
|
1,479.3
|
|
|
|
|
|
|
|
|
|
(1) |
|
The carrying value of debt on the Consolidated Balance Sheet in
Elans Annual Report on
Form 20-F
for the year ended December 31, 2010 is net of unamortized
original issue discount of $14.6 million. |
25
DESCRIPTION
OF OTHER DEBT
For a more detailed description of Elans other debt and
obligations, refer to Note 22 to Elans consolidated
financial statements included in its Annual Report on
Form 20-F
for the year ended December 31, 2010.
26
DESCRIPTION
OF THE EXCHANGE NOTES
We initially issued the Notes under an indenture (the
Indenture) dated August 17, 2010 among
Elan Finance public limited company and Elan Finance Corp., as
co-issuers (together, the Issuer), Elan
Corporation, plc, as a guarantor of the Notes (the
Company), the Subsidiary Note Guarantors
named therein and The Bank of New York Mellon, as Trustee (the
Trustee), in a private transaction that was
not subject to the registration requirements of the Securities
Act.
The terms of the Notes include those stated in the Indenture and
those made a part of the Indenture by reference to the
Trust Indenture Act of 1939 (the TIA).
We summarize below certain provisions of the Indenture, but do
not restate the Indenture in its entirety. We urge you to read
the Indenture because it, and not this description, defines your
rights. You can obtain a copy of the Indenture in the manner
described under Where You Can Find More Information.
You can find the definition of capitalized terms used in this
section under Certain Definitions. When we refer to:
|
|
|
|
|
the Company in this section, we mean Elan
Corporation, plc and not its Subsidiaries; and
|
|
|
|
Notes in this section, we mean the Notes
originally issued on the Issue Date, Exchange Notes issued
therefor and any Additional Notes.
|
The Exchange Notes will be represented by one or more registered
global notes without interest coupons (the Global
Notes). The Global Notes will be deposited upon
issuance with the Trustee as custodian for The Depository
Trust Company (DTC), in New York, New
York, and registered in the name of DTC or its nominee for
credit to an account of a direct or indirect participant in DTC
(including the Euroclear System (Euroclear)
or Clearstream Banking, S.A. (Clearstream)),
as described below under Depositary
Procedures. So long as DTC or its nominee is the
registered owner or holder of any of the Notes, DTC or such
nominee will be considered the sole owner or holder of such
Notes represented by the Global Notes for all purposes of the
Indenture.
Ranking
of the Notes, the Elan Note Guarantee and the Subsidiary Note
Guarantees
The Notes are senior unsecured obligations of the Issuer and
rank equally in right of payment with all existing and future
unsecured and unsubordinated Indebtedness of the Issuer,
including, without limitation, the Existing 2013 Notes and the
Existing 2016 Notes issued October 2009. The Notes are
effectively subordinated to all of the Issuers secured
Indebtedness, to the extent of the value of the assets securing
that Indebtedness.
The Company unconditionally guarantees the performance of all
obligations of the Issuer under the Indenture and the Notes. The
Elan Note Guarantee is a senior unsecured obligation of the
Company and ranks equally in right of payment with all existing
and future unsecured and unsubordinated Indebtedness of the
Company, including, without limitation, the Companys
guarantees of the Existing 2013 Notes and the Existing 2016
Notes issued October 2009. The Elan Note Guarantee is
effectively subordinated to all of the Companys secured
Indebtedness, to the extent of the value of the assets securing
that Indebtedness. The Elan Note Guarantee is effectively
subordinated to all obligations, including trade payables, of
the Companys Subsidiaries that are not Subsidiary Note
Guarantors.
The Companys existing and, subject to certain exceptions
(see Note Guarantees below), future Material
Restricted Subsidiaries (other than the Issuer) will guarantee
all obligations of the Issuer under the Indenture and the Notes.
The Subsidiary Note Guarantees are senior unsecured obligations
of the Subsidiary Note Guarantors and rank equally in right of
payment with all existing and future unsecured and
unsubordinated Indebtedness of the Subsidiary Note Guarantors,
including, without limitation, their guarantees of the Existing
2013 Notes and the Existing 2016 Notes issued October 2009. The
Subsidiary Note Guarantees are effectively subordinated to all
of the Subsidiary Note Guarantors secured Indebtedness, to
the extent of the value of the assets securing that Indebtedness.
27
As of December 31, 2010, the Company and its Subsidiaries
had $1,285.0 million of outstanding indebtedness (aggregate
principal amount of debt outstanding, not including trade
payables) on its consolidated balance sheet, none of which was
secured.
Principal,
Maturity and Interest
The Issuer issued $200,000,000 principal amount of Notes on the
Issue Date. The Notes will mature on October 15, 2016
unless redeemed prior thereto as described herein. Interest on
the Notes accrues at the rate of 8.75% per annum and is payable
semiannually in arrears on each April 15 and October 15,
commencing
on ,
2011. Payments will be made to the Persons who are registered
Holders of Notes at the close of business on April 1 and
October 1, respectively, immediately preceding the
applicable interest payment date. Interest on the Notes will
accrue from the most recent date to which interest has been paid
or, if no interest has been paid, from and including the Issue
Date. Interest will be computed on the basis of a
360-day year
comprised of twelve
30-day
months.
Denomination
and Sinking Fund
The Issuer will issue Notes in denominations of $100,000 and
integral multiples of $1,000 in excess thereof. The Notes will
not be entitled to the benefit of any mandatory sinking fund.
Interest
Upon Redemption and Payment Instructions
The redemption of Notes with unpaid and accrued interest to the
date of redemption will not affect the right of Holders of
record on a record date to receive interest due on an interest
payment date. When we refer to the Issuers obligation to
pay interest upon the redemption, repurchase or acceleration of
Notes, we are including additional interest, if any, payable
under the registration rights agreement relating to the Notes
(the Registration Rights Agreement).
Initially, the Trustee will act as Paying Agent and Registrar
for the Notes. The Issuer may change the Paying Agent and
Registrar without notice to Holders. If a Holder has given wire
transfer instructions to the Issuer, the Issuer will make all
principal, premium and interest payments on those Notes in
accordance with those instructions. All other payments on the
Notes will be made at the office or agency of the Paying Agent
and Registrar in New York City unless the Issuer elects to make
interest payments by check mailed to the registered Holders at
their registered addresses. For so long as the Notes are
admitted to the official list of the Irish Stock Exchange and
trading on its regulated market, the Issuer will maintain a
paying agent having its specified office in a member state of
the European Union (as required by the applicable listing rules
of the Irish Stock Exchange).
Additional
Notes
Subject to the limitations set forth under
Certain Covenants Limitation on
Incurrence of Additional Indebtedness, the Issuer may
incur additional Indebtedness. At the Issuers option, this
additional Indebtedness may consist of additional Notes
(Additional Notes) issued in one or more
transactions, which have identical terms (other than issue date)
as the Notes issued on the Issue Date. Holders of Additional
Notes would have the right to vote together with Holders of the
Notes issued on the Issue Date as one class.
Payment
of Additional Amounts
All payments made by the Issuer, the Company, the Subsidiary
Note Guarantors and any successor Person to the Issuer, the
Company or the Subsidiary Note Guarantors (each, a
Payor) will be made free and clear of and
without deduction or withholding for or on account of any
present or future taxes, duties, assessments, or other
governmental charges (Taxes) imposed or
levied by or on behalf of (i) Ireland or any political
subdivision or governmental authority thereof or therein having
power to tax, (ii) any jurisdiction from or through which
payment is made by a Payor or its paying agent, or any political
subdivision or governmental authority thereof or therein having
the power to tax, or (iii) any other jurisdiction in which
any Payor is organized or otherwise is a resident for tax
purposes, or any political subdivision or governmental authority
28
thereof or therein having the power to tax (any of the
aforementioned being a Taxing Jurisdiction),
unless such withholding or deduction is required by law. If a
Payor is required by law to make any such withholding or
deduction (including, without limitation, because the Notes are
not listed on the Irish Stock Exchange), the Payor will pay to
Holders of the Notes such additional amounts
(Additional Amounts) as may be necessary in
order that every payment of principal, premium, if any, Change
of Control Payment, Asset Sale Offer Amount, redemption price or
interest in respect of any Notes, or any payment in respect of
the Elan Note Guarantee or any Subsidiary Note Guarantee, after
deduction or withholding (including any such deduction or
withholding from such Additional Amounts) for, Taxes imposed
upon or as a result of such payment , will not be less than the
amount provided for in the Notes and the Indenture to be then
due and payable; provided that the foregoing obligation
to pay Additional Amounts will not apply:
(a) to any Taxes that would not have been imposed but for
the Holder or beneficial owner of a Note (or the fiduciary,
settler, beneficiary, member or shareholder of, or possessor of
power over, the Holder or beneficial owner of such Note, if the
Holder or beneficial owner is an estate, nominee, trust,
partnership or corporation) being a resident, domiciliary or
national of, or engaging in business or maintaining a permanent
establishment or being physically present in, a Taxing
Jurisdiction, or otherwise having some present or former
connection with a Taxing Jurisdiction other than the mere
holding of such Notes;
(b) to any Taxes that would not have been imposed but for
the fact that such Holder or beneficial owner (i) presented
its Notes for payment more than 30 days after the date on
which such payment or such Note became due and payable or the
date on which payment thereof is duly provided for, whichever is
later (except to the extent that the Holder would have been
entitled to Additional Amounts if it had presented such Notes
for payment on any day within the
30-day
period) or (ii) presented such Notes for payment in a
Taxing Jurisdiction, unless such Notes could not have been
presented for payment elsewhere free from any Taxes on
presentation;
(c) to any Taxes that would not have been imposed but for
the Holders or beneficial owners failure to comply,
following a request by the Issuer or the Company to the Holder,
with any certification, identification or reporting requirements
(including, without limitation, with respect to the nationality,
residence, identity or connection with a Taxing Jurisdiction of
the Holder or beneficial owner of the Notes), if compliance is
required by the applicable law of the Taxing Jurisdiction, as a
precondition to exemption from such Taxes;
(d) to any payment under or with respect to a Note to any
Holder that is a fiduciary or partnership or any person other
than the sole beneficial owner of such payment or Note, to the
extent that a beneficiary or settlor with respect to such
fiduciary, a member of such partnership or the beneficial owner
of such payment or Note would not have been entitled to the
Additional Amounts had such beneficiary, settlor, or beneficial
owner been the actual Holder of such Note;
(e) any withholding or deduction in respect of any Taxes
where such withholding or deduction is imposed on a payment to
an individual that is required to be made pursuant to European
Council Directive 2003/48/EC or any other directive implementing
the conclusions of the ECOFIN Council meeting of November 26 and
27, 2000 on the taxation of savings income or any law
implementing or complying with or introduced in order to conform
to, such Directive; provided that this clause (e)
shall not apply if a withholding tax or deduction is imposed on
a payment made by a paying agent and the Issuer has not, at the
date of such payment, maintained a paying agent in a
jurisdiction that would not have been obliged to withhold or
deduct tax pursuant to the aforementioned Directive or any other
directive implementing the conclusions of the ECOFIN Council
meeting of November 26 and 27, 2000 on the taxation of savings
income or any law implementing or complying with or introduced
in order to conform to, such Directive.
(f) to any estate, inheritance, gift, sales, personal
property, or, subject to the last paragraph of this covenant,
excise or transfer tax, or any other tax, assessment or other
governmental charge that is similar to any of the foregoing;
(g) to any Taxes that are payable other than by withholding
or deduction at source; or
29
(h) to any combination of clauses (a) through
(g) above.
All references to principal, premium, Change of Control Payment,
Asset Sale Offer Amount, redemption price or interest will be
deemed to include references to any Additional Amounts payable
with respect to such principal, premium, Change of Control
Payment, Asset Sale Offer Amount, redemption price or interest.
The applicable Payor will provide the Trustee with documentation
evidencing the payment of any amounts deducted or withheld
promptly upon such Payors payment thereof, and copies of
such documentation will be made available by the Trustee to
Holders upon request.
The applicable Payor will pay any present or future stamp, court
or documentary taxes, charges or levies that arise in any Taxing
Jurisdiction from the execution, delivery or registration of
each Note or any other related document or instrument referred
to in the Indenture or such Note.
Note
Guarantees
Each Note Guarantor will unconditionally guarantee the
performance of all obligations of the Issuer under the Indenture
and the Notes, in each case, on a senior unsecured basis. The
obligations of each Note Guarantor in respect of its Note
Guarantee will be limited to the maximum amount as will result
in the obligations not constituting a fraudulent conveyance,
fraudulent transfer or similar illegal transfer under applicable
law. See Risk Factors Risks Related to the
Notes and the Exchange Offer A guarantee of the
Notes by Elan or its subsidiaries may be voidable, subordinated
or limited in scope under laws governing fraudulent transfers
and insolvency or under law governing corporate authority.
Each Note Guarantor that makes a payment or distribution under
its Note Guarantee is entitled to a contribution from each other
Note Guarantor in a pro rata amount based on adjusted net
assets of each Note Guarantor.
As of the Issue Date, all of the Companys Material
Restricted Subsidiaries, except for Elan Science One Limited,
Neotope Biosciences Limited and Elan Science Three Limited, were
Restricted Subsidiaries. However, under the
circumstances described below under Certain
Covenants Limitation on Designation of Unrestricted
Subsidiaries, the Issuer will be permitted to designate
any of its Subsidiaries as Unrestricted
Subsidiaries. The effect of designating a Subsidiary as an
Unrestricted Subsidiary will be that:
|
|
|
|
|
the Unrestricted Subsidiary will not be subject to many of the
restrictive covenants in the Indenture;
|
|
|
|
a Subsidiary that has previously been a Subsidiary Note
Guarantor and that is designated an Unrestricted Subsidiary will
be released from its Subsidiary Note Guarantee and its
obligations under the Indenture and the Registration Rights
Agreement; and
|
|
|
|
the assets, income, cash flow and other financial results of an
Unrestricted Subsidiary will not be consolidated with those of
the Company or the Issuer for purposes of calculating compliance
with the restrictive covenants contained in the Indenture.
|
Each Note Guarantor will be released and relieved of its
obligations under its Note Guarantee, the Indenture and the
Registration Rights Agreement in the event:
|
|
|
|
|
there is a Legal Defeasance of the Notes as described under
Legal Defeasance and Covenant Defeasance;
|
|
|
|
in the case of a Subsidiary Note Guarantor only, there is a sale
or other disposition of (x) Capital Stock of the applicable
Guarantor if after such sale, disposition or other transfer,
such Guarantor is no longer a Restricted Subsidiary or
(y) all or substantially all of the assets of such
Subsidiary Note Guarantor, or a sale or other disposition
(including through merger, consolidation or otherwise) of all of
the Capital Stock of such Subsidiary Note Guarantor then held by
the Issuer and the other Restricted Subsidiaries; or
|
|
|
|
in the case of a Subsidiary Note Guarantor only, such Subsidiary
Note Guarantor is designated as an Unrestricted Subsidiary in
accordance with the covenant described under
Certain Covenants Limitation on
Designation of Unrestricted Subsidiaries;
|
30
provided that the transaction is carried out pursuant to
and in accordance with all other applicable provisions of the
Indenture.
If any Person (other than the Issuer) becomes a Restricted
Subsidiary (including upon a Revocation of the Designation of a
Subsidiary as an Unrestricted Subsidiary) after October 2,
2009 and such Restricted Subsidiary has a Capitalization of at
least $10,000, the Company will cause that Restricted Subsidiary
concurrently to become a Subsidiary Note Guarantor on a senior
unsecured basis by executing a supplemental indenture and
providing the Trustee with an Officers Certificate and
Opinion of Counsel; provided that there may be excluded
as Subsidiary Note Guarantors (i) Restricted Subsidiaries
of the Company not excluded pursuant to clause (ii) or
(iii) of this proviso, whether existing on October 2,
2009 or which become Restricted Subsidiaries thereafter, that do
not together constitute Material Restricted Subsidiaries,
(ii) any Foreign Restricted Subsidiary in the event that
the provision of a Subsidiary Note Guarantee by such Foreign
Restricted Subsidiary would result in a material adverse tax
consequence to the Company or any of its Subsidiaries and
(iii) any Receivables Subsidiary; and provided further
that if, other than in connection with the creation or
acquisition of a Restricted Subsidiary, clause (i) of the
foregoing proviso fails to be satisfied as of the end of any
fiscal quarter, the Company will cause one or more of its
Restricted Subsidiaries that are not Subsidiary Note Guarantors
to become Subsidiary Note Guarantors in accordance with the
foregoing such that the Restricted Subsidiaries of the Company
that are not Subsidiary Note Guarantors other than pursuant to
clause (ii) or (iii) of the above proviso do not
together constitute a Material Restricted Subsidiary. See
Risk Factors Risks Related to the Notes and
the Exchange Offer Not all of Elans
subsidiaries will guarantee the Notes and the assets of the
non-guarantor subsidiaries may not be available to Elan for
payment on its guarantee of the Notes.
Optional
Redemption
Optional Redemption. Except as stated below,
the Issuer may not redeem the Notes prior to October 15,
2012. On and after October 15, 2012 the Issuer may redeem
the Notes, at its option, in whole at any time or in part from
time to time, upon not less than 30 days and not more
than 60 days prior notice mailed by first-class mail
to each Holders registered address, at the following
redemption prices, expressed as percentages of the principal
amount thereof, plus accrued and unpaid interest thereon to the
redemption date, if redeemed during the
12-month
period commencing on October 15 of any year set forth below:
|
|
|
|
|
Year
|
|
Percentage
|
|
|
2012
|
|
|
108.750
|
%
|
2013
|
|
|
104.375
|
%
|
2014
|
|
|
102.188
|
%
|
2015 and thereafter
|
|
|
100.000
|
%
|
Make-Whole Redemption. At any time prior to
October 15, 2012, the Notes may also be redeemed by the
Issuer or any other Person designated by the Issuer in whole but
not in part, at the Issuers option, at a redemption price
equal to 100% of the principal amount thereof plus the
Applicable Premium as of, and accrued but unpaid interest, if
any, to the date of redemption. Such redemption may be made upon
notice mailed by first-class mail to each Holders
registered address, not less than 30 and not more than
60 days prior to the redemption date. The Issuer may
provide in such notice that payment of such price and
performance of the Issuers obligations with respect to
such redemption or purchase may be performed by another Person.
Applicable Premium means, with respect to a
Note at any redemption date, the greater of:
(a) 1.0% of the principal amount of such Note; and
(b) the excess of:
(1) the present value at such redemption date of:
(x) the redemption price of such Note on October 15,
2012 (such redemption price being that described in the first
paragraph of this Optional Redemption section) plus
31
(y) all required remaining scheduled interest payments due
on such Note through October 15, 2012, other than accrued
interest to such redemption date, computed using a discount rate
equal to the Treasury Rate plus 50 basis points per annum
discounted on a semi-annual bond equivalent basis, over
(2) the principal amount of such Note on such redemption
date.
Calculation of the Applicable Premium will be made by the Issuer
or on behalf of the Issuer by such Person as the Issuer shall
designate and will not be a duty or obligation of the Trustee.
Treasury Rate means, with respect to any
redemption date, the yield to maturity at the time of
computation of United States Treasury securities with a constant
maturity (as compiled and published in the most recent Federal
Reserve Statistical Release H.15(519) that has become publicly
available at least two business days prior to such redemption
date (or, if such Statistical Release is no longer published,
any publicly available source of similar market data)) most
nearly equal to the period from such redemption date to
October 15, 2012; provided that if the period from
such redemption date to October 15, 2012 is not equal to
the constant maturity of the United States Treasury security for
which a weekly average yield is given, the Treasury Rate will be
obtained by linear interpolation (calculated to the nearest
one-twelfth of a year) from the weekly average yields of United
States Treasury securities for which such yields are given,
except that if the period from such redemption date to
October 15, 2012 is less than one year, the weekly average
yield on actually traded United States Treasury securities
adjusted to a constant maturity of one year will be used.
Optional Redemption upon Equity
Offerings. Notwithstanding the foregoing, at any
time, or from time to time, after November 30, 2011 and on
or prior to October 15, 2012, the Issuer or the Company
may, at its option, upon not less than 30 days and
not more than 60 days prior notice mailed by
first-class mail to each Holders registered address,
redeem in the aggregate up to 35% of the aggregate principal
amount of the Notes issued under the Indenture with the net cash
proceeds of one or more Equity Offerings at a redemption price
equal to 108.750% of the principal amount thereof, plus accrued
and unpaid interest thereon through the redemption date;
provided that:
|
|
|
|
|
after giving effect to any such redemption at least 65% of the
aggregate principal amount of the Notes issued under the
Indenture remains outstanding; and
|
|
|
|
the Issuer makes such redemption not more than 90 days
after the consummation of such Equity Offering.
|
Equity Offering means any public offering or
private sale of at least $35 million in gross proceeds
after the issue date of Qualified Capital Stock of the Company,
other than public offerings with respect to the Companys
Capital Stock registered on
Form S-8.
Acquisition
of Notes
The Issuer and the Company may acquire Notes by means other than
a redemption, whether pursuant to an issuer tender offer, open
market purchase or otherwise, so long as the acquisition does
not otherwise violate the terms of the Indenture.
Tax
Redemption
The Notes are redeemable for cash at the Issuers option
prior to their maturity in the event of certain changes in the
tax laws of a Taxing Jurisdiction after the date of issuance of
the Notes as specified below. If, as a result of any change in,
or amendment to, the laws (including any regulations or rulings
promulgated thereunder) and treaties of a Taxing Jurisdiction,
or any change in or amendment to any official position
concerning the interpretation, administration or application of
such laws, treaties, regulations or rulings (including a
holding, judgment or order by a court of competent jurisdiction
or any action taken by a taxing authority which action is
generally applied or is taken with respect to the applicable
Payor), which change, amendment, interpretation, administration,
or application is announced and becomes effective on or after
the date of issuance of the Notes (or, if the applicable Taxing
Jurisdiction became a Taxing Jurisdiction on a date
32
after the date of issuance of the Notes, a change, amendment,
interpretation, administration or application that is announced
and becomes effective more than six months after such later
date), the applicable Payor has or would become obligated to pay
Additional Amounts to the Holder of any Notes, and such
obligation cannot be avoided by the applicable Payor taking
commercially reasonable measures (consistent with practices and
interpretations generally followed or in effect at the time such
measures could be taken) available to it, then the Issuer may,
at its option, redeem the Notes in whole but not in part, upon
not less than 30 days and not more than
90 days notice mailed by first-class mail to each
Holders registered address, at a redemption price equal to
100% of the Notes aggregate principal amount thereof plus
accrued and unpaid interest and Additional Amounts, if any, on
such Notes, to (but excluding) the redemption date.
For the avoidance of doubt, the Notes shall not be redeemable
under this paragraph because the Notes have not been listed or
fail to remain listed on the Irish Stock Exchange, unless such
failure is caused by a change in tax law, interpretation, etc.
that otherwise could serve as a basis for redemption of the
Notes under this Tax Redemption provision.
Optional
Redemption and Repurchase Procedures
In the event that less than all of the Notes are to be redeemed
at any time, selection of Notes for redemption will be made by
the Trustee in compliance with the requirements of the principal
national securities exchange, if any, on which the Notes are
listed or, if the Notes are not then listed on a national
securities exchange, on a pro rata basis, by lot or by
any other method as the Trustee deems fair and appropriate. If a
partial redemption is made in accordance with
Notes Optional Redemption upon Equity
Offerings, selection of the Notes or portions thereof for
redemption will, subject to the preceding sentence, be made by
the Trustee only on a pro rata basis or on as nearly a
pro rata basis as is practicable (subject to the
procedures of The Depository Trust Company), unless the
method is otherwise prohibited. No Notes in a principal amount
of $100,000 or less may be redeemed in part and Notes in a
principal amount in excess of $100,000 may be redeemed in part
in multiples of $1,000 in excess thereof only.
If Notes are to be redeemed in part only, the notice of
redemption will state the portion of the principal amount
thereof to be redeemed. A new Note in a principal amount equal
to the unredeemed portion thereof (if any) will be issued in the
name of the Holder thereof upon cancellation of the original
Note (or appropriate adjustments to the amount and beneficial
interests in a global note will be made, as appropriate).
On and after the redemption date, interest will cease to accrue
on Notes or portions thereof called for redemption as long as
the Issuer has deposited with the Paying Agent funds in
satisfaction of the applicable redemption price pursuant to the
Indenture. Upon redemption of any Notes by the Issuer or any
other Person, such Notes will be cancelled.
Change of
Control
Upon the occurrence of a Change of Control, each Holder will
have the right to require that the Issuer repurchase all or a
portion (equal to $100,000 or an integral multiple of $1,000 in
excess thereof) of such Holders Notes at a purchase price
in cash equal to 101% of the principal amount thereof, plus
accrued and unpaid interest thereon to the date of repurchase
(the Change of Control Payment);
provided, however, that the Issuer will not be
obligated to repurchase Notes pursuant to this covenant in the
event that it has exercised its right to redeem all of the Notes
as described under Optional Redemption.
No such purchase in part shall reduce the principal amount of
Notes held by any Holder to be below $100,000.
Within 30 days following the date upon which the Change of
Control occurred, the Issuer shall send, by first-class mail, a
notice to each Holder of Notes as shown on the register of
Holders, with a copy to the Trustee, offering to repurchase the
Notes as described above (a Change of Control
Offer). The Change of Control Offer will state, among
other things, the repurchase date (the Change of
Control Payment Date), which shall be a Business Day
no earlier than 30 days nor later than 60 days from
the date the notice is mailed, other than as may be required by
law.
33
On the Change of Control Payment Date, the Issuer will, to the
extent lawful:
|
|
|
|
|
accept for payment all Notes or portions thereof properly
tendered and not validly withdrawn pursuant to the Change of
Control Offer;
|
|
|
|
deposit with the Paying Agent funds in an amount equal to the
Change of Control Payment in respect of all Notes or portions
thereof so tendered and not validly withdrawn; and
|
|
|
|
deliver or cause to be delivered to the Trustee the Notes so
accepted together with an Officers Certificate stating the
aggregate principal amount of Notes or portions thereof being
repurchased by the Company.
|
If only a portion of a Note is purchased pursuant to a Change of
Control Offer, a new Note in a principal amount equal to the
portion thereof not purchased will be issued in the name of the
Holder thereof upon cancellation of the original Note (or
adjustments to the amount and beneficial interests in a global
note will be made, as appropriate); provided that each
such new Note will be in a principal amount of $100,000 or an
integral multiple of $1,000 in excess thereof. Notes (or
portions thereof) purchased pursuant to a Change of Control
Offer will be cancelled and cannot be reissued.
If a Change of Control Offer occurs, there can be no assurance
that the Issuer, the Company or the Subsidiary Note Guarantors
will have available funds sufficient to make the Change of
Control Payment for all the Notes that might be tendered by
Holders seeking to accept the Change of Control Offer because
the Issuer, the Company or one or more of the Subsidiary Note
Guarantors might also be required to prepay any Pari Passu
Indebtedness existing at the time of a Change of Control having
financial covenants with Change of Control provisions in favor
of the holders thereof. In the event the Issuer is required to
repurchase outstanding Notes pursuant to a Change of Control
Offer, the Issuer expects that it, the Company or one or more
Subsidiary Note Guarantors would seek third-party financing to
the extent that the Issuer, the Company or one or more
Subsidiary Note Guarantors do not have available funds to meet
the Issuers purchase obligations and any other obligations
in respect of Pari Passu Indebtedness. However, there can be no
assurance that the Issuer, the Company or one or more Subsidiary
Note Guarantors would be able to obtain necessary financing. The
Issuers ability to purchase Notes, or the Companys
ability to satisfy its Elan Note Guarantee with respect thereto
or the Subsidiary Note Guarantors ability to satisfy their
Subsidiary Note Guarantors with respect thereto with cash may be
limited by the terms of its or their then- existing borrowing
agreements or by the terms of the Companys or its
Subsidiaries then-existing borrowing agreements due to
dividend restrictions.
Holders will not be entitled to require the Issuer to purchase
their Notes in the event of a takeover, recapitalization,
leveraged buyout or similar transaction which is not a Change of
Control. In addition, a recent Delaware Chancery Court decision
raised questions about the enforceability of repurchase
obligations, which are similar to those in the Indenture,
related to the triggering of a change of control as a result of
a change in the composition of a Board of Directors.
Accordingly, the effectiveness of the provisions of the
Indenture that require us to repurchase Notes as a result of
certain changes in the composition of directors on our Board of
Directors may be uncertain.
A Change of Control Offer may be made in advance of a Change of
Control, conditional upon consummation of such Change of
Control, if a definitive agreement is in place at the time of
such Change of Control Offer.
Notwithstanding the foregoing, the Issuer will not be required
to make a Change of Control Offer upon a Change of Control, as
provided above, if, in connection with or in contemplation of
any Change of Control, the Issuer or a third party has made an
offer to purchase (an Alternative Offer) any
and all Notes validly tendered at a purchase price in cash equal
to or higher than the Change of Control Payment and has
purchased all Notes properly tendered in accordance with the
terms of such Alternative Offer.
Other Indebtedness of the Company or its Subsidiaries may
contain prohibitions on the occurrence of events that would
constitute a Change of Control or require that Indebtedness to
be repurchased upon a Change of Control. Other Indebtedness of
the Company or its Subsidiaries may have cross-default
provisions that could be triggered by a default under the change
of control provisions in such Indebtedness, thereby
34
accelerating the maturity of such Pari Passu Indebtedness.
Moreover, the exercise by the Holders of their right to require
the Issuer to repurchase the Notes upon a Change of Control
could cause a default under other Indebtedness even if the
Change of Control itself does not.
With respect to any disposition of assets, the phrase all
or substantially all as used in the Indenture (including
as set forth under the definition of Change of
Control and Certain Covenants Limitation
on Merger, Consolidation and Sale of Assets below) varies
according to the facts and circumstances of the subject
transaction, has no clearly established meaning under New York
law (which governs the Indenture) and is subject to judicial
interpretation. Accordingly, in certain circumstances there may
be a degree of uncertainty in ascertaining whether a particular
transaction would involve a disposition of all or
substantially all of the assets of the Company, and
therefore it may be unclear as to whether a Change of Control
has occurred and whether the Holders have the right to require
the Issuer to repurchase Notes.
The Issuer will comply with the requirements of
Rule 14e-1
under the Exchange Act and any other applicable securities laws
and regulations in connection with the repurchase of Notes in
connection with a Change of Control Offer. To the extent that
the provisions of any securities laws or regulations conflict
with the Change of Control provisions of the
Indenture, the Issuer will comply with the applicable securities
laws and regulations and will not be deemed to have breached its
obligations under the Indenture by doing so.
Notices
Notices regarding the Notes shall, unless expressly provided
otherwise, be given in writing by first-class postage or
overnight delivery to each registered holder of Notes at such
holders address as it appears in the security register
maintained for such purposes, not later than the latest date,
and not earlier than the earliest date, prescribed under the
Notes for giving of such notice.
Certain
Covenants
Covenant
Suspension
From and after the Issue Date (or the first date following a
Covenant Reinstatement Date (as defined below)) on which both
(a) the Notes are rated Investment Grade by each of
Moodys Investors Service, Inc. (or any successor thereto)
(Moodys) and Standard &
Poors Ratings Group (or any successor thereto)
(S&P) and (b) there does not exist
a Default or Event of Default under the Indenture (collectively,
a Rating Event), the Company and the
Restricted Subsidiaries will no longer be subject to the
covenants in the Indenture described below under the headings
Limitation on Incurrence of Additional
Indebtedness, Limitation on Restricted
Payments, Limitation on Asset
Sales, Limitation on Designation of
Unrestricted Subsidiaries, Limitation on
Dividend and Other Payment Restrictions Affecting Restricted
Subsidiaries, clause (b) of the first paragraph under
Limitation on Merger, Consolidation and Sale
of Assets and Limitation on Transactions
with Affiliates (collectively, the Suspended
Covenants). During any Suspension Period, all
references to Restricted Subsidiaries shall be deemed to refer
to Subsidiaries.
In the event that following a Rating Event, one or both of the
Rating Agencies subsequently withdraws its ratings or downgrades
the ratings assigned to the Notes below Investment Grade, the
Company and its Restricted Subsidiaries will thereafter again be
subject to the Suspended Covenants from such date (a
Covenant Reinstatement Date) until the next
subsequent Rating Event, if any (a Covenant
Reinstatement Period). There will not be deemed to
have occurred a Default or Event of Default with respect to the
Suspended Covenants during a Suspension Period or after that
time based solely on events that occurred during that time.
Compliance with the provisions of the covenant described under
Limitation on Restricted Payments with
respect to Restricted Payments made during a Covenant
Reinstatement Period will be calculated as though that covenant
had been in effect during the entire period of time from
October 2, 2009. Liens of the Company and its Restricted
Subsidiaries outstanding on a Covenant Reinstatement Date that
were incurred or deemed to be incurred during a Suspension
Period pursuant to clause (28)(ii) of the definition of
Permitted Liens will be deemed to be incurred on
such Covenant Reinstatement Date pursuant to clause (23)(a) of
the definition of Permitted Liens; provided
that if the aggregate amount of Indebtedness secured by such
Liens exceeds the aggregate amount permitted under such clause
(23)(a), the Liens securing
35
Indebtedness in excess of such amount will be deemed to be
incurred as Permitted Liens under a separate exception therefor,
or if they remain outstanding as of the date of the next
subsequent Rating Event, if any, clause (28)(ii) of the
definition of Permitted Liens.
There can be no assurance that a Rating Event will occur or, if
one occurs, that the Notes will maintain an Investment Grade
rating.
In the event Moodys or S&P is no longer in existence
or issuing ratings, such organization may be replaced by a
nationally recognized statistical rating organization (as
defined in
Rule 15c3-1(c)(2)(vi)(F)
under the Exchange Act or any successor provision) designated by
the Company with notice to the Trustee and the foregoing
provisions will apply to the rating issued by the replacement
rating agency.
The Indenture contains, among others, the following covenants:
Limitation
on Incurrence of Additional Indebtedness
(a) The Company will not, and will not cause or permit any
of the Restricted Subsidiaries to, directly or indirectly, Incur
any Indebtedness, including Acquired Indebtedness, except that:
(1) the Company, the Issuer and the Subsidiary Note
Guarantors may Incur Indebtedness, including Acquired
Indebtedness; and
(2) any Restricted Subsidiary may Incur Acquired
Indebtedness,
if, immediately after giving pro forma effect to the
Incurrence thereof and the application of the proceeds
therefrom, the Consolidated Net Fixed Charge Coverage Ratio of
the Company would be greater than or equal to 2.0 to 1.0.
(b) Notwithstanding paragraph (a) above, the Company
and the Restricted Subsidiaries, as applicable, may Incur the
following Indebtedness (Permitted
Indebtedness):
(1) Indebtedness in respect of the Notes (excluding
Additional Notes), the Elan Note Guarantee and the Subsidiary
Note Guarantees;
(2) Indebtedness Incurred by the Company and the Restricted
Subsidiaries pursuant to any Debt Facility (including, without
limitation, letters of credit and bankers acceptances
issued or created thereunder, with such letters of credit and
bankers acceptances being deemed to have a principal
amount equal to the face amount thereof) in an aggregate
principal amount at any one time outstanding not to exceed the
greater of:
(A) $175 million; and
(B) the sum of (x) 60% of the net book value of
inventory of the Company and the Restricted Subsidiaries and
(y) 85% of the net book value of accounts receivable of the
Company and the Restricted Subsidiaries (to the extent such
receivables or any other receivables of the Company or such
Restricted Subsidiary, as the case may be, are not then being
financed pursuant to a Qualified Receivables Transaction or as a
basis for Indebtedness Incurred pursuant to clause (13) of
this paragraph), in each case at the date of determination
(excluding inventory and accounts receivable sold by the Company
or a Restricted Subsidiary).
(3) Indebtedness of the Company and the Restricted
Subsidiaries (other than Indebtedness specified in
clauses (1) and (2) above or clauses (4), (5), (6),
(7), (8), (9), (10), (12) and (13) below) outstanding
on October 2, 2009 including, without limitation, the
Existing 2013 Notes and the guarantees thereof by the Note
Guarantors;
(4) Hedging Obligations entered into by the Company and the
Restricted Subsidiaries in the ordinary course of business and
not for speculative purposes;
(5) Indebtedness of the Company to a Restricted Subsidiary;
provided that any such Indebtedness is made pursuant to
an intercompany note and, if the Company Incurs such
Indebtedness to a Restricted
36
Subsidiary that is not a Subsidiary Note Guarantor, such
Indebtedness is subordinated in right of payment to the
Companys obligations under the Elan Note Guarantee;
provided, further, that any subsequent issuance or
transfer of any Capital Stock or any other event which results
in any such Restricted Subsidiary ceasing to be a Restricted
Subsidiary or any other subsequent transfer of any such
Indebtedness (except to the Company or another Restricted
Subsidiary) will be deemed, in each case, to be an Incurrence of
such Indebtedness;
(6) Indebtedness of a Restricted Subsidiary to the Company
or to another Restricted Subsidiary; provided that any
such Indebtedness is made pursuant to an intercompany note and,
if the Issuer or a Subsidiary Note Guarantor Incurs such
Indebtedness to a Restricted Subsidiary that is not a Subsidiary
Note Guarantor, such Indebtedness is subordinated in right of
payment to, in the case of the Issuer, the Notes or, in the case
of a Subsidiary Note Guarantor, such Subsidiary Note
Guarantors obligations under its Subsidiary Note
Guarantee; provided, further, that any subsequent
issuance or transfer of any Capital Stock or any other event
which results in any Restricted Subsidiary lending such
Indebtedness ceasing to be a Restricted Subsidiary or any other
subsequent transfer of any such Indebtedness (except to the
Company or another Restricted Subsidiary) will be deemed, in
each case to be an Incurrence of such Indebtedness;
(7) Indebtedness of the Company or any of the Restricted
Subsidiaries arising from the honoring by a bank or other
financial institution of a check, draft or similar instrument
drawn against insufficient funds in the ordinary course of
business; provided that such Indebtedness is extinguished
within five business days of Incurrence;
(8) Indebtedness of the Company or any of the Restricted
Subsidiaries with respect to letters of credit issued in the
ordinary course of business in respect of health, disability or
other employee benefits or property, casualty or liability
insurance or self-insurance, or other Indebtedness with respect
to reimbursement-type obligations regarding workers
compensation claims; provided that, upon the drawing of
any such letter of credit, the reimbursement obligation with
respect thereto is reimbursed within 30 days following such
drawing;
(9) Indebtedness of the Company or any of the Restricted
Subsidiaries arising from agreements for indemnification,
adjustment of purchase price, earn-outs or similar obligations,
in each case Incurred in connection with the disposition or
acquisition of any business, asset or a Subsidiary, other than a
Guarantee of Indebtedness Incurred by any Person acquiring all
or any portion of such business, assets or Subsidiary for
purposes of financing such acquisition; provided that
(A) such Indebtedness is not reflected on the balance sheet
of the Company or any Restricted Subsidiary (contingent
obligations referred to in a footnote to financial statements
and not otherwise reflected on the balance sheet will not be
deemed to be reflected on such balance sheet for purposes of
this clause (A)) and (B) in the case of a disposition, the
maximum aggregate liability in respect of all such Indebtedness
under this clause (9) will at no time exceed the gross
proceeds, including non-cash proceeds (the Fair Market Value of
such non-cash proceeds being measured at the time received and
without giving effect to any subsequent changes in value),
actually received by the Company and the Restricted Subsidiaries
in connection with such disposition;
(10) Indebtedness of the Company or any of the Restricted
Subsidiaries consisting of
take-or-pay
obligations contained in supply agreements, in each case in the
ordinary course of business;
(11) Acquired Indebtedness Incurred in connection with the
acquisition of a Permitted Business; provided that after
giving effect to such acquisition, merger or consolidation, and
the Incurrence of such Acquired Indebtedness, (x) the
Company would be permitted to Incur at least $1.00 of additional
Indebtedness pursuant to paragraph (a) of this covenant or
(y) the Consolidated Net Fixed Charge Coverage Ratio of the
Company would be greater than immediately prior to such
acquisition, merger, consolidation and Incurrence;
(12) Indebtedness arising in connection with endorsement of
instruments of deposit in the ordinary course of business;
(13) the Incurrence by a Receivables Subsidiary of
Indebtedness in a Qualified Receivables Transaction that is
without recourse to the Company or any Restricted Subsidiary or
their respective
37
assets (other than such Receivables Subsidiary and its assets
and, as to the Company and its Subsidiaries, other than pursuant
to Standard Securitization Undertakings) and is not Guaranteed
by the Company or any Subsidiary;
(14) Indebtedness of the Company, the Issuer or any
Subsidiary Note Guarantor not to exceed, at any one time
outstanding, including all Refinancing Indebtedness Incurred to
Refinance Indebtedness Incurred pursuant to this clause (14),
two times the net cash proceeds received by the Company on or
after July 1, 2009 from the issuance and sale of Qualified
Capital Stock to a Person that is not a Subsidiary of the
Company, to the extent such net cash proceeds have not been used
to make a Restricted Payment pursuant to clause (3)(B) of the
first paragraph or clause (2)(y), (3)(x) or (6) of the
second paragraph of the covenant described under
Limitation on Restricted Payments;
(15) Refinancing Indebtedness in respect of any
Indebtedness Incurred as permitted under paragraph (a) of
this covenant and clauses (1), (3) and (11) of this
paragraph (b) or any Refinancing Indebtedness Incurred to
Refinance such Refinancing Indebtedness;
(16) Capitalized Lease Obligations and Purchase Money
Indebtedness of the Company or any Restricted Subsidiary in an
aggregate principal amount at any one time outstanding,
including all Refinancing Indebtedness Incurred to Refinance
Indebtedness Incurred pursuant to this clause (16), not to
exceed $35 million;
(17) obligations of the Company or any Restricted
Subsidiary in respect of completion guarantees and performance,
bid and surety bonds or similar letters of credit to secure
performance obligations in the ordinary course of business;
(18) additional Indebtedness of the Company or any
Restricted Subsidiary in an aggregate principal amount at any
one time outstanding not to exceed $50 million; and
(19) (a) Indebtedness of the Company, the Issuer or
any Subsidiary Note Guarantors Incurred in connection with the
acquisition of all or a part of a Permitted Business;
provided that, after giving effect to the Incurrence of
such Indebtedness and the use of proceeds therefrom,
(i) the Consolidated Net Fixed Charge Coverage Ratio of the
Company would be greater than immediately prior to such
Incurrence and the use of proceeds therefrom and
(ii) Indebtedness Incurred by the Company and its
Restricted Subsidiaries in connection with such acquisition does
not exceed the greater of 65% of the Fair Market Value of the
acquired Permitted Business (or portion thereof acquired by the
Company, the Issuer or any Subsidiary Note Guarantors) and 3.5
times the Consolidated EBITDA (multiplied by the percentage of
such Permitted Business acquired by the Company, the Issuer or
any Subsidiary Note Guarantors in the case of an acquisition of
less than all of a Permitted Business) of such Permitted
Business for the most recent four fiscal quarters for which
financial statements for such acquired Permitted Business are
available and (b) all Refinancing Indebtedness Incurred to
Refinance any Indebtedness Incurred pursuant to clause (19)(a).
(c) For purposes of determining compliance with, and the
outstanding principal amount of, any particular Indebtedness
Incurred pursuant to and in compliance with this covenant, any
Indebtedness issued at a discount (including Indebtedness on
which interest is payable through the issuance of additional
Indebtedness) will be deemed Incurred at the time of original
issuance of the Indebtedness at the accreted amount thereof.
Accrual of interest, the accretion of accreted value, the
payment of interest in the form of additional Indebtedness, the
payment of dividends on Disqualified Capital Stock in the form
of additional shares of Disqualified Capital Stock with the same
terms and increases in Indebtedness outstanding solely as a
result of fluctuations in the exchange rate of currencies will
not be deemed to be an Incurrence of Indebtedness. For purposes
of determining any particular amount of Indebtedness under this
Limitation on Incurrence of Additional Indebtedness
covenant, Guarantees, Liens or obligations with respect to
letters of credit otherwise supporting Indebtedness otherwise
included in the determination of such particular amount will not
be included. For purposes of determining compliance with this
covenant, in the event that an item of Indebtedness meets the
criteria of more than one of the categories of Permitted
Indebtedness described in clauses (b)(1) through (19) above
or is entitled to be Incurred pursuant to paragraph
(a) above, the Company will, in its sole
38
discretion, classify and may later reclassify such item of
Indebtedness and may divide and classify and may later
reclassify such Indebtedness in more than one of the types of
Indebtedness described.
Limitation
on Restricted Payments
The Company will not, and will not cause or permit any of the
Restricted Subsidiaries to, directly or indirectly, take any of
the following actions (each, a Restricted
Payment):
(a) declare or pay any dividend or return of capital or
make any distribution on or in respect of shares of Capital
Stock of the Company or any Restricted Subsidiary to holders of
such Capital Stock, other than:
|
|
|
|
|
dividends, distributions or returns of capital payable in
Qualified Capital Stock of the Company,
|
|
|
|
dividends, distributions or returns of capital payable to the
Company
and/or a
Restricted Subsidiary, or
|
|
|
|
pro rata dividends, distributions or returns of capital
paid to the Company
and/or the
Restricted Subsidiaries, on the one hand, and minority holders
of Capital Stock of a Restricted Subsidiary, on the other hand;
|
(b) purchase, redeem or otherwise acquire or retire for
value:
|
|
|
|
|
any Capital Stock of the Company, or
|
|
|
|
any Capital Stock of any Restricted Subsidiary, except for
(i) Capital Stock held by the Company or a Restricted
Subsidiary and (ii) purchases, redemptions, acquisitions or
retirement for value of Capital Stock on a pro rata basis
from the Company
and/or any
Restricted Subsidiary, on the one hand, and minority holders of
Capital Stock of a Restricted Subsidiary, on the other hand,
according to their respective percentage ownership of the
Capital Stock of such Restricted Subsidiary;
|
(c) make any principal payment on, purchase, defease,
redeem, prepay or otherwise acquire or retire for value, prior
to any scheduled final maturity, scheduled repayment or
scheduled sinking fund payment, as the case may be, any
Subordinated Indebtedness (other than the payment, redemption,
repurchase, defeasance, acquisition or retirement of
(i) Subordinated Indebtedness in anticipation of satisfying
a sinking fund obligation, principal installment or final
maturity, in each case due within 120 days of the date of
such payment, purchase, defeasance, redemption, prepayment,
acquisition or retirement, and (ii) Indebtedness permitted
under clauses (5) and (6) of the paragraph (b) of
the covenant described under Limitation on
Incurrence of Additional Indebtedness); or
(d) make any Investment (other than Permitted Investments);
if, at the time of such Restricted Payment:
(1) a Default or an Event of Default has occurred and is
continuing or would occur as a consequence thereof;
(2) immediately after giving effect to such transaction on
a pro forma basis, the Company would not be able to Incur
at least $1.00 of additional Indebtedness pursuant to paragraph
(a) of the covenant described under
Limitation on Incurrence of Additional
Indebtedness; or
(3) the aggregate amount (the amount expended for these
purposes, if other than in cash, being the Fair Market Value of
the relevant property) of the proposed Restricted Payment, and
all other Restricted Payments made on or after July 1, 2009
up to the date thereof (including Restricted Payments permitted
by clauses (1), (3)(y) and (z) and (4) of the next
succeeding paragraph, but excluding all other Restricted
Payments permitted by the next succeeding paragraph) will exceed
the sum, without duplication, of:
(A) 50% of cumulative Consolidated Net Income of the
Company accrued during the period, treated as one accounting
period, beginning with the first full fiscal quarter commencing
on or after July 1, 2009 to the end of the most recent
fiscal quarter for which consolidated financial information
39
of the Company is available at the time of such Restricted
Payment (or if such cumulative Consolidated Net Income is a
loss, $0); plus
(B) 100% of the aggregate net cash proceeds and the Fair
Market Value of property and assets (other than cash) to be used
in a Permitted Business, in each case received by the Company on
or after July 1, 2009 from (i) any contribution to the
equity capital of the Company not representing an interest in
Disqualified Capital Stock or (ii) issuance and sale of
Qualified Capital Stock of the Company, including Qualified
Capital Stock issued upon the conversion, exercise or exchange
of Indebtedness, warrants or options (with any such
Indebtedness, warrants or options being treated as an asset used
in a Permitted Business) excluding, in each case, any net cash
proceeds, and the Fair Market Value of property and assets other
than cash:
(w) received from a Subsidiary of the Company;
(x) to the extent used to Incur Indebtedness pursuant to
clause (14) of paragraph (b) of the covenant described
under Limitation on Incurrence of Additional
Indebtedness;
(y) applied in accordance with clause (2), (3), (4) or
(6) of the second paragraph of this covenant below; or
(z) received by the Company from the issuance of Designated
Preferred Stock; plus
(C) the amount of Investment Returns calculated as of such
date.
Notwithstanding the preceding paragraph, this covenant does not
prohibit:
(1) the payment of any dividend, distribution or any
redemption within 60 days after the date of declaration
thereof, if such payment or redemption would have been permitted
on the date of declaration pursuant to the preceding paragraph;
(2) any purchase, redemption, repurchase, defeasance or
other acquisition or retirement of any shares of Capital Stock
of the Company:
(x) in exchange for Qualified Capital Stock of the Company
(including any such exchange pursuant to the exercise of a
conversion right or privilege in connection with which cash is
paid in lieu of fractional shares); and
(y) through the application of the proceeds received by the
Company within 90 days from a sale of Qualified Capital
Stock of the Company or a contribution to the equity capital of
the Company not representing an interest in Disqualified Capital
Stock, in each case not received from a Subsidiary of the
Company;
provided that the value of any such Qualified Capital
Stock issued in exchange for such acquired Capital Stock and any
such proceeds will be excluded from clause (3)(B) of the first
paragraph of this covenant;
(3) the prepayment, purchase, redemption, repurchase,
defeasance or other acquisition or retirement of any
Subordinated Indebtedness:
(x) solely in exchange for, or through the application of
the proceeds within 90 days of a sale, other than to a
Subsidiary of the Company, of Qualified Capital Stock of the
Company or Refinancing Indebtedness for such Subordinated
Indebtedness;
(y) if no Default or Event of Default has occurred and is
continuing, from Net Cash Proceeds from Asset Sales remaining
after the application thereof as required by the covenant
described under Limitation on Asset
Sales (including after making any Asset Sale Offer
required to be made pursuant to such covenant and the
application of the entire Asset Sale Offer Amount to purchase
all Notes tendered pursuant to such Asset Sale Offer); or
(z) if no Default or Event of Default has occurred and is
continuing, following the occurrence of a Change of Control (or
other similar event described therein as a change of
control), but only if the Issuer shall have complied with
the covenant described under Change of
Control and, if
40
required, purchased all Notes tendered pursuant to the offer to
repurchase all the Notes required thereby, prior to purchasing
or repaying such Subordinated Indebtedness;
provided that the value of any Qualified Capital Stock
issued in exchange for such Subordinated Indebtedness and any
such proceeds will be excluded from clause (3)(B) of the first
paragraph of this covenant;
(4) if no Default or Event of Default has occurred and is
continuing, repurchases or acquisitions by the Company of
Capital Stock of the Company or options, warrants, rights or
other securities exercisable or convertible into Capital Stock
of the Company from officers, employees, directors or
consultants or former officers, employees, directors or
consultants of the Company or any of its Subsidiaries or their
authorized representatives pursuant to any management equity
plan or stock option plan or any other management or employee
benefit plan or other agreement or arrangement in an amount not
to exceed $5 million in any calendar year; provided
that if all or part of such $5 million is not used in a
given year, it may be used in the next succeeding calendar year;
provided, further, that such amount in any
calendar year may be increased by an amount not to exceed the
cash proceeds received by the Company or any of its Restricted
Subsidiaries from the sale of Qualified Capital Stock of the
Company to management, directors and consultants of the Company
and its Restricted Subsidiaries that occurs on or after
July 1, 2009; provided, further, that any
such cash proceeds will be excluded from clause (3)(B) of the
first paragraph of this covenant;
(5) if no Default or Event of Default has occurred and is
continuing, the declaration and payment of dividends or
distributions to holders of any class or series of Disqualified
Capital Stock of the Company or any of its Restricted
Subsidiaries Incurred in accordance with the covenant described
under Limitation on Incurrence of Additional
Indebtedness;
(6) the making of any Restricted Payment in exchange for,
or through the application of the proceeds of a sale within
90 days, other than to a Subsidiary of the Company, of
Qualified Capital Stock; provided that any such proceeds
will be excluded from clause (3)(B) of the first paragraph of
this covenant;
(7) non-cash repurchases of Common Stock deemed to occur
upon the exercise of stock options if such Common Stock
represents a portion of the exercise price of such options;
(8) if no Default or Event of Default has occurred and is
continuing, the distribution, as a dividend or otherwise, of
shares of Capital Stock of, or Indebtedness owed to the Company
or a Restricted Subsidiary of the Company by, Unrestricted
Subsidiaries; provided that the acquisition of such
Capital Stock or the lending of such Indebtedness was treated as
a Restricted Payment;
(9) if no Default or Event of Default has occurred or is
continuing, other Restricted Payments made after October 2,
2009 in an amount not to exceed in the aggregate
$50 million;
(10) the declaration and payment of dividends or
distributions to holders of any class or series of Designated
Preferred Stock (other than Disqualified Capital Stock) of the
Company or any of its Restricted Subsidiaries issued after
October 2, 2009; provided that, immediately after
giving pro forma effect to the issuance of such Designated
Preferred Stock (assuming the payment of dividends thereon even
if permitted to accrue under the terms thereof), the Company
could Incur at least $1.00 of additional Indebtedness pursuant
to paragraph (a) of the covenant described under
Limitation on Incurrence of Additional
Indebtedness; and
(11) the purchase of accounts receivable pursuant to a
Receivables Repurchase Obligation in connection with a Qualified
Receivables Transaction.
For purposes of any Designation of any Restricted Subsidiary as
an Unrestricted Subsidiary, all outstanding Investments by the
Company and its Restricted Subsidiaries in the Restricted
Subsidiary subject to such Designation will be deemed to be
Restricted Payments in an amount determined in accordance with
the definition of Investment.
The amount of all Restricted Payments (other than cash) will be
the fair market value on the date of the Restricted Payment of
the asset(s) or securities proposed to be transferred or issued
by the Company or such
41
Subsidiary, as the case may be, pursuant to the Restricted
Payment. The fair market value of any assets or securities that
are required to be valued by this covenant will be determined in
good faith by the Board of Directors of the Company.
Limitation
on Asset Sales
The Company will not, and will not permit any of the Restricted
Subsidiaries to, consummate an Asset Sale unless:
(1) the Company or the applicable Restricted Subsidiary, as
the case may be, receives consideration at the time of such
Asset Sale at least equal to the Fair Market Value of the assets
sold or otherwise disposed of, and
(2) at least 75% of the consideration received for the
assets sold by the Company or the Restricted Subsidiary, as the
case may be, in the Asset Sale will be in the form of cash or
Cash Equivalents.
Solely for purposes of clause (2) of the immediately
preceding paragraph, the following will be deemed to be cash:
(a) the amount (without duplication) of any liabilities
(other than liabilities that are by their terms subordinated to
the Notes, the Elan Note Guarantee or any Subsidiary Note
Guarantee) of the Company or such Restricted Subsidiary that is
expressly assumed by the transferee in such Asset Sale and
with respect to which the Company or such Restricted Subsidiary,
as the case may be, is unconditionally released by the holder of
such Indebtedness;
(b) the amount of any obligations, notes or other
securities received from such transferee that are within
120 days converted by the Company or such Restricted
Subsidiary to cash or Cash Equivalents (to the extent of the
cash or Cash Equivalents actually so received); and
(c) the Fair Market Value of (i) any assets (other
than securities) received by the Company or any Restricted
Subsidiary to be used by it in a Permitted Business,
(ii) Capital Stock in a Person that is engaged in a
Permitted Business that is or thereby becomes a Restricted
Subsidiary or (iii) a combination of (i) and (ii).
The Company or such Restricted Subsidiary, as the case may be,
may apply the Net Cash Proceeds of any such Asset Sale within
365 days after receipt thereof, at its option, to:
(a) prepay, repay or purchase any Pari Passu Indebtedness
of the Company, the Issuer or any Subsidiary Note Guarantor
(provided that if the Company shall so prepay, repay or
repurchase any such Pari Passu Indebtedness, the Company shall
make an offer to purchase the pro rata principal amount of the
Notes (in accordance with the procedures set forth below for an
Asset Sale Offer) at a purchase price equal to 100% of the
principal amount of the Notes to be purchased, plus accrued and
unpaid interest thereon, to the date of purchase) or
Indebtedness of a Restricted Subsidiary that is not a Subsidiary
Note Guarantor and, in the case of any such repayment under any
revolving credit facility, to effect a permanent reduction in
the commitments with respect thereto; and/or
(b) purchase, acquire or otherwise invest in:
(1) any property or assets that replace the property or
assets that are the subject of such Asset Sale,
(2) any property or assets (other than securities or
current assets as determined in accordance with GAAP) useful to
the Company or any Restricted Subsidiary in the conduct of a
Permitted Business from a Person other than the Company and the
Restricted Subsidiaries,
(3) all or substantially all of the assets of a Person
engaged in a Permitted Business,
(4) the Capital Stock of a Person engaged in a Permitted
Business that (i) is a Restricted Subsidiary to the extent
such Capital Stock is acquired from a Person other than the
Company or its
42
Subsidiaries or (ii) becomes a Restricted Subsidiary as a
result of the acquisition of such Capital Stock by the Company
or another Restricted Subsidiary, or
(5) a combination of (1), (2), (3) and (4); and/or
(c) make a capital expenditure that is useful to the
Company or any Restricted Subsidiary in the conduct of a
Permitted Business.
To the extent all or a portion of the Net Cash Proceeds of any
Asset Sale is not applied within the 365 days after the
Asset Sale as described in clause (a), (b) or (c) of
the immediately preceding paragraph, the Company will make an
offer to purchase Notes (the Asset Sale
Offer) at a purchase price equal to 100% of the
principal amount of the Notes to be purchased, plus accrued and
unpaid interest thereon, to the date of purchase (the
Asset Sale Offer Amount). The Company will
purchase pursuant to an Asset Sale Offer from all tendering
Holders on a pro rata basis, and, at the Companys
option, on a pro rata basis from the holders of any other
Pari Passu Indebtedness with similar provisions requiring the
Company to offer to purchase, redeem or repay the other Pari
Passu Indebtedness with the proceeds of Asset Sales, that
principal amount (or accreted value in the case of Indebtedness
issued with original issue discount) of Notes and the other Pari
Passu Indebtedness to be purchased, redeemed or repaid at the
price set forth in the documentation governing such other Pari
Passu Indebtedness equal to such unapplied Net Cash Proceeds.
The Company may, however, defer an Asset Sale Offer until there
is an aggregate amount of unapplied Net Cash Proceeds from one
or more Asset Sales equal to or in excess of $20 million.
At that time, the entire amount of unapplied Net Cash Proceeds,
and not just the amount in excess of $20 million, will be
applied as required pursuant to this covenant. Pending the final
application of any Net Cash Proceeds, the Company may
temporarily reduce revolving credit borrowings or otherwise
invest or use the Net Cash Proceeds in any manner that is not
prohibited by the Indenture.
Each notice of an Asset Sale Offer will be mailed first class,
postage prepaid, to each Holder of Notes as shown on the
register of Holders within 20 days following the
365th day of the receipt of Net Cash Proceeds of any Asset
Sale, with a copy to the Trustee, offering to purchase the Notes
as described above. Each notice of an Asset Sale Offer will
state, among other things, the purchase date (the Asset
Sale Offer Payment Date), which shall be a Business
Day no earlier than 30 days nor later than 60 days
from the date the notice is mailed, other than as may be
required by law. Upon receiving notice of an Asset Sale Offer,
Holders may elect to tender their Notes in whole or in part (in
a principal amount of $100,000 or an integral multiple of $1,000
in excess thereof such that no Note of less than $100,000
remains outstanding thereafter) in exchange for cash.
On the Asset Sale Offer Payment Date, the Company will, to the
extent lawful:
(1) accept for payment all Notes or portions thereof
properly tendered (and not validly withdrawn) pursuant to the
Asset Sale Offer;
(2) deposit with the Paying Agent funds in an amount equal
to the Asset Sale Offer Amount in respect of all Notes or
portions thereof so tendered; and
(3) deliver or cause to be delivered to the Trustee the
Notes so accepted together with an Officers Certificate
stating the aggregate principal amount of Notes or portions
thereof being purchased by the Company.
To the extent Holders of Notes, and holders of other Pari Passu
Indebtedness, if any, which are the subject of an Asset Sale
Offer, properly tender and do not validly withdraw Notes or the
other Pari Passu Indebtedness in an aggregate amount exceeding
the amount of unapplied Net Cash Proceeds, the Company will
purchase the Notes and the other Pari Passu Indebtedness on a
pro rata basis (based on amounts tendered). If only a
portion of a Note is purchased pursuant to an Asset Sale Offer,
a new Note in a principal amount equal to the portion thereof
not purchased will be issued in the name of the Holder thereof
upon cancellation of the original Note (or appropriate
adjustments to the amount and beneficial interests in a global
note will be made, as appropriate); provided that each
such new Note will be in a principal amount of
43
$100,000 or an integral multiple of $1,000 in excess thereof.
Notes (or portions thereof) purchased pursuant to an Asset Sale
Offer will be cancelled and cannot be reissued.
The Company will comply with the requirements of
Rule 14e-1
under the Exchange Act and any other applicable securities laws
in connection with the purchase of Notes pursuant to an Asset
Sale Offer. To the extent that the provisions of any applicable
securities laws or regulations conflict with the Asset
Sale provisions of the Indenture, the Company will comply
with these laws and regulations and will not be deemed to have
breached its obligations under the Asset Sale
provisions of the Indenture by doing so.
Upon completion of an Asset Sale Offer, the amount of Net Cash
Proceeds will be reset at zero. Accordingly, to the extent that
the aggregate amount of Notes and other Indebtedness tendered
pursuant to an Asset Sale Offer is less than the aggregate
amount of unapplied Net Cash Proceeds, the Company may use any
remaining Net Cash Proceeds for general corporate purposes of
the Company and its Restricted Subsidiaries.
In the event of the transfer of substantially all (but not all)
of the property and assets of the Company and its Restricted
Subsidiaries as an entirety to a Person in a transaction
permitted under Limitation on Merger,
Consolidation and Sale of Assets, the Surviving Entity
will be deemed to have sold the properties and assets of the
Company and its Restricted Subsidiaries not so transferred for
purposes of this covenant, and will comply with the provisions
of this covenant with respect to the deemed sale as if it were
an Asset Sale. In addition, the Fair Market Value of properties
and assets of the Company or its Restricted Subsidiaries so
deemed to be sold will be deemed to be Net Cash Proceeds for
purposes of this covenant.
If at any time any non-cash consideration received by the
Company or any Restricted Subsidiary, as the case may be, in
connection with any Asset Sale is converted into or sold or
otherwise disposed of for cash (other than interest received
with respect to any non-cash consideration), the conversion or
disposition will be deemed to constitute an Asset Sale hereunder
and the Net Cash Proceeds thereof will be applied in accordance
with this covenant within 365 days after such conversion or
disposition.
Limitation
on Designation of Unrestricted Subsidiaries
The Company may designate after the Issue Date any Subsidiary of
the Company (including any newly acquired or newly formed
Subsidiary of the Company, but excluding either Issuer) as an
Unrestricted Subsidiary under the Indenture (a
Designation) only if:
(1) no Default or Event of Default has occurred and is
continuing after giving effect to such Designation;
(2) the Subsidiary to be so designated and its Subsidiaries
do not at the time of Designation own any Capital Stock or
Indebtedness of, or own or hold any Lien on any property of, the
Company or any other Subsidiary of the Company that is not a
Subsidiary of the Subsidiary so designated;
(3) the Subsidiary to be so designated and its Subsidiaries
do not at the time of Designation have and do not thereafter
Incur any Indebtedness pursuant to which the lender has recourse
to any of the assets of the Company or any of its Restricted
Subsidiaries; and
(4) either (x) the Subsidiary to be so designated has
total consolidated assets of $1,000 or less or (y) if such
Subsidiary has consolidated assets greater than $1,000, then
such Designation would be permitted under the covenant described
under Limitation on Restricted Payments.
The Company may revoke any Designation of a Subsidiary as an
Unrestricted Subsidiary (a Revocation) only
if, immediately after giving effect to such Revocation:
(1) (x) the Company could Incur at least $1.00 of
additional Indebtedness under paragraph (a) of the covenant
described under Limitation on Incurrence of
Additional Indebtedness or (y) the Consolidated Net
Fixed Charge Coverage Ratio of the Company would be greater than
immediately prior to such Revocation, in each case on a pro
forma basis taking into account such Revocation;
44
(2) all Liens of such Unrestricted Subsidiary outstanding
immediately following such Revocation would, if Incurred at such
time, have been permitted to be Incurred for all purposes of the
Indenture; and
(3) no Default or Event of Default has occurred and is
continuing after giving effect to such Revocation.
Each Designation and Revocation must be evidenced by promptly
delivering to the Trustee a Board Resolution of the Board of
Directors of the Company giving effect to such Designation or
Revocation, as the case may, and an Officers Certificate
certifying compliance with the preceding provisions.
Limitation
on Dividend and Other Payment Restrictions Affecting Restricted
Subsidiaries
The Company will not, and will not cause or permit any of the
Restricted Subsidiaries to, directly or indirectly, create or
otherwise cause or permit to exist or become effective any
encumbrance or consensual restriction on the ability of any
Restricted Subsidiary to:
(1) pay dividends or make any other distributions on or in
respect of its Capital Stock to the Company or any other
Restricted Subsidiary or pay any Indebtedness owed to the
Company or any other Restricted Subsidiary;
(2) make loans or advances to the Company or any other
Restricted Subsidiary; or
(3) transfer any of its property or assets to the Company
or any other Restricted Subsidiary; except, in each case, for
encumbrances or restrictions existing under or by reason of:
(a) applicable law, rule, regulation or order;
(b) any agreement or instrument in existence on
October 2, 2009;
(c) the Notes, the Elan Note Guarantee, the Subsidiary Note
Guarantees and the Indenture;
(d) customary non-assignment provisions of any contract and
customary provisions restricting assignment or subletting in any
lease governing a leasehold interest of any Restricted
Subsidiary and customary restrictions imposed on the transfer of
copyrighted, patented or trademarked materials;
(e) any instrument governing Acquired Indebtedness, which
encumbrance or restriction is not applicable to any Person, or
the properties or assets of any Person, other than the Person or
the properties or assets of the Person, so acquired;
(f) a binding agreement which has been entered into for the
sale or disposition of Capital Stock or assets of such
Restricted Subsidiary; provided that such restrictions
apply solely to the Capital Stock or assets of such Restricted
Subsidiary being sold;
(g) secured Indebtedness otherwise permitted to be Incurred
pursuant to the covenant described under
Limitation on Incurrence of Additional
Indebtedness and Limitation on
Liens that limit the right of the debtor with respect to
the assets securing such Indebtedness;
(h) customary provisions in partnership agreements, limited
liability company organizational governance documents, joint
venture, asset sale and stock sale agreements and other similar
agreements entered into in the ordinary course of business that
restrict the transfer of ownership interests in such
partnership, limited liability company, joint venture or similar
Person;
(i) restrictions on cash or other deposits or net worth
imposed by customers, suppliers or landlords under contracts
entered into in the ordinary course of business;
(j) Indebtedness or other encumbrances or restrictions of a
Receivables Subsidiary in connection with a Qualified
Receivables Transaction; provided that such restrictions
apply only to such Receivables Subsidiary;
(k) any other agreement governing Indebtedness entered into
after October 2, 2009 that contains encumbrances and
restrictions that are not materially more restrictive, taken as
a whole, with respect
45
to any Restricted Subsidiary than those in effect on
October 2, 2009 with respect to that Restricted Subsidiary
pursuant to agreements in effect on October 2, 2009;
(l) other Indebtedness of Restricted Subsidiaries that are
Subsidiary Note Guarantors in an aggregate principal amount at
any one time outstanding not to exceed
$175 million; and
(m) any encumbrances or restrictions imposed by any
amendments, amendments and restatements, supplements,
modifications, extensions, renewals, replacements or
refinancings of the contracts, instruments or obligations
referred to in clauses (a) through (l) above;
provided that such amendments, amendments and
restatements, supplements, modifications, extensions, renewals,
replacements or refinancings are, in the good faith judgment of
the Company, not materially more restrictive, taken as a whole,
with respect to such encumbrances and restrictions than those
prior to such amendments, amendments and restatements,
supplements, modifications, extensions, renewals, replacements
or refinancings.
Limitation
on Liens
The Company will not, and will not cause or permit the Issuer or
any Subsidiary Note Guarantor to, directly or indirectly, Incur
any Liens of any kind (except for Permitted Liens) against or
upon any of their respective properties or assets, whether owned
on October 2, 2009 or acquired after October 2, 2009,
or any proceeds therefrom, to secure any Indebtedness unless
contemporaneously therewith effective provision is made to
secure the Notes, in the case of the Issuer, the Elan Note
Guarantee, in the case of the Company, and the relevant
Subsidiary Note Guarantee, in the case of a Subsidiary Note
Guarantor, and all other amounts due under the Indenture, in
each case, equally and ratably with such Indebtedness (or, in
the event that such Indebtedness is subordinated in right of
payment to the Notes, the Elan Note Guarantee or the relevant
Subsidiary Note Guarantee, as the case may be, prior to such
Indebtedness) with a Lien on the same properties and assets
securing such Indebtedness for so long as such Indebtedness is
secured by such Lien.
Limitation
on Merger, Consolidation and Sale of Assets
The Company will not, and will not cause or permit the Issuer
to, and the Issuer will not, in a single transaction or series
of related transactions, consolidate or merge with or into any
Person (whether or not the Company or the Issuer, as applicable,
is the surviving or continuing Person), or sell, assign,
transfer, lease, convey or otherwise dispose of all or
substantially all of the properties and assets of the Company
(determined on a consolidated basis for the Company and the
Restricted Subsidiaries) or the Issuer, as applicable, to any
Person (each such event involving the Company, a
Company Merger or Sale Event, and each such
event involving the Issuer, an Issuer Merger or Sale
Event) unless:
(a) either:
(1) except in the case of a consolidation or merger between
the Company and the Issuer, the Company, in the case of a
Company Merger or Sale Event, or the Issuer, in the case of an
Issuer Merger or Sale Event, will be the surviving or continuing
Person, or
(2) the Person (if other than the Company or the Issuer, as
applicable) formed by such consolidation or into which the
Company or the Issuer, as applicable, is merged or the Person
which acquires by sale, assignment, transfer, lease, conveyance
or other disposition the properties and assets of the Company
and the Restricted Subsidiaries, or of the Issuer, as the case
may be, substantially as an entirety (the Surviving
Entity):
(A) will be a corporation, partnership or limited liability
company organized and existing under the laws of the United
States of America, any state thereof or the District of
Columbia, Bermuda, Canada, Switzerland, Japan, any AAA Rated
Country or any European Union Country; provided that, in
the case of the Surviving Entity for Elan Finance Corp., only
the United States of America, any state thereof or the District
of Columbia shall be permitted jurisdictions of
organization; and
46
(B) will expressly assume, by supplemental indenture (in
form and substance reasonably satisfactory to the Trustee),
executed and delivered to the Trustee, all obligations of the
Issuer under the Notes and the Indenture, in the case of an
Issuer Merger or Sale Event, or all obligations of the Company
under the Elan Note Guarantee and the Indenture, in the case of
a Company Merger or Sale Event and all obligations of the Issuer
or the Company, as applicable, under the Registration Rights
Agreement;
(b) immediately after giving effect to such transaction and
the assumption contemplated by clause (a)(2)(B) above (including
giving effect on a pro forma basis to any Indebtedness,
including any Acquired Indebtedness, Incurred or to be Incurred
in connection with or in respect of such transaction) and the
use of any net proceeds therefrom, the Company (after an Issuer
Merger or Sale Event or after a Company Merger or Sale Event if
the Company is the surviving or continuing Person) or such
Surviving Entity (after a Company Merger or Sale Event):
(1) could incur $1.00 of additional Indebtedness pursuant
to paragraph (a) of the covenant described under
Limitation on Incurrence of Additional
Indebtedness; or
(2) would have a Consolidated Net Fixed Charge Coverage
Ratio equal to or greater than the Consolidated Net Fixed Charge
Coverage Ratio of the Company immediately prior to such
transaction;
(c) immediately after giving effect to such transaction and
the assumption contemplated by clause (a)(2)(B) above
(including, without limitation, giving effect on a pro forma
basis to any Indebtedness, including any Acquired Indebtedness,
Incurred or to be Incurred and the use of any net proceeds
therefrom and any Lien granted in connection with or in respect
of the transaction), no Default or Event of Default will have
occurred or be continuing; and
(d) the Company, the Issuer or the Surviving Entity,
whichever entity is the surviving or continuing Person after a
Company Merger or Sale Event or an Issuer Merger or Sale Event,
has delivered to the Trustee an Officers Certificate and
an Opinion of Counsel, each stating that the consolidation,
merger, sale, assignment, transfer, lease, conveyance or other
disposition and, if required in connection with such
transaction, the supplemental indenture, comply with the
applicable provisions of the Indenture and the Elan Note
Guarantee (only with respect to a Company Merger or Sale Event)
and that all conditions precedent in the Indenture relating to
such transaction have been satisfied.
For purposes of this covenant, the sale, assignment, transfer,
lease, conveyance or other disposition of all or substantially
all of the properties and assets of one or more Restricted
Subsidiaries of the Company, the Capital Stock of which
constitutes all or substantially all of the properties and
assets of the Company (determined on a consolidated basis for
the Company and the Restricted Subsidiaries), will be deemed to
be the transfer of all or substantially all of the properties
and assets of the Company.
Notwithstanding the foregoing clauses (b) and
(c) above:
(1) the Company or any Restricted Subsidiary may merge or
consolidate with or into, or sell, assign, transfer, lease,
convey or otherwise dispose of all or any part of its properties
or assets to, the Company, the Issuer or another Restricted
Subsidiary; and
(2) the Company and the Issuer may merge or consolidate
with or into, or transfer all of its properties and assets to,
an Affiliate of the Company or the Issuer, as the case may be,
incorporated or formed solely for the purpose of either
reincorporating or reforming the Company or the Issuer, as the
case may be, in another jurisdiction listed in clause (a)(2)(A)
above so long as the amount of Indebtedness of the Company and
its Restricted Subsidiaries is not increased thereby.
Upon any Company Merger or Sale Event in which the Company is
not the surviving or continuing Person, the Surviving Entity
will succeed to, and be substituted for, and may exercise every
right and power of, the Company under the Indenture and the Elan
Note Guarantee with the same effect as if such Surviving Entity
had been named as such.
47
Upon any Issuer Merger or Sale Event in which the Issuer is not
the continuing Person, the Surviving Entity will succeed to, and
be substituted for, and may exercise every right and power of,
the Issuer under the Indenture and the Notes with the same
effect as if such Surviving Entity had been named as such.
For the avoidance of doubt, compliance with this covenant will
not affect the obligations of the Issuer under
Change of Control, if applicable.
Except as provided in the third paragraph under the heading
Note Guarantees, no Subsidiary Note
Guarantor may, in a single transaction or series of related
transactions, consolidate or merge with or into any Person
(whether or not such Subsidiary Note Guarantor is the surviving
or continuing Person), other than the Company, the Issuer or
another Subsidiary Note Guarantor, unless:
(a) either:
(1) such Subsidiary Note Guarantor will be the surviving or
continuing Person; or
(2) the Person (if other than such Subsidiary Note
Guarantor) formed by such consolidation or into which such
Subsidiary Note Guarantor is merged will expressly assume, by
supplemental indenture (in form and substance reasonably
satisfactory to the Trustee), executed and delivered to the
Trustee, all obligations of such Subsidiary Note Guarantor under
the Subsidiary Note Guarantee of such Subsidiary Note Guarantor
and the Indenture and all obligations of such Subsidiary Note
Guarantor under the Registration Rights Agreement; and
(b) immediately after giving effect to such transaction, no
Default or Event of Default will have occurred or be continuing.
Upon any consolidation or merger of a Subsidiary Note Guarantor
in which such Subsidiary Note Guarantor is not the surviving or
continuing Person, the surviving or continuing Person formed by
such consolidation or into which such Subsidiary Note Guarantor
is merged will succeed to, and be substituted for, and may
exercise every right and power of, such Subsidiary Note
Guarantor under the Subsidiary Note Guarantee of such Subsidiary
Note Guarantor with the same effect as if such surviving or
continuing Person had been named as such.
Limitation
on Transactions with Affiliates
(a) The Company will not, and will not permit any
Restricted Subsidiary to, directly or indirectly, enter into any
transaction or series of related transactions (including,
without limitation, the purchase, sale, lease or exchange of any
property or the rendering of any service) with, or for the
benefit of, any of its Affiliates (each an Affiliate
Transaction), unless:
(1) the terms of such Affiliate Transaction are not
materially less favorable to the Company or such Restricted
Subsidiary than those that could be obtained in a comparable
transaction at such time on an arms-length basis from a
Person that is not an Affiliate of the Company or such
Restricted Subsidiary;
(2) in the event that such Affiliate Transaction involves
aggregate payments, or transfers of property or services with a
Fair Market Value, in excess of $5 million, the terms of
such Affiliate Transaction will be approved by a majority of the
members of the Board of Directors of the Company (including a
majority of the disinterested members thereof), the approval to
be evidenced by a Board Resolution, delivered to the Trustee,
stating that the Board of Directors has determined that such
transaction complies with the preceding provisions; and
(3) in the event that such Affiliate Transaction involves
aggregate payments, or transfers of property or services with a
Fair Market Value, in excess of $15 million, the Company or
such Restricted Subsidiary will, prior to the consummation
thereof, obtain and deliver to the Trustee an opinion from an
Independent Financial Advisor that such Affiliate Transaction is
either fair, from a financial point of view, to the Company and
its Restricted Subsidiaries or is on terms not materially less
favorable to the Company or such Restricted Subsidiary than
those that could be obtained in a comparable transaction at
48
such time on an arms-length basis from a Person that is
not an Affiliate of the Company or such Restricted Subsidiary.
(b) Paragraph (a) above will not apply to:
(1) Affiliate Transactions with or among the Company and
any Restricted Subsidiary (other than a Receivables Subsidiary)
or between or among Restricted Subsidiaries (other than a
Receivables Subsidiary);
(2) reasonable director, officer, employee and consultant
compensation (including bonuses) and other benefits (including,
without limitation, retirement, health, stock option and other
benefit plans), indemnification agreements or arrangements,
compensation, employment and severance agreements or
arrangements, in each case approved by the Board of Directors or
senior management of the Company;
(3) transactions effected as part of a Qualified
Receivables Transaction that are customary in connection
therewith;
(4) (A) any transaction with an Affiliate where the
only consideration paid by the Company or a Restricted
Subsidiary is Qualified Capital Stock of the Company or
(B) the issuance or sale of any Qualified Capital Stock of
the Company;
(5) Affiliate Transactions undertaken pursuant to the terms
of any contractual obligations or rights in existence on
October 2, 2009, and any amendment or supplement thereto
that, taken in its entirety, is not materially less favorable to
the Company or a Restricted Subsidiary, as the case may be, than
such contractual obligation or right as in effect on
October 2, 2009;
(6) Permitted Investments and any Restricted Payments made
in compliance with the covenant described under
Limitation on Restricted
Payments; and
(7) transactions with a Person (other than an Unrestricted
Subsidiary) that is an Affiliate of the Company solely because
the Company or a Restricted Subsidiary owns an equity interest
in, or otherwise controls, such Person; provided that no
Affiliate of the Company or any of its Subsidiaries other than
the Company or a Restricted Subsidiary has a beneficial interest
in such Person.
Reports
to Holders
Notwithstanding that the Company may not be required to be or
remain subject to the reporting requirements of
Section 13(a) or 15(d) of the Exchange Act, so long as any
Notes remain outstanding, the Company will file with or furnish
to the Commission, within the time periods applicable to the
Company under the Exchange Act (unless such filing is not
permitted under the Exchange Act or by the Commission), the
annual reports, information, documents and other reports that
the Company is required to file with the Commission pursuant to
such Section 13(a) or 15(d) or would be so required to file
if the Company were so subject. The Company will also, within
15 days after the date on which the Company so files the
same with the Commission (or would be required to so file if
filing is not permitted by the Commission), deliver to the
Holders by first-class mail to each Holders registered
address and to the Trustee, copies of any such information,
documents and reports (without exhibits) so required to be filed.
The availability of the foregoing materials on either the
Commissions Electronic Data Gathering, Analysis and
Retrieval System (or any successor system) or on the
Companys website will be deemed to satisfy the
Companys delivery obligation.
In addition, at any time when the Company or the Issuer is not
subject to or is not current in its reporting obligations, the
Company or the Issuer, as the case may be, will make available,
upon request, to any Holder, to securities analysts and to any
prospective purchaser of Notes the information required pursuant
to Rule 144A(d)(4) under the Securities Act so long as the
Notes are not freely transferable under the Securities Act.
49
Events of
Default
The following are Events of Default with
respect to the Notes:
(1) default in the payment when due of the principal of or
premium, if any, on any Notes, including the failure to make a
required payment to purchase Notes tendered pursuant to an
optional redemption, Change of Control Offer or Asset Sale Offer;
(2) default for 30 days or more in the payment when
due of interest (including additional interest payable under the
Registration Rights Agreement) or Additional Amounts on any
Notes;
(3) the failure by the Company, the Issuer or any
Restricted Subsidiary to comply with the covenant described
under Certain Covenants Limitation
on Merger, Consolidation and Sale of Assets;
(4) the failure by the Company or any Restricted Subsidiary
to comply with any other covenant or agreement contained in the
Indenture or in the Notes for 60 days or more after written
notice thereof to the Company from the Trustee or the Holders of
at least 25% in aggregate principal amount of the outstanding
Notes;
(5) default by the Company or any Restricted Subsidiary
under any Indebtedness which:
(a) is caused by a failure to pay principal on such
Indebtedness at its final stated maturity prior to the
expiration of any applicable grace period provided in such
Indebtedness; or
(b) results in the acceleration of such Indebtedness prior
to its final stated maturity;
and, in each case, the principal or accreted amount of
Indebtedness covered by (a) or (b) at the relevant
time aggregates $40.0 million or more;
(6) failure by the Company or any of the Restricted
Subsidiaries to pay one or more final judgments entered by a
court or courts of competent jurisdiction against any of them
that exceed $40.0 million (net of amounts covered by
insurance or bonded) for the payment of money, which judgment(s)
are not satisfied, annulled, rescinded, discharged or stayed for
a period of 60 days or more after such entry;
(7) certain events of bankruptcy affecting the Company, the
Issuer or any Significant Subsidiary or any group of Restricted
Subsidiaries that, taken together, would constitute a
Significant Subsidiary; or
(8) the Elan Note Guarantee or any Subsidiary Note
Guarantee of any Subsidiary Note Guarantor that is a Significant
Subsidiary is, or Subsidiary Note Guarantees of any group of
Subsidiary Note Guarantors that, taken together, would
constitute a Significant Subsidiary are, held to be
unenforceable or invalid in a judicial proceeding, or the
Company, any such Subsidiary Note Guarantor or any such group of
Subsidiary Note Guarantors, denies or disaffirms the
Companys obligations under its Elan Note Guarantee, such
Subsidiary Note Guarantors obligations under its
Subsidiary Note Guarantee or such group of Subsidiary Note
Guarantors obligations under their Subsidiary Note
Guarantees, as the case may be.
If an Event of Default (other than an Event of Default specified
in clause (7) above with respect to the Company) occurs and
is continuing, the Trustee, by written notice to the Issuer, or
the Holders of at least 25% in aggregate principal amount of the
Notes then outstanding, by written notice to the Issuer and the
Trustee, may declare (an acceleration
declaration) the unpaid principal of and premium, if
any, and accrued and unpaid interest on all the Notes to be
immediately due and payable. Upon such acceleration declaration,
the unpaid principal of and premium, if any, and accrued and
unpaid interest on all the Notes will become immediately due and
payable. If an Event of Default specified in clause (7)
above with respect to the Company occurs, then the unpaid
principal of and premium, if any, and accrued and unpaid
interest on all the Notes will become immediately due and
payable without any declaration or other act on the part of the
Trustee or any Holder.
At any time after an acceleration declaration with respect to
the Notes, as described in the preceding paragraph, the Holders
of at least a majority in aggregate principal amount of the
outstanding Notes may waive all past defaults and rescind and
annul such acceleration and its consequences if all existing
Events of
50
Default except nonpayment of principal and interest that has
become due solely because of the acceleration, have been cured
or waived as provided in the Indenture, and the rescission would
not conflict with any judgment, decree or order of a court of
competent jurisdiction.
The Holders of at least a majority in aggregate principal amount
of the then-outstanding Notes may waive any existing Default or
Event of Default under the Indenture, and its consequences,
except a default in the payment of the principal of, premium, if
any (including Additional Amounts), or interest (including any
additional interest) on any Notes or in respect of a covenant or
provision of the Indenture that cannot be modified or superseded
without the consent of the Holder of each outstanding Note
affected.
Subject to the provisions of the Indenture relating to the
duties of the Trustee, in case an Event of Default occurs and is
continuing, the Trustee will be under no obligation to exercise
any of its rights or powers under the Indenture at the request,
order or direction of any of the Holders, unless such Holders
have offered to the Trustee indemnity or security reasonably
satisfactory to it against any loss, liability or expense.
Subject to all provisions of the Indenture and applicable law,
the Holders of a majority in aggregate principal amount of then
outstanding Notes have the right to direct the time, method and
place of conducting any proceeding for any remedy available to
the Trustee or exercising any trust or power conferred on the
Trustee.
No Holder of any Notes will have any right to institute any
proceeding with respect to the Indenture or for any remedy
thereunder, unless:
(1) such Holder gives to the Trustee written notice of a
continuing Event of Default;
(2) Holders of at least 25% in aggregate principal amount
of then outstanding Notes make a written request to pursue the
remedy;
(3) such Holders of the Notes have offered to the Trustee
security or indemnity reasonably satisfactory to it against any
loss, liability or expense;
(4) the Trustee does not comply within 60 days after
receipt of such notice and the offer of security or
indemnity; and
(5) during such
60-day
period the Holders of a majority in aggregate principal amount
of then-outstanding Notes do not give the Trustee a written
direction which, in the opinion of the Trustee, is inconsistent
with the request;
provided that a Holder of a Note may institute suit for
enforcement of payment of the principal of and premium, if any,
or interest on such Note on or after the respective due dates
expressed in such Note (after giving effect to the grace period
specified in clause (1) of the first paragraph of this
Events of Default section).
The Company is required to deliver to the Trustee written notice
of any event which would constitute certain Defaults or Events
of Default, their status and what action the Company is taking
or proposes to take in respect thereof. In addition, the Company
shall deliver to the Trustee, within 180 days after the end
of each fiscal year, an Officers Certificate indicating
whether the signers thereof know of any Default or Event of
Default that occurred during the previous fiscal year. The
Indenture provides that if a Default or Event of Default occurs,
is continuing and is actually known to the Trustee, the Trustee
must mail to each Holder of Notes notice of the Default or Event
of Default within 90 days after the occurrence thereof.
Except in the case of a Default or Event of Default in the
payment of principal of, premium (including Additional Amounts),
if any, or interest (including additional interest, if any) on
any Note, the Trustee may withhold notice if and so long as a
committee of its trust officers in good faith determines that
withholding such notice is in the interests of the Holders of
Notes.
Legal
Defeasance and Covenant Defeasance
The Issuer may, at its option and at any time, elect to have its
obligations and the obligations of the Company and the
Subsidiary Note Guarantors discharged with respect to the
outstanding Notes (Legal Defeasance). Legal
Defeasance means that (i) the Issuer will be deemed to have
paid and discharged the
51
entire Indebtedness represented by the outstanding Notes,
(ii) the Company will be deemed to have paid and discharged
the entire Indebtedness related to such Notes to the extent
represented by the Elan Note Guarantee and (iii) the
Subsidiary Note Guarantors will be deemed to have paid and
discharged the entire Indebtedness related to such Notes to the
extent represented by the Subsidiary Note Guarantees, and the
Indenture will cease to be of further force or effect as to
outstanding Notes and the Elan Notes Guarantee and the
Subsidiary Note Guarantees with respect to such Notes, except
for:
(1) the rights of Holders to receive payments in respect of
the principal of, premium, if any, and interest on the Notes
when such payments are due solely from the trust specified in
clause (1) of the second succeeding paragraph;
(2) the Issuers obligations with respect to the Notes
concerning issuing temporary Notes, registration of Notes,
mutilated, destroyed, lost or stolen Notes and the maintenance
of an office or agency for payments;
(3) the rights, powers, trust, duties and immunities of the
Trustee and the Issuers obligations in connection
therewith; and
(4) the Legal Defeasance provisions of the Indenture.
In addition, the Issuer may, at its option and at any time,
elect to have the obligations of the Company and the Restricted
Subsidiaries released with respect to most of the covenants that
are described in the Indenture, except as otherwise described in
the Indenture (Covenant Defeasance), and
thereafter any omission to comply with such obligations will not
constitute a Default or Event of Default with respect to the
Notes. In the event Covenant Defeasance occurs, certain events
(not including non-payment, bankruptcy, receivership,
reorganization and insolvency events) described under
Events of Default will no longer
constitute an Event of Default with respect to the Notes. The
Issuer may exercise its Legal Defeasance option regardless of
whether it previously exercised Covenant Defeasance.
In order to exercise either Legal Defeasance or Covenant
Defeasance:
(1) the Issuer must irrevocably deposit with the Trustee,
in trust for the benefit of the Holder of Notes, cash in
U.S. dollars, U.S. Government Obligations, or a
combination thereof, in such amounts as will be sufficient,
without reinvestment, in the opinion of a nationally recognized
firm of independent public accountants selected by the Issuer,
to pay the principal of, premium, if any, and interest on the
Notes, on the stated date for payment thereof or on the
applicable redemption date, as the case may be;
(2) in the case of Legal Defeasance, the Issuer will have
delivered to the Trustee an Opinion of Counsel from counsel in
the United States reasonably acceptable to the Trustee to the
effect that:
(a) the Issuer or the Company has received from, or there
has been published by, the Internal Revenue Service, a letter
ruling of the Internal Revenue Service; or
(b) since October 2, 2009, there has been a change in
the applicable U.S. federal income tax law,
in either case to the effect that, and based thereon such
Opinion of Counsel will state that, the Holders of the Notes
will not recognize income, gain or loss for U.S. federal
income tax purposes as a result of such Legal Defeasance and
will be subject to U.S. federal income tax on the same
amounts, in the same manner and at the same times as would have
been the case if such Legal Defeasance had not occurred;
provided, however, that such Opinion of Counsel
need not be delivered if all Notes not previously delivered to
the Trustee for cancellation have become due and payable or will
become due and payable at their Stated Maturity within one year
under arrangements satisfactory to the Trustee;
(3) in the case of Covenant Defeasance, the Issuer has
delivered to the Trustee an Opinion of Counsel in the United
States reasonably acceptable to the Trustee to the effect that
the Holders of the Notes will not recognize income, gain or loss
for U.S. federal income tax purposes as a result of such
Covenant Defeasance and will be subject to U.S. federal
income tax on the same amounts, in the same
52
manner and at the same times as would have been the case if such
Covenant Defeasance had not occurred;
(4) in the case of Legal Defeasance or Covenant Defeasance,
the Issuer has delivered to the Trustee:
(a) an Opinion of Counsel in Ireland (or such other
jurisdiction in which the Issuer
and/or the
Company is organized) from counsel reasonably acceptable to the
Trustee and independent of the Issuer and the Company to the
effect that the Holders of the Notes will not recognize income,
gain or loss for Irish (or such other jurisdiction in which the
Issuer is organized) tax purposes as a result of Legal
Defeasance or Covenant Defeasance, as the case may be, and will
be subject to Irish (or such other jurisdiction in which the
Issuer
and/or the
Company is organized) taxes on the same amounts, in the same
manner and at the same times as would have been the case if such
Legal Defeasance or Covenant Defeasance, as the case may be, had
not occurred; or
(b) a ruling directed to the Trustee received from the tax
authorities of Ireland (or such other jurisdiction in which the
Issuer
and/or the
Company is organized) to the same effect as the Opinion of
Counsel described in clause (a) above;
(5) the Company will have delivered to the Trustee an
Officers Certificate stating that such Legal Defeasance or
Covenant Defeasance will not result in a breach or violation of,
or constitute a default under, the Indenture or any other
material agreement or instrument to which the Company or any of
its Subsidiaries is a party or by which the Company or any of
its Subsidiaries is bound (except any breach, violation or
default as a result of the borrowing of the funds required to
effect the deposit pursuant to clause (1) of this
paragraph);
(6) the Issuer will have delivered to the Trustee an
Officers Certificate stating that the deposit was not made
with the intent of preferring the Holders of the Notes over any
other creditors of the Issuer or the Company or with the intent
of defeating, hindering, delaying or defrauding any other
creditors of the Issuer or the Company; and
(7) the Issuer will have delivered to the Trustee an
Officers Certificate and an Opinion of Counsel from
counsel reasonably acceptable to the Trustee and independent of
the Issuer and the Company, each stating that all conditions
precedent provided for in, in the case of the Officers
Certificate, clauses (1) through (6) of this paragraph
and, in the case of the Opinion of Counsel, clauses (2)
and/or (3) and (4) of this paragraph, in each case,
have been complied with.
Satisfaction
and Discharge
The Indenture will be discharged and will cease to be of further
effect (except as to rights of registration of transfer or
exchange of the Notes, which will survive until all Notes have
been cancelled) as to all outstanding Notes when either:
(1) all the Notes that have been authenticated and
delivered (except lost, stolen or destroyed Notes which have
been replaced or paid and Notes for whose payment money has been
deposited in trust or segregated and held in trust by the Issuer
and thereafter repaid to the Issuer or discharged from this
trust) have been delivered to the Trustee for
cancellation; or
(2) (a) all Notes not delivered to the Trustee for
cancellation otherwise have become due and payable, will become
due and payable, or may be called for redemption, within one
year or have been called for redemption pursuant to the
provisions described under Optional
Redemption, and the Issuer has irrevocably deposited or
caused to be deposited with the Trustee funds in trust
sufficient to pay and discharge the entire Indebtedness
(including all principal and accrued interest) on the Notes not
theretofore delivered to the Trustee for cancellation;
(b) the Issuer has paid all sums payable by it under the
Indenture; and
(c) the Issuer has delivered irrevocable instructions to
the Trustee to apply the deposited money toward the payment of
the Notes at maturity or on the date of redemption, as the case
may be.
53
In addition, the Issuer must deliver an Officers
Certificate and an Opinion of Counsel stating that all
conditions precedent to satisfaction and discharge have been
complied with.
Transfer
and Exchange
A Holder of the Notes will be able to register the transfer of
or exchange Notes only in accordance with the provisions of the
Indenture. The Registrar may require a Holder, among other
things, to furnish appropriate endorsements and transfer
documents and to pay any taxes and fees required by law or
permitted by the Indenture. Without the prior consent of the
Issuer, the Registrar is not required to register the transfer
of or exchange any Note:
(1) selected for redemption;
(2) for a period of 15 days before a selection of
Notes to be redeemed; or
(3) between a record date and the next succeeding interest
payment date.
For restrictions on the transfer and exchange of any Note, see
Book-Entry.
Modification
of the Indenture
From time to time, the Issuer, the Company, the Subsidiary Note
Guarantors and the Trustee, without the consent of the Holders,
may amend the Indenture or the Notes for certain specified
purposes, including curing ambiguities, defects or
inconsistencies, adding guarantees or covenants, issuing
Additional Notes or Exchange Notes, to provide for the
assumption of the Companys or the Issuers
obligations to the Holders in the case of a merger,
consolidation or sale of all or substantially all of its assets
in accordance with Limitation on Merger,
Consolidation and Sale of Assets, to release any
Subsidiary Note Guarantor from any of its obligations under its
Subsidiary Note Guarantee or the Indenture (to the extent
permitted by the Indenture), to make any other change that does
not materially adversely affect the rights of any Holder or, in
the case of the Indenture, to maintain the qualification of the
Indenture under the Trust Indenture Act. Other
modifications and amendments of the Indenture or the Notes may
be made with the consent of the Holders of at least a majority
in principal amount of then outstanding Notes issued under the
Indenture, except that, without the consent of each Holder
affected thereby, no amendment may:
(1) reduce the amount of Notes whose Holders must consent
to an amendment or waiver;
(2) reduce the rate of or change or have the effect of
changing the time for payment of interest, including defaulted
interest and additional interest, if any, on any Notes or change
in any adverse respect the obligation of the Issuers and the
Note Guarantors to pay Additional Amounts;
(3) reduce the principal of or change or have the effect of
changing the Stated Maturity of any Notes, or change the date on
which any Notes may be subject to redemption or repurchase, or
reduce the redemption or repurchase price therefor;
(4) make any Notes payable in money other than that stated
in the Notes;
(5) make any change in provisions of the Indenture
entitling each Holder to receive payment of principal of,
premium, if any, and interest on such Note on or after the due
date thereof or to bring suit to enforce such payment, or
permitting Holders of a majority in principal amount of Notes to
waive Defaults or Events of Default;
(6) amend, change or modify in any material respect the
obligation of the Issuer to make and consummate a Change of
Control Offer in respect of a Change of Control that has
occurred;
(7) make any change in the provisions of the Indenture
described under Payment of Additional
Amounts that adversely affects the rights of any Holder of
Notes or amend the terms of the Notes in a way that would result
in a loss of exemption from Taxes;
(8) eliminate or modify in any manner the obligations of
the Company with respect to its Elan Note Guarantee or of any
Subsidiary Note Guarantor that is a Significant Subsidiary (or
group of Subsidiary Note Guarantors that, taken together, would
constitute a Significant Subsidiary) in respect of its
54
Subsidiary Note Guarantee (or their Subsidiary Note Guarantees),
which adversely affects Holders in any material respect, except
as contemplated in the Indenture; or
(9) make any change in the provisions of the Indenture or
the related definitions affecting the ranking of the Notes, the
Elan Note Guarantee or any Subsidiary Note Guarantee in a manner
which adversely affects the Holders.
Governing
Law; Jurisdiction
The Indenture and the Notes will be governed by, and construed
in accordance with, the law of the State of New York. The
Issuer, the Subsidiary Note Guarantors and the Company consent
to the non-exclusive jurisdiction of the Federal and State
courts located in the City of New York, Borough of Manhattan,
and have appointed an agent for service of process with respect
to any actions brought in these courts arising out of or based
on the Indenture or the Notes.
The
Trustee
Except during the continuance of an Event of Default, the
Trustee will perform only such duties as are specifically set
forth in the Indenture. During the existence of an Event of
Default, the Trustee will exercise such rights and powers vested
in it by the Indenture, and use the same degree of care and
skill in its exercise as a prudent person would exercise or use
under the circumstances in the conduct of his own affairs.
The Indenture and the provisions of the TIA contain certain
limitations on the rights of the Trustee, should it become a
creditor of the Issuer, to obtain payments of claims in certain
cases or to realize on certain property received in respect of
any such claim as security or otherwise. Subject to the TIA, the
Trustee will be permitted to engage in other transactions;
provided that if the Trustee acquires any conflicting
interest as described in the TIA, it must eliminate such
conflict or resign as provided in the TIA.
No
Personal Liability
No incorporator, director, officer, employee, shareholder or
controlling Person, as such, of the Issuer, the Company or any
Subsidiary Note Guarantor will have any liability for any
obligations of the Issuer under the Notes or the Indenture, the
Company under the Elan Note Guarantee or the Indenture or any
Subsidiary Note Guarantor under its Subsidiary Note Guarantee or
the Indenture for any claims based on, in respect of or by
reason of such obligations or their creation. By accepting a
Note, each Holder waives and releases all such liability. The
waiver and release are part of the consideration for issuance of
the Notes, the Elan Note Guarantee and the Subsidiary Note
Guarantees. The waiver may not be effective to waive liabilities
under the U.S. federal securities laws. It is the view of
the Commission that this type of waiver is against public policy.
Certain
Definitions
Set forth below is a summary of certain of the defined terms
used in the Indenture. Reference is made to the Indenture for a
full definition of all such terms, as well as any other terms
used herein for which no definition is provided.
AAA Rated Country means a country having, at
any date of determination, a credit rating of AAA from S&P
or Aaa from Moodys.
Acceleration Declaration has the meaning set
forth under Events of Default.
Acquired Indebtedness means, with respect to
any specified Person, (a) Indebtedness of any other Person
existing at the time such other Person becomes a Restricted
Subsidiary of or merges or consolidates with or into such
specified Person or (b) Indebtedness secured by a Lien
encumbering any asset acquired by such specified Person, in each
case, other than Indebtedness Incurred as consideration in, in
contemplation of, or to provide all or any portion of the funds
or credit support utilized to consummate, the transaction or
series of related transactions pursuant to which such Restricted
Subsidiary becomes a Restricted Subsidiary or was otherwise
acquired by such specified Person, or such asset was acquired by
such specified Person, as applicable. Such Indebtedness will be
deemed to have been Incurred at the time such Person becomes a
55
Restricted Subsidiary of or merges or consolidates with or into
such specified Person or at the time such asset is acquired by
such specified Person.
Additional Amounts has the meaning set forth
under Payment of Additional Amounts
above.
Additional Notes has the meaning set forth
under Additional Notes above.
Affiliate means, with respect to any
specified Person, any other Person who directly or indirectly
through one or more intermediaries controls, or is controlled
by, or is under common control with, such specified Person. The
term control means the possession, directly
or indirectly, of the power to direct or cause the direction of
the management and policies of a Person, whether through the
ownership of voting securities, by contract or otherwise. No
Person (other than the Company or any Subsidiary of the Company)
in which a Receivables Subsidiary makes an Investment in
connection with a Qualified Receivables Transaction will be
deemed to be an Affiliate of the Company or any of its
Subsidiaries solely by reason of such Investment. For purposes
of the covenant described under Certain
Covenants Limitation on Transactions with
Affiliates, Affiliates will be deemed to include, with
respect to any specified Person, any other Person (1) which
beneficially owns or holds, directly or indirectly, 10% or more
of any class of the Voting Stock of the specified Person or
(2) of which 10% or more of the Voting Stock is
beneficially owned or held, directly or indirectly, by the
specified Person. For purposes of this definition, the terms
controlling, controlled by
and under common control with have
correlative meanings.
Affiliate Transaction has the meaning set
forth under Certain Covenants
Limitation on Transactions with Affiliates.
Alternative Offer has the meaning set forth
under Change of Control.
Applicable Premium has the meaning set forth
under Optional Redemption Make
Whole Redemption.
Asset Acquisition means:
(1) an Investment by the Company or any Restricted
Subsidiary in any other Person pursuant to which such Person
becomes a Restricted Subsidiary, or is merged with or into the
Company or any Restricted Subsidiary;
(2) the acquisition by the Company or any Restricted
Subsidiary of the assets of any Person (other than a Subsidiary
of the Company) which constitute all or substantially all of the
assets of such Person or comprises any division or line of
business of such Person or any other properties or assets of
such Person other than in the ordinary course of
business; or
(3) any Revocation with respect to an Unrestricted
Subsidiary.
Asset Sale means any direct or indirect sale,
disposition, issuance, conveyance, transfer, lease, assignment
or other transfer, including a Sale and Leaseback Transaction
(each, a disposition), by the Company or any
Restricted Subsidiary of:
(a) any Capital Stock (other than Capital Stock of the
Company); or
(b) any properties or assets (other than Capital Stock,
cash or Cash Equivalents) of the Company or any Restricted
Subsidiary made outside the ordinary course of business.
Notwithstanding the foregoing, the following items will not be
deemed to be Asset Sales:
(1) a disposition permitted under Certain
Covenants Limitation on Merger, Consolidation and
Sale of Assets;
(2) the disposition of damaged, obsolete or worn-out
equipment or assets that are no longer useful in the business of
the Company or any of its Restricted Subsidiaries;
(3) the making of Permitted Investments and Restricted
Payments permitted under the covenant described under
Certain Covenants Limitation on
Restricted Payments;
(4) the creation of or realization on any Lien permitted
under the Indenture;
56
(5) the sale or grant of licenses or sublicenses to use, or
the assignment of, patents, trade secrets, know-how and other
intellectual property, and the grant of licenses or sublicenses
to use, or the lease or sublease of, other properties or assets
of the Company or any Restricted Subsidiary to the extent not
materially interfering with the business of the Company and the
Restricted Subsidiaries;
(6) a disposition between or among the Company
and/or the
Restricted Subsidiaries;
(7) sales of accounts receivable and related assets of the
type described in the definition of Qualified Receivables
Transaction to a Receivables Subsidiary in a Qualified
Receivables Transaction;
(8) a transfer of accounts receivable and related assets of
the type described in the definition of Qualified
Receivables Transaction (or a fractional undivided
interest therein) by a Receivables Subsidiary in a Qualified
Receivables Transaction;
(9) the surrender or waiver of contract rights or the
settlement, release or surrender of contract, tort or other
claims of any kind;
(10) any disposition of Capital Stock, Indebtedness or
other securities of an Unrestricted Subsidiary;
(11) any disposition by the Company or any of its
Restricted Subsidiaries of any security classified, under GAAP,
as an investment security or a marketable investment security on
the consolidated balance sheet of the Company as of
October 2, 2009; provided that the aggregate Net
Cash Proceeds received by the Company or its Restricted
Subsidiaries with respect to securities disposed of pursuant to
this clause (11) shall not exceed
$135 million; and
(12) any disposition that, but for this clause, would be an
Asset Sale, if after giving effect to such disposition, the
aggregate Fair Market Value of the assets disposed of in such
transaction or any such series of related transactions does not
exceed $5 million.
Asset Sale Offer has the meaning set forth
under Certain Covenants Limitation
on Asset Sales.
Asset Sale Offer Amount has the meaning set
forth under Certain Covenants
Limitation on Asset Sales.
Asset Sale Offer Payment Date has the meaning
set forth under Certain Covenants
Limitation on Asset Sales.
Asset Sale Transaction means any Asset Sale
and, whether or not constituting an Asset Sale, (1) any
Designation with respect to an Unrestricted Subsidiary and
(2) any sale or other disposition of property or assets
excluded from the definition of Asset Sale by
clause (3) or (11) of that definition.
Board of Directors means, with respect to any
Person, the board of directors, management committee or similar
governing body of such Person or any duly authorized committee
thereof.
Board Resolution means, with respect to any
Person, a copy of a resolution certified by the Secretary or an
Assistant Secretary of such Person to have been duly adopted by
the Board of Directors of such Person and to be in full force
and effect on the date of such certification, and delivered to
the Trustee.
Capital Stock means:
(1) with respect to any Person that is a corporation, any
and all shares, interests, participations or other equivalents
(however designated and whether or not voting) of corporate
stock, including each class of Common Stock and Preferred Stock
of such Person;
(2) with respect to any Person that is not a corporation,
any and all partnership or other equity or ownership interests
of such Person; and
(3) any warrants, rights or options to purchase any of the
instruments or interests referred to in clause (1) or
(2) above (but excluding any debt securities convertible,
exercisable or exchangeable into the same).
Capitalization means, with respect to any
Person, combined debt and equity capital or assets.
57
Capitalized Lease Obligations means, with
respect to any Person, the obligations of such Person under a
lease that are required to be classified and accounted for as
capital lease obligations for financial reporting purposes under
GAAP. For purposes of this definition, the amount of such
obligations at any date will be the capitalized amount of such
obligations at such date, determined in accordance with GAAP.
Cash Equivalents means:
(1) marketable direct obligations issued by, or
unconditionally guaranteed by, the government of the United
States or any European Union Country or issued by any agency
thereof and backed by the full faith and credit of the United
States or any European Union Country, in each case maturing
within one year from the date of acquisition thereof;
(2) marketable direct obligations issued by any state of
the United States of America or any European Union Country or
any political subdivision of any such jurisdiction or any public
instrumentality thereof maturing within one year from the date
of acquisition thereof and, at the time of acquisition, having
one of the two highest ratings obtaining from either S&P or
Moodys (or the equivalent rating by a comparable rating
agency in any European Union Country);
(3) commercial paper maturing no more than one year from
the date of creation thereof and, at the time of acquisition,
having a rating of at least
A-1 from
S&P or at least
P-1 from
Moodys;
(4) overnight bank deposits, demand deposits, certificates
of deposit, time deposits, bankers acceptances or money
market deposits (or, with respect to foreign banks, similar
instruments) maturing within one year from the date of
acquisition thereof issued by any bank organized under the laws
of the United States of America or any state thereof or the
District of Columbia, or any European Union Country, or any
U.S. branch of a
non-U.S. bank
having at the date of acquisition thereof combined capital and
surplus of not less than $500 million (or the foreign
currency equivalent thereof);
(5) repurchase obligations with a term of not more than
30 days for underlying securities of the types described in
clauses (1), (2) or (4) above entered into with any
bank meeting the qualifications specified in clause (4)
above; and
(6) investments in money market funds which invest
substantially all of their assets in securities of the types
described in clauses (1) through (5) above.
Change of Control means the occurrence of one
or more of the following events:
(1) the sale, assignment, transfer, lease, conveyance or
other disposition of, in a single transaction or in a series of
related transactions, all or substantially all the properties
and assets of the Company and its Subsidiaries, taken as a
whole, to any Person;
(2) any person or group (as such
terms are defined in Sections 13(d) and 14(d) of the
Exchange Act) is or becomes the beneficial owner (as
defined in
Rules 13d-3
and 13d-5
under the Exchange Act), directly or indirectly, in the
aggregate of more than 40% of the total voting power of the
Voting Stock of the Company;
(3) individuals who on October 2, 2009 constituted the
Board of Directors of the Company (together with any new
directors whose election to such Board of Directors of the
Company or whose nomination for election by the shareholders of
the Company was approved by a vote of a majority of the
directors of the Company then still in office who were either
directors on October 2, 2009 or whose election or
nomination for election was previously so approved) cease for
any reason to constitute a majority of the Board of Directors of
the Company;
(4) the approval by the holder of Capital Stock of the
Company of any plan or proposal for the liquidation or
dissolution of the Company (whether or not in compliance with
the provisions of the Indenture); or
(5) the Company consolidates with, or merges with or into,
another Person, other than a transaction where the Person or
Persons that, immediately prior to such transaction
beneficially owned the outstanding Voting Stock of
the Company are, by virtue of such prior ownership, the
beneficial owners
58
in the aggregate of a majority of the total voting power of then
outstanding Voting Stock of the surviving or transferee person
(or if such surviving or transferee Persons is a direct or
indirect wholly owned subsidiary of another Person, such Person
who is the ultimate parent entity), in each case whether or not
such transaction is otherwise in compliance with the Indenture.
Change of Control Offer has the meaning set
forth under Change of Control.
Change of Control Payment has the meaning set
forth under Change of Control.
Change of Control Payment Date has the
meaning set forth under Change of
Control.
Commission means the Securities and Exchange
Commission, or any successor agency thereto with respect to the
regulation or registration of securities.
Commodity Price Protection Agreement means,
with respect to any Person, any forward contract, futures
contract, commodity swap, commodity option or other similar
agreement or arrangement (including derivative agreements or
arrangements) as to which such Person is a party or a
beneficiary relating to, or the value of which is dependent upon
or which is designed to protect such Person against,
fluctuations in commodity prices.
Common Stock means, with respect to any
Person, any and all shares, interests or other participations in
and other equivalents (however designated and whether voting or
non-voting) of such Persons common equity interests,
whether outstanding on October 2, 2009 or issued after
October 2, 2009, and includes, without limitation, all
series and classes of such common equity interests.
Company Merger or Sale Event has the meaning
set forth under the covenant described under
Certain Covenants Limitation on
Merger, Consolidation and Sale of Assets.
Consolidated EBITDA means, with respect to
any Person for any period, Consolidated Net Income for such
Person for such period, plus, without duplication, the
following, to the extent deducted in calculating such
Consolidated Net Income:
(1) Consolidated Income Tax Expense for such Person for
such period; plus
(2) Consolidated Net Interest Expense for such Person for
such period; plus
(3) Consolidated Non-cash Charges for such Person for such
period; plus
(4) any fees, expenses or charges related to any Equity
Offering or Incurrence of Indebtedness permitted by the
Indenture (whether or not consummated or Incurred).
less, without duplication:
(a) all non-cash credits and gains increasing Consolidated
Net Income for such Person for such period (excluding any such
credit or gain which constitutes the reversal of an accrual of,
or a reserve for, anticipated cash charges for any future
period); and
(b) all cash payments made by such Person and its
Subsidiaries (Restricted Subsidiaries, in the case of the
Company) during such period relating to non-cash charges that
were added back in determining Consolidated EBITDA in any prior
period.
Consolidated Income Tax Expense means, with
respect to any Person for any period, the provision for income
taxes payable by such Person and its Subsidiaries (Restricted
Subsidiaries, in the case of the Company) for such period,
determined on a consolidated basis in accordance with GAAP.
Consolidated Net Fixed Charge Coverage Ratio
means, with respect to any Person as of any date of
determination, the ratio of the aggregate amount of Consolidated
EBITDA of such Person for the four most recent full consecutive
fiscal quarters for which financial statements for such Person
are available ending prior to the date of such determination to
Consolidated Net Fixed Charges of such Person for such period.
For purposes of this definition, Consolidated EBITDA
and Consolidated Net Fixed Charges will be
calculated
59
after giving effect on a pro forma basis, for the period (the
Period) for which the Consolidated Net Fixed
Charge Coverage Ratio is being determined to:
(1) the Incurrence of any Indebtedness of such Person or
any of its Subsidiaries (Restricted Subsidiaries, in the case of
the Company), including the Incurrence of any Indebtedness
giving rise to the need to make such determination, occurring
during such Period or at any time subsequent to the last day of
such Period and on or prior to such date of determination, as if
such Incurrence occurred on the first day of such Period;
(2) the repayment, redemption, repurchase, defeasance or
other acquisition, retirement or discharge of any Indebtedness
of such Person or any of its Subsidiaries (Restricted
Subsidiaries, in the case of the Company) that is no longer
outstanding on such date of determination, including the
repayment, redemption, repurchase, defeasance or other
acquisition, retirement or discharge of any Indebtedness
occurring in connection with a transaction giving rise to the
need to make such determination, occurring during such Period or
at any time subsequent to the last day of such Period and on or
prior to such date of determination, as if such repayment,
redemption, repurchase, defeasance or other acquisition,
retirement or discharge occurred on the first day of such
Period; and
(3) any Asset Sale Transaction or Asset Acquisition by such
Person or any of its Subsidiaries (Restricted Subsidiaries, in
the case of the Company), including any Asset Sale Transaction
or Asset Acquisition giving rise to the need to make such
determination, that occurred during such Period or at any time
subsequent to the last day of such Period and on or prior to
such date of determination, as if such Asset Sale Transaction or
Asset Acquisition occurred on the first day of such Period.
For purposes of this definition, whenever pro forma effect is to
be given to any Asset Sale Transaction, Asset Acquisition or
other transaction, or the amount of income or earnings relating
thereto and the amount of Consolidated Net Interest Expense
associated with any Indebtedness Incurred or repaid, redeemed,
repurchased, defeased or otherwise acquired, retired or
discharged in connection therewith, the pro forma calculations
in respect thereof (including, without limitation, in respect of
anticipated cost savings or synergies relating to any such Asset
Sale Transaction, Asset Acquisition or other transaction) will
be as determined in good faith by a responsible financial or
accounting officer of such Person. If any Indebtedness bears a
floating rate of interest and is being given pro forma effect,
the interest expense on such Indebtedness will be calculated as
if the rate in effect on the date of determination had been the
applicable rate for the entire period (taking into account any
Interest Rate Agreement applicable to such Indebtedness). If any
Indebtedness bears, at the option of such Person or a Subsidiary
of such Person (Restricted Subsidiary, in the case of the
Company), a rate of interest based on a prime or similar rate, a
eurocurrency interbank offered rate or other fixed or floating
rate, and such Indebtedness is being given pro forma effect, the
interest expense on such Indebtedness will be calculated by
applying such optional rate as such Person or such Subsidiary
(Restricted Subsidiary, in the case of the Company) may
designate. If any Indebtedness that is being given pro forma
effect was Incurred under a revolving credit facility, the
interest expense on such Indebtedness will be computed based
upon the average daily balance of such Indebtedness during the
applicable period. Interest on a Capitalized Lease Obligation
will be deemed to accrue at an interest rate determined in good
faith by a responsible financial or accounting officer of such
Person to be the rate of interest implicit in such Capitalized
Lease Obligation in accordance with GAAP.
Consolidated Net Fixed Charges means, with
respect to any Person for any period, the sum, without
duplication, of:
(1) Consolidated Net Interest Expense for such Person for
such period; plus
(2) the amount of all cash dividends or distributions on
any series of Preferred Stock or Disqualified Stock of such
Person or any Subsidiary of such Person (Restricted Subsidiary,
in the case of the Company) paid during such period, excluding
dividends and distributions paid to such Person or another
Subsidiary of such Person (Restricted Subsidiary, in the case of
the Company).
60
Consolidated Net Income means, with respect
to any specified Person for any period, the aggregate net income
(or loss) of such specified Person and its Subsidiaries for such
period on a consolidated basis, determined in accordance with
GAAP; provided that there will be excluded therefrom:
(1) net after-tax gains or losses realized upon any Asset
Sale Transaction or abandonments or reserves relating thereto;
(2) (a) net after-tax items classified as
extraordinary gains or losses and (b) non-cash unusual or
nonrecurring gains or losses (including, without limitation, all
non-cash restructuring and acquisition integration costs and any
non-cash expense or charge related to the repurchase of Capital
Stock or warrants or options to purchase Capital Stock);
(3) the net income (but not loss) of any Subsidiary of the
specified Person (Restricted Subsidiary, in the case of the
Company) to the extent that a corresponding amount could not be
distributed to the specified Person at the date of determination
as a result of any restriction pursuant to such constituent
documents of such Subsidiary (Restricted Subsidiary, in the case
of the Company) or any law, regulation, agreement or judgment
applicable to any such distribution unless such restrictions
have been legally waived; provided, however, that
for purposes of calculating Consolidated EBITDA, the net income
(but not loss) of a Subsidiary Note Guarantor shall not be
excluded hereunder to the extent that a corresponding amount
could not be distributed to the specified Person at the date of
determination as a result of any restriction pursuant to any
applicable law, rule or regulation or restrictions permitted by
clause (l) of Certain
Covenants Limitation on Dividend and Other Payment
Restrictions Affecting Restricted Subsidiaries;
(4) the net income (but not loss) of any Person, other than
the specified Person and its Subsidiaries (Restricted
Subsidiaries, in the case of the Company), except that the
specified Persons equity in the net income of such Person
for such period will be included in such Consolidated Net Income
up to the aggregate amount actually distributed by such Person
during such period to the specified Person or a Subsidiary of
the specified Person (Restricted Subsidiary, in the case of the
Company) as a dividend or other distribution (subject, in the
case of a dividend or other distribution to a Subsidiary
(Restricted Subsidiary, in the case of the Company), to the
limitations contained in clause (3) above) and excluding
any amounts included in the definition of Investment
Return;
(5) any restoration to income of any contingency reserve,
except to the extent that provision for such reserve was made
out of Consolidated Net Income accrued at any time on or after
July 1, 2009;
(6) the cumulative effect of changes in accounting
principles;
(7) all deferred financing costs written off and net
after-tax gains or losses attributable to early extinguishment
of Indebtedness;
(8) any unrealized gains or losses with respect to Hedging
Obligations;
(9) any non-cash compensation charge, including, without
limitation, in connection with the grant of stock, stock options
or other equity-based awards;
(10) net after-tax gains or losses from discontinued
operations;
(11) any increase in depreciation or amortization or any
non-cash charges (such as purchased in-process research and
development or capitalized manufacturing profit in inventory)
resulting from purchase accounting in connection with any
acquisition that is consummated on or after July 1, 2009;
(12) for purposes of the covenant described under
Certain Covenants Limitation on
Restricted Payments, the net income (or loss) of any
Person acquired in a pooling of interests
transaction for any period prior to the date of such
acquisition; and
(13) net after-tax non-cash gains or losses due solely to
fluctuations of currency values and unrealized gains or losses
with respect to Hedging Obligations.
61
In addition, for purposes of clause (3)(C) of the first
paragraph of the covenant described under
Certain Covenants Limitation on
Restricted Payments, any Investment Return included in
such clause will be excluded from Consolidated Net Income.
Consolidated Net Interest Expense means, with
respect to any Person for any period, the aggregate of cash and
non-cash interest expense of such Person and its Subsidiaries
(Restricted Subsidiaries, in the case of the Company) for such
period, net of any interest income of such Person and its
Subsidiaries (Restricted Subsidiaries, in the case of the
Company), determined on a consolidated basis in accordance with
GAAP, excluding, to the extent otherwise included in such
interest expense, amortization or write-off of deferred
financing costs, but including, without limitation, the
following, whether or not constituting interest expense in
accordance with GAAP:
(1) any amortization or accretion of debt discount or any
interest paid on Indebtedness of such Person or its Subsidiaries
(Restricted Subsidiaries, in the case of the Company) in the
form of additional Indebtedness;
(2) all capitalized interest;
(3) commissions, discounts and other fees and charges
Incurred in respect of letters of credit or bankers
acceptances;
(4) any interest not otherwise included in Consolidated Net
Interest Expense for such Person on Indebtedness of another
Person (other than a Subsidiary (Restricted Subsidiary in the
case of the Company) of such Person) that is Guaranteed by such
Person or one of its Subsidiaries (Restricted Subsidiaries, in
the case of the Company) or secured by a Lien on the assets of
such Person or one of its Subsidiaries (Restricted Subsidiaries,
in the case of the Company) whether or not such Guarantee or
Lien is called upon; and
(5) interest expense attributable to Capitalized Lease
Obligations.
Consolidated Net Interest Expense will be determined after
giving effect to any net payments made or received by such
Person and its Subsidiaries (Restricted Subsidiaries, in the
case of the Company) with respect to Interest Rate Agreements.
Consolidated Non-cash Charges means, with
respect to any Person for any period, the aggregate
depreciation, amortization and other non-cash charges, expenses
or losses of such Person and its Subsidiaries (Restricted
Subsidiaries, in the case of the Company) for such period,
determined on a consolidated basis in accordance with GAAP
(excluding any such charge which constitutes an accrual of, or a
reserve for cash charges for, any anticipated future period).
Consolidated Total Assets means the total
consolidated assets of the Company and the Restricted
Subsidiaries as set forth on the most recent balance sheet of
the Company, prepared in accordance with GAAP.
Covenant Defeasance has the meaning set forth
under Legal Defeasance and Covenant
Defeasance.
Covenant Reinstatement Date has the meaning
set forth under Certain Covenants Covenant
Suspension.
Covenant Reinstatement Period has the meaning
set forth under Certain Covenants Covenant
Suspension.
Currency Agreement means, with respect to any
Person, any foreign exchange contract, currency swap agreement
or other similar agreement or arrangement (including derivative
agreements or arrangements) as to which such Person is a party
or a beneficiary designed to hedge foreign currency risk of such
Person.
Debt Facility means one or more debt
facilities, commercial paper facilities or indentures, in each
case with banks or other institutional lenders or a trustee
(which may be outstanding at the same time), providing for
revolving credit loans, term loans, letters of credit,
receivables financing, commercial paper or any other form of
senior debt securities and, in each case, as such agreements may
be amended, amended and restated,
62
supplemented, modified, extended, refinanced, replaced or
otherwise restructured, in whole or in part from time to time
(including increasing the amount of available borrowings
thereunder or adding Subsidiaries of the Company as borrowers or
guarantors thereunder) with respect to all or any portion of the
Indebtedness under such agreement or agreements or any successor
or replacement agreement or agreements and whether by the same
or any other agent, lender or group of lenders or trustee or
trustees.
Default means an event or condition the
occurrence of which is, or with the lapse of time or the giving
of notice or both would be, an Event of Default.
Designated Preferred Stock means Preferred
Stock of the Company that is issued for cash (other than to a
Subsidiary of the Company) and is so designated as Designated
Preferred Stock, pursuant to an Officers Certificate, on
the issue date thereof, the cash proceeds of which are excluded
from the calculation set forth in clause (3)(B) of the first
paragraph of the covenant described under
Certain Covenants Limitation on
Restricted Payments.
Designation has the meanings set forth under
Certain Covenants Limitation on
Designation of Unrestricted Subsidiaries.
Disqualified Capital Stock means, with
respect to any Person, that portion of any Capital Stock of such
Person which, by its terms (or by the terms of any security into
which it is convertible or exercisable, or for which it is
exchangeable, at the option of the holder thereof), or upon the
happening of any event, matures or is mandatorily redeemable,
pursuant to a sinking fund obligation or otherwise, or is
redeemable at the sole option of the holder thereof (other than
as a result of a change of control or asset sale; provided
that the relevant change of control or asset sale
provisions, taken as a whole, are no more favorable in any
material respect to the holders of such Capital Stock than the
change of control and asset sale provisions applicable to the
Notes and any purchase requirements triggered thereby may not
become operative prior to compliance with the provisions of the
Indenture described under Change of
Control or Certain Covenants
Limitation on Asset Sales, as the case may be, including
the purchase of the Notes tendered pursuant thereto), in any
case, on or prior to the Stated Maturity of the Notes;
provided that any Capital Stock of such Person that would
otherwise be Disqualified Capital Stock that, by its terms,
authorizes such Person to satisfy in full its obligations with
respect to the payment of dividends or upon maturity, redemption
(pursuant to a sinking fund or otherwise) or repurchase thereof
or otherwise by the delivery of Capital Stock that is not
Disqualified Capital Stock, and that is not convertible,
puttable or exchangeable for Disqualified Capital Stock or
Indebtedness, will not be deemed to be Disqualified Capital
Stock so long as such Person satisfies its obligations with
respect thereto solely by the delivery of Capital Stock that is
not Disqualified Capital Stock.
Elan Note Guarantee means the guarantee of
the Issuers obligations under the Notes and the Indenture
provided by the Company pursuant to the Indenture.
Equity Offering has the meaning set forth
under Optional Redemption.
European Union Country means any member of
the European Union.
Event of Default has the meaning set forth
under Events of Default.
Exchange Act means the Securities Exchange
Act of 1934, as amended, or any successor statute or statutes
thereto.
Exchange Notes has the meaning set forth
under Exchange Offer; Registration Rights.
Existing 2013 Notes means the outstanding
8.875% Senior Fixed Rate Notes due 2013 and the outstanding
Senior Floating Rate Notes due 2013 issued from time to time
pursuant to the Existing 2013 Notes Indenture.
Existing 2013 Notes Indenture means the
Indenture, dated as of November 22, 2006, by and among the
Issuer, the Company, the note guarantors named therein and The
Bank of New York Mellon (formerly known as The Bank of New
York), as trustee, as may be amended, modified or supplemented
from time to time.
Existing 2016 Notes issued October 2009 means
the 8.75% Senior Notes due 2016 issued from time to time
pursuant to the Existing 2016 October 2009 Notes Indenture.
63
Existing 2016 October 2009 Notes
Indenture means the Indenture, dated as of
October 2, 2009, by and among the Issuer, the Company, the
note guarantors named therein and BNY Corporate Trustee Services
Limited, as trustee, as may be amended, modified or supplemented
from time to time.
Fair Market Value means, with respect to any
asset, the price (after taking into account any liabilities
relating to such assets) which could be negotiated in an
arms-length free market transaction, for cash, between a
willing seller and a willing and able buyer, neither of which is
under any compulsion to complete the transaction; provided
that the Fair Market Value of any such asset will be
determined conclusively by the Board of Directors of the Company
acting in good faith.
Foreign Restricted Subsidiary means any
Restricted Subsidiary incorporated or organized in any
jurisdiction outside the United States or Ireland.
GAAP means generally accepted accounting
principles set forth in the opinions and pronouncements of the
Accounting Principles Board of the American Institute of
Certified Public Accountants and statements and pronouncements
of the Financial Accounting Standards Board or in such other
statements by such other entity as may be approved by a
significant segment of the accounting profession of the United
States, as in effect on or after July 1, 2009.
Guarantee means any obligation, contingent or
otherwise, of any Person directly or indirectly guaranteeing any
Indebtedness of any other Person:
(1) to purchase or pay, or advance or supply funds for the
purchase or payment of, such Indebtedness of such other Person,
whether arising by virtue of partnership arrangements, or by
agreement to keep-well, to purchase assets, goods, securities or
services, to
take-or-pay,
or to maintain financial statement conditions or
otherwise; or
(2) entered into for purposes of assuring in any other
manner the obligee of such Indebtedness of the payment thereof
or to protect such obligee against loss in respect thereof, in
whole or in part,
provided that the term Guarantee will not
include endorsements for collection or deposit in the ordinary
course of business. Guarantee used as a verb
has a corresponding meaning.
Hedging Obligations, of any Person, means the
obligations of such Person pursuant to any Interest Rate
Agreement, Currency Agreement or Commodity Price Protection
Agreement.
Holder means the Person in whose name a Note
is registered in the Note Register.
Incur means, with respect to any Indebtedness
or other obligation of any Person, to create, issue, incur
(including by conversion, exchange or otherwise), assume,
Guarantee or otherwise become liable in respect of such
Indebtedness or other obligation on the balance sheet of such
Person (and Incurrence,
Incurred and Incurring
will have meanings correlative to the foregoing); provided
that a change in GAAP that results in an obligation of such
Person that exists at such time becoming Indebtedness will not
be deemed an Incurrence of such Indebtedness. Accrual of
interest, the accretion of accreted value, the payment of
interest in the form of additional Indebtedness, the payment of
dividends on Disqualified Capital Stock in the form of
additional shares of Disqualified Capital Stock with the same
terms and increases in Indebtedness outstanding solely as a
result of fluctuations in the exchange rate of currencies will
not be deemed to be an Incurrence of Indebtedness. Any
Indebtedness issued at a discount (including Indebtedness on
which interest is payable through the issuance of additional
Indebtedness) will be deemed Incurred at the time of original
issuance of the Indebtedness at the accreted amount thereof.
Indebtedness means, with respect to any
Person, without duplication:
(1) the principal amount (or, if less, the accreted value)
of all obligations of such Person for borrowed money;
(2) the principal amount (or, if less, the accreted value)
of all obligations of such Person evidenced by bonds,
debentures, notes or other similar instruments;
(3) all Capitalized Lease Obligations of such Person;
64
(4) all obligations of such Person issued or assumed as the
deferred purchase price of property, all conditional sale
obligations and all obligations under any title retention
agreement (but not including trade accounts payable and other
accrued liabilities arising in the ordinary course of business
that are not overdue by 120 days or more or are being
contested in good faith by appropriate proceedings promptly
instituted and diligently conducted);
(5) all letters of credit, bankers acceptances or
similar credit transactions, including reimbursement obligations
in respect thereof;
(6) Guarantees of such Person in respect of Indebtedness of
any other Person referred to in clauses (1) through
(5) above and clauses (8) and (9) below (other
than by endorsement of negotiable instruments for collection in
the ordinary course of business);
(7) all Indebtedness of any other Person of the type
referred to in clauses (1) through (6) above which is
secured by any Lien on any property or asset of such Person, the
amount of such Indebtedness being deemed to be the lesser of
(a) the Fair Market Value of such property or asset and
(b) the amount of the Indebtedness so secured;
(8) to the extent not otherwise included in this
definition, all obligations under Hedging Obligations of such
Person (the amount of any such obligation to be equal at any
time to the termination value of such agreement or arrangement
giving rise to such Hedging Obligation that would be payable by
such Person at any time); and
(9) the redemption, repayment or other repurchase amount of
such Person with respect to any Disqualified Capital Stock
issued by such Person, but excluding accrued dividends (the
amount of such obligation to be equal at any time to the maximum
fixed involuntary redemption, repayment or repurchase price for
such Disqualified Capital Stock, or if less (or if such
Disqualified Capital Stock has no such fixed price), to the
involuntary redemption, repayment or repurchase price calculated
in accordance with the terms thereof as if then redeemed, repaid
or repurchased, and if such price is based upon or measured by
the Fair Market Value of such Disqualified Capital Stock, such
Fair Market Value will be as conclusively determined in good
faith by the Board of Directors of the Company or the Board of
Directors of the issuer of such Disqualified Capital Stock, in
each case as evidenced by a Board Resolution).
Independent Financial Advisor means an
accounting, appraisal or investment banking firm of nationally
recognized standing that is, in the good faith determination of
the Company, qualified to perform the task for which it has been
engaged and which is independent in connection with the relevant
transaction.
Interest Rate Agreement of any Person means
any interest rate protection agreement, interest rate swaps,
caps, floors or collars, option, future or derivative agreements
or arrangements and similar agreements or arrangements
and/or other
types of hedging agreements as of which such Person is a party
or beneficiary designed to hedge interest rate risk of such
Person.
Investment means, with respect to any Person,
any:
(1) direct or indirect loan, advance or other extension of
credit (other than accounts receivable and trade credit and
advances to customers, suppliers, directors, officers or
employees in the ordinary course of business, in each case
accounted for as current assets by such Person) (including,
without limitation, a Guarantee) to any other Person;
(2) capital contribution (by means of any transfer of cash
or other property to others or any payment for property or
services for the account or use of others) to any other Person
(excluding accounts receivable and trade credit incurred in the
ordinary course and accounted for as current assets by such
Person which do not constitute equity capital of such
Person); or
(3) purchase or acquisition by such Person for
consideration of any Capital Stock, bonds, notes, debentures or
other securities or evidences of Indebtedness issued by any
other Person.
Invest, Investing and
Invested will have corresponding meanings.
65
For purposes of the definition of Unrestricted
Subsidiary and the covenant described under
Certain Covenants Limitation on
Restricted Payments, the Company will be deemed to have
made an Investment in an Unrestricted Subsidiary at
the time of its Designation in an amount equal to the portion
(proportionate to the equity interest of such Person and its
Subsidiaries (Restricted Subsidiaries, in the case of the
Company) at the time) of the Fair Market Value of the net assets
of such Unrestricted Subsidiary at the time of its Designation.
Any property transferred to or from an Unrestricted Subsidiary
will be valued at its Fair Market Value at the time of such
transfer. If the Company or any Restricted Subsidiary sells or
otherwise disposes of any Capital Stock of a Restricted
Subsidiary (including any issuance and sale of Capital Stock by
a Restricted Subsidiary) such that, after giving effect to any
such sale or disposition, such Restricted Subsidiary would cease
to be a Subsidiary of the Company, the Company will be deemed to
have made an Investment on the date of any such sale or
disposition equal to the Fair Market Value of the Capital Stock
of such former Restricted Subsidiary held by the Company or any
Restricted Subsidiary immediately following such sale or other
disposition. The amount of any Investment outstanding at any
time will be the original cost of such Investment without giving
effect to any subsequent changes in value.
Investment Grade means (1) with respect
to S&P, any of the rating categories from and including AAA
to and including BBB- and (2) with respect to Moodys,
any of the rating categories from and including Aaa to and
including Baa3.
Investment Return means, in respect of any
Investment (other than a Permitted Investment) that was treated
as a Restricted Payment made on or after July 1, 2009 by
the Company or any Restricted Subsidiary:
(1) the aggregate amount of cash and the Fair Market Value
of property or assets other than cash received by the Company or
any of its Restricted Subsidiaries from:
(a) the sale or other disposition (other than to the
Company or any of its Restricted Subsidiaries) of any such
Investment and from repurchases and redemptions of such
Investment from the Company and its Restricted Subsidiaries by
any Person (other than the Company or any of its Restricted
Subsidiaries) and from repayments of any loan or advance which
constitutes such an Investment;
(b) the sale (other than to the Company or any of its
Restricted Subsidiaries) of the Capital Stock of an Unrestricted
Subsidiary; and
(c) a distribution or dividend from an Unrestricted
Subsidiary; and
(2) in the event of the Revocation of the Designation of an
Unrestricted Subsidiary, or the merger or consolidation of an
Unrestricted Subsidiary with or into, or the transfer or
conveyance by an Unrestricted Subsidiary to, or the liquidation
of an Unrestricted Subsidiary into, the Company or any of its
Restricted Subsidiaries, the Fair Market Value of such
Investment in such Unrestricted Subsidiary at the time of
Revocation, merger, consolidation or liquidation (or of the
assets transferred or conveyed, as applicable), after deducting
any Indebtedness associated with such Unrestricted Subsidiary
subject to such Revocation, merger, consolidation or liquidation
or any Indebtedness associated with the assets so transferred or
conveyed.
Issue Date means the first date of issuance
of Notes under the Indenture.
Issuer Merger or Sale Event has the meaning
set forth under Certain Covenants
Limitation on Merger, Consolidation or Sale of Assets.
Legal Defeasance has the meaning set forth
under Legal Defeasance and Covenant
Defeasance.
Lien means, with respect to any property or
asset, any lien, mortgage, deed of trust, pledge, security
interest, charge or encumbrance of any kind (including any
conditional sale or other title retention agreement and any
lease in the nature thereof) in respect of such asset;
provided that the lessee in respect of a Capitalized
Lease Obligation will be deemed to have Incurred a Lien on the
property leased thereunder.
66
Material Restricted Subsidiary means all
Restricted Subsidiaries of the Company which, in the aggregate,
do not constitute minor subsidiaries as defined in
Rule 3-10(h)
of
Regulation S-X
promulgated pursuant to the Exchange Act as in effect on
October 2, 2009.
Moodys has the meaning set forth under
Certain Covenants Covenant
Suspension.
Net Cash Proceeds means, with respect to any
Asset Sale, the proceeds in the form of cash or Cash
Equivalents, including payments in respect of deferred payment
obligations when received in the form of cash or Cash
Equivalents, received by the Company or any of the Restricted
Subsidiaries from such Asset Sale (including, without
limitation, any cash or Cash Equivalents received upon the sale
or other disposition of any non-cash consideration received in
such Asset Sale), net of:
(1) direct costs relating to such Asset Sale (including,
without limitation, legal, accounting and investment banking
fees and sales commissions) and the sale or disposition of such
non-cash consideration, and any relocation expenses incurred as
a result thereof;
(2) taxes paid or payable in respect of such Asset Sale and
the sale or disposition of such non-cash consideration after
taking into account any reduction in consolidated tax liability
due to available tax credits or deductions and any tax sharing
arrangements;
(3) all payments made, and all payments required to be
made, on any Indebtedness secured by a Lien that is required to
be repaid in connection with such Asset Sale; and
(4) appropriate amounts to be provided by the Company or
any Restricted Subsidiary, as the case may be, as a reserve, in
accordance with GAAP, against any liabilities associated with
such Asset Sale and retained by the Company or any Restricted
Subsidiary, as the case may be, after such Asset Sale,
including, without limitation, pension and other post-employment
benefit liabilities, liabilities related to environmental
matters and liabilities under any indemnification obligations
associated with such Asset Sale, but excluding any reserves with
respect to Indebtedness.
Note Guarantee means each of the Elan Note
Guarantee and each Subsidiary Note Guarantee.
Note Guarantor means the Company (for so long
as it provides the Elan Note Guarantee) and each Subsidiary Note
Guarantor.
Officer means, with respect to any Person,
the Chairman of the Board of Directors, the Chief Executive
Officer, the Chief Financial Officer, the President, any Vice
President, the Treasurer, the Secretary or any Assistant
Secretary of such Person.
Officers Certificate means a
certificate signed by two Officers.
Opinion of Counsel means a written opinion of
counsel, who may be an employee of or counsel for the Company.
Pari Passu Indebtedness means, with respect
to the Issuer, the Company or any Subsidiary Note Guarantor, the
Notes, the Elan Note Guarantee or the relevant Subsidiary Note
Guarantee, as the case may be, and any other Indebtedness of the
Issuer, the Company or a Subsidiary Note Guarantor, as the case
may be, which ranks equal in right of payment with the Notes,
the Elan Note Guarantee or the relevant Subsidiary Note
Guarantee, as the case may be, including, without limitation,
the Existing 2013 Notes and the guarantees thereof by the Note
Guarantors
and/or the
Issuer, as applicable.
Period has the meaning set forth in the
definition of Consolidated Net Fixed Charge Coverage
Ratio.
Permitted Business means the business or
businesses conducted by the Company and the Restricted
Subsidiaries as of October 2, 2009, any business activity
that is a reasonable extension, development or expansion thereof
or any business ancillary or complementary thereto.
Permitted Indebtedness has the meaning set
forth under paragraph (b) of Certain
Covenants Limitation on Incurrence of Additional
Indebtedness.
67
Permitted Investments means:
(1) Investments by the Company or any Restricted Subsidiary
in any Person if as a result of such Investment (a) such
Person becomes a Restricted Subsidiary of the Company or
(b) such Person, in one transaction or a series of related
transactions, is merged, consolidated with or into, or transfers
or conveys all or substantially all of its assets to, or is
liquidated into, the Company or a Restricted Subsidiary of the
Company;
(2) Investments by any Restricted Subsidiary in the Company
or any other Restricted Subsidiary;
(3) Investments by the Company in any Restricted Subsidiary;
(4) Investments in cash and Cash Equivalents;
(5) Investments in existence, or made pursuant to legally
binding written commitments in existence, on October 2,
2009, and any extension, modification or renewal of any
Investments existing on October 2, 2009, but only to the
extent not involving additional advances, contributions or other
Investments of cash or other assets or other increase thereof
(other than as a result of the accrual or accretion of interest
or original issue discount or the issuance of
pay-in-kind
securities, in each case pursuant to the terms of such
Investment as in existence on October 2, 2009);
(6) securities or other Investments received as
consideration for, or retained in connection with, any Asset
Sale made in compliance with the covenant described under
Certain Covenants Limitation on
Asset Sales or any other sale or disposition of properties
or assets not constituting an Asset Sale;
(7) securities or other Investments received in settlement
of debts created in the ordinary course of business and owing to
the Company or any of its Restricted Subsidiaries, or as a
result of foreclosure, perfection or enforcement or any Lien, or
in satisfaction of judgments, including in connection with any
bankruptcy proceeding or other reorganization of another Person;
(8) Hedging Obligations Incurred in compliance with clause
(b)(4) of the covenant described under Certain
Covenants Limitation on Incurrence of Additional
Indebtedness;
(9) pledges or deposits described in the definition of
Permitted Liens;
(10) bonds secured by assets leased to and operated by the
Company or any of its Restricted Subsidiaries that were issued
in connection with the financing of such assets so long as the
Company or any Restricted Subsidiary may obtain title to such
assets at any time by paying a nominal fee, canceling such bonds
or terminating the transaction;
(11) any Investment to the extent made using solely
Qualified Capital Stock of the Company as consideration;
(12) any Investment by the Company or any of its Restricted
Subsidiaries in a Permitted Business (other than an Investment
in an Unrestricted Subsidiary) including, without limitation,
investments in joint ventures that are not Subsidiaries of the
Company, in an amount, taken together with all other Investments
made pursuant to this clause (12), not to exceed the greater of
$200 million and 5% of Consolidated Total Assets (with the
amount of each Investment being measured at the time made
without giving effect to any subsequent change in value);
provided that if any Investment pursuant to this
clause (12) is made in any Person that is not a Restricted
Subsidiary of the Company at the date of making of such
Investment and such Person becomes a Restricted Subsidiary of
the Company after October 2, 2009, such Investment will
thereafter be deemed to have been made pursuant to
clause (2) or (3) above, as the case may be, and will
cease to have been made pursuant to this clause (12) for so
long as such Person continues to be a Restricted Subsidiary;
(13) Investments consisting of the licensing or
contribution of intellectual property pursuant to development,
marketing or manufacturing agreements or arrangements or similar
agreements or arrangements with other Persons;
68
(14) Investments consisting of purchases and acquisitions
of inventory, supplies, materials and equipment or purchases of
contract rights or licenses or leases of intellectual property,
in each case in the ordinary course of business;
(15) the acquisition by a Receivables Subsidiary in
connection with a Qualified Receivables Transaction of Capital
Stock of a trust or other Person established by such Receivables
Subsidiary to effect such Qualified Receivables Transaction and
any other Investment by the Company or any Subsidiary of the
Company in a Receivables Subsidiary or any Investment by a
Receivables Subsidiary in any other Person in connection with a
Qualified Receivables Transaction, in each case as customary in
connection therewith; and
(16) advances to officers, directors and employees for
business-related expenses and other similar expenses, in each
case in the ordinary course of business.
Permitted Liens means any of the following:
(1) Liens Incurred or pledges or deposits made in the
ordinary course of business in connection with workers
compensation, unemployment insurance and other types of social
security or other insurance-related obligations (including,
without limitation, pledges or deposits securing liability to
insurance carriers under insurance and self-insurance
arrangements), including any Lien securing letters of credit
issued in the ordinary course of business in connection
therewith;
(2) Liens upon specific items of inventory or other goods
and proceeds of any Person securing such Persons
obligations in respect of bankers acceptances or similar
credit transactions issued or created for the account of such
Person to facilitate the purchase, shipment or storage of such
inventory or other goods;
(3) Liens securing reimbursement obligations with respect
to commercial letters of credit which encumber documents and
other property relating to such letters of credit and products
and proceeds thereof;
(4) Liens securing Hedging Obligations that relate to
Indebtedness that is Incurred in accordance with
Certain Covenants Limitation on
Incurrence of Additional Indebtedness;
(5) Liens existing on October 2, 2009;
(6) Liens securing Acquired Indebtedness Incurred in
accordance with Certain Covenants
Limitation on Incurrence of Additional Indebtedness
(including clause (b)(11) thereof); provided that
(a) such Liens secured such Acquired Indebtedness at the
time of and prior to the Incurrence of such Acquired
Indebtedness by the Company or a Restricted Subsidiary and were
not granted in connection with, or in anticipation of the
Incurrence of, such Acquired Indebtedness by the Company or a
Restricted Subsidiary; and
(b) such Liens do not extend to any property or assets of
the Company or any Restricted Subsidiary other than the property
or assets (plus improvements, accessions, proceeds or dividends
or distributions in respect thereof) that secured the Acquired
Indebtedness prior to the time such Indebtedness became Acquired
Indebtedness of the Company or a Restricted Subsidiary;
(7) Liens securing Purchase Money Indebtedness; provided
that (a) the Indebtedness will not exceed the cost of
such property and is not secured by a Lien on any property or
assets other than the property or assets so acquired,
constructed or installed and improvements thereon and
(b) the Lien securing such Indebtedness shall be created
within 180 days after such acquisition, construction or
installation or, in the case of any Refinancing of any such
Indebtedness, within 180 days after such Refinancing;
(8) any interest or title of a lessor under any Capitalized
Lease Obligation; provided that such Liens do not extend
to any property or asset which is not leased property subject to
such Capitalized Lease Obligation;
69
(9) Liens for taxes, assessments or other governmental
charges not yet delinquent or the nonpayment of which in the
aggregate would not reasonably be expected to have a material
adverse effect on the Company and the Restricted Subsidiaries or
that are being contested in good faith and by appropriate
proceedings if adequate reserves with respect thereto are
maintained on the books of the Company or a Subsidiary thereof,
as the case may be, in accordance with GAAP;
(10) carriers, warehousemens, mechanics,
landlords, materialmens, repairmens or other
like Liens arising in the ordinary course of business in respect
of obligations that are not overdue for a period of more than
60 days or that are bonded or that are being contested in
good faith and by appropriate proceedings;
(11) pledges, deposits or Liens to secure the performance
of bids, tenders, trade, government or other contracts (other
than for borrowed money), obligations for utilities, leases,
licenses, statutory obligations, completion guarantees, surety,
judgment, appeal or performance bonds, other similar bonds,
instruments or obligations, and other obligations of a like
nature incurred in the ordinary course of business;
(12) easements (including reciprocal easement agreements),
rights-of-way,
building, zoning and similar restrictions, utility agreements,
covenants, reservations, restrictions, encroachments, charges
and other similar encumbrances or title defects incurred, or
leases or subleases granted to others, in the ordinary course of
business, which do not in the aggregate materially interfere
with the ordinary conduct of the business of the Company and the
Restricted Subsidiaries, taken as a whole;
(13) (i) mortgages, Liens, security interests,
restrictions, encumbrances or any other matters of record that
have been placed by any developer, landlord or other third party
on property over which the Company or any Restricted Subsidiary
of the Company has easement rights or on any leased property and
subordination or similar agreements relating thereto and
(ii) any condemnation or eminent domain proceedings
affecting any real property;
(14) Liens arising out of judgments, decrees, orders or
awards in respect of which the Company will in good faith be
prosecuting an appeal or proceedings for review, which appeal or
proceedings will not have been finally terminated, or the period
within which such appeal or proceedings may be initiated will
not have expired;
(15) leases or subleases granted to others that do not
materially interfere with the ordinary course of business of the
Company and the Restricted Subsidiary, taken as a whole;
(16) Liens on Capital Stock or other securities of an
Unrestricted Subsidiary that secure Indebtedness or other
obligations of such Unrestricted Subsidiary;
(17) any encumbrance or restriction (including, but not
limited to, put and call agreements) with respect to Capital
Stock of any joint venture or similar arrangement pursuant to
any joint venture or similar agreement;
(18) Liens encumbering deposits made to secure obligations
arising from statutory, regulatory, contractual or warranty
requirements of the Company or any Restricted Subsidiary,
including rights of offset and setoff;
(19) bankers liens, rights of setoff and other
similar Liens existing solely with respect to cash and Cash
Equivalents on deposit in one or more accounts maintained by the
Company or any Restricted Subsidiary, in each case granted in
the ordinary course of business in favor of the bank or banks
with which such accounts are maintained, securing amounts owing
to such bank with respect to cash management and operating
account arrangements, including those involving pooled accounts
and netting arrangements; provided that in no case will
any such Lien secure the repayment of Indebtedness;
(20) Liens in favor of the Company, the Issuer or any
Subsidiary Note Guarantor;
(21) Liens on accounts payable and related assets of the
type specified in the definition of Qualified Receivables
Transaction incurred in connection with a Qualified
Receivables Transaction;
70
(22) Liens arising from filing Uniform Commercial Code
Financing Statements regarding leases;
(23) Liens securing (a) at any time other than a
Suspension Period, Indebtedness under the Debt Facilities in an
aggregate principal amount not to exceed the amount of
Indebtedness permitted to be Incurred under clause (b)(2) of the
covenant described under Certain
Covenants Limitation on Incurrence of Additional
Indebtedness (whether or not such Indebtedness is Incurred
under such clause (b)(2)), or (b) the Notes, the Elan Note
Guarantee or the Subsidiary Note Guarantees;
(24) Liens on property or assets of a Person existing at
the time such Person is acquired or merged with or into or
consolidated with the Company or any Restricted Subsidiary (and
not in connection therewith or in anticipation thereof);
(25) Liens on property or assets at the time the Company or
any Restricted Subsidiary acquired such property or assets and
not incurred in connection therewith or in anticipation thereof;
provided that such Liens do not extend to any other
property or assets (plus improvements, accessions, proceeds or
dividends or distributions in respect thereof) of the Company or
any Restricted Subsidiary;
(26) Liens in favor of customs and revenue authorities
arising as a matter of law to secure payment of customs duties
in connection with the importation of goods;
(27) Liens securing Refinancing Indebtedness of
Indebtedness secured by Liens referred to in the foregoing
clauses (5), (6), (7), (24) and (25); provided that
such Liens do not extend to any other property or assets of the
Company or any Restricted Subsidiary; and
(28) Liens (other than Liens securing Subordinated
Indebtedness) which, when the Indebtedness relating to those
Liens is added to all other then outstanding Indebtedness of the
Company and the Restricted Subsidiaries secured by Liens and not
listed in clauses (1) through (27) above, do not
exceed (i) $25 million or (ii) during a
Suspension Period, 15% of Consolidated Total Assets; provided
that the aggregate principal amount of Indebtedness secured
by Liens outstanding under clause 23(a) of this definition
of Permitted Liens on the date of the relevant
Rating Event shall be deemed to have been Incurred pursuant to
this clause (ii) as of the date such Indebtedness was
originally Incurred.
Person means an individual, partnership,
limited partnership, corporation, company, limited liability
company, unincorporated organization, trust or joint venture, or
a governmental agency or political subdivision thereof.
Preferred Stock means, with respect to any
Person, any Capital Stock of such Person that has preferential
rights over any other Capital Stock of such Person with respect
to dividends, distributions or redemptions or upon liquidation.
Purchase Money Indebtedness means
Indebtedness Incurred for the purpose of financing or
refinancing all or any part of the purchase price, or other cost
of acquisition, construction, installation or improvement, of
any property (real or personal) or asset by the Company or any
Restricted Subsidiary, and whether acquired through the direct
purchase or acquisition of such property or assets or the
purchase or acquisition of the Capital Stock of any Person
owning such property or assets, or otherwise.
Qualified Capital Stock means any Capital
Stock that is not Disqualified Capital Stock and any warrants,
rights or options to purchase or acquire Capital Stock that is
not Disqualified Capital Stock that are not convertible or
exchangeable into Disqualified Capital Stock.
Qualified Receivables Transaction means any
transaction or series of transactions entered into by the
Company or any of its Subsidiaries pursuant to which the Company
or any of its Subsidiaries sells, conveys or otherwise transfers
to (i) a Receivables Subsidiary (in the case of a transfer
by the Company or any of its Subsidiaries) and (ii) any
other Person that is not a Subsidiary of the Company and
satisfies the provisions of clauses (a) through (c) of
the definition of Receivables Subsidiary (in the case of a
transfer by a Receivables Subsidiary), or grants a security
interest in, any accounts receivable (whether now existing or
arising in the future) of the Company or any of its
Subsidiaries, and any assets related thereto, including, without
limitation, all collateral securing such accounts receivable,
all contracts and contract rights and all guarantees or other
obligations in respect of such accounts receivable, proceeds of
such accounts receivable and other assets which
71
are customarily transferred or in respect of which security
interests are customarily granted in connection with asset
securitization transactions involving accounts receivable and
any Hedging Obligations entered into by the Company or any of
its Subsidiaries in connection with such accounts receivable.
The grant of a security interest in any accounts receivable of
the Company or any Restricted Subsidiaries (other than a
Receivables Subsidiary) to secure a Debt Facility will not be
deemed a Qualified Receivables Transaction.
Rating Event has the meaning set forth under
Certain Covenants Covenant
Suspension.
Receivables Repurchase Obligation means any
obligation of a seller of accounts receivables in a Qualified
Receivables Transaction to repurchase accounts receivables
arising as a result of a breach of a representation, warranty or
covenant or otherwise, including as a result of an account
receivable or portion thereof becoming subject to any asserted
defense, dispute, offset or counterclaim of any kind as a result
of any action taken by, any failure to take action by or any
other event relating to the seller.
Receivables Subsidiary means a Subsidiary of
the Company (or another Person formed for the purpose of
engaging in a Qualified Receivables Transaction in which the
Company or any Subsidiary of the Company makes an Investment and
to which the Company or any Subsidiary of the Company transfers
accounts receivable and related assets) which engages in no
activities other than in connection with the financing of
accounts receivable of the Company and its Subsidiaries, all
proceeds thereof and all rights (contractual or other),
collateral and other assets relating thereto, and any business
or activities incidental or related to such business, and which
is designated by the Board of Directors of the Company (as
provided below) as a Receivables Subsidiary (a) no portion
of the Indebtedness or any other obligations (contingent or
otherwise) of which (i) is Guaranteed by the Company or any
Subsidiary of the Company (excluding Guarantees of obligations
(other than the principal of and interest on Indebtedness)
pursuant to Standard Securitization Undertakings), (ii) is
recourse to or obligates the Company or any Subsidiary of the
Company in any way other than pursuant to Standard
Securitization Undertakings or (iii) subjects any property
or asset of the Company or any Subsidiary of the Company,
directly or indirectly, contingently or otherwise, to the
satisfaction thereof, other than pursuant to Standard
Securitization Undertakings, (b) with which neither the
Company nor any Subsidiary of the Company has any material
contract agreement, arrangement or understanding other than on
terms which the Company reasonably believes to be no less
favorable to the Company or such Subsidiary than those that
might be obtained at the time from Persons who are not
Affiliates of the Company and (c) to which neither the
Company nor any Subsidiary of the Company has any obligation to
maintain or preserve such Persons financial condition or
cause such Person to achieve certain levels of operating
results. Any such designation by the Board of Directors of the
Company will be evidenced to the Trustee by filing with the
Trustee a certified copy of the Board Resolution of the Board of
Directors (which resolution will be conclusive) of the Company
giving effect to such designation and an Officers
Certificate certifying that such designation complied with the
foregoing conditions.
Refinance means, in respect of any security
or Indebtedness, to refinance, extend (including pursuant to any
defeasance or discharge mechanism), renew, refund, repay,
prepay, redeem, defease or retire, or to issue a security or
Indebtedness in exchange or replacement for, such security or
Indebtedness in whole or in part. Refinanced and
Refinancing will have correlative meanings.
Refinanced Indebtedness has the meaning set
forth in the definition of Refinancing Indebtedness.
Refinancing Indebtedness means any
Indebtedness of the Company or any Restricted Subsidiary issued
to Refinance, within 90 days after the Incurrence of such
Indebtedness, any other Indebtedness of the Company or any of
its Subsidiaries (the Refinanced
Indebtedness); provided that:
(1) the principal amount (or accreted value, in the case of
Indebtedness issued at a discount) of the Refinanced
Indebtedness does not exceed the principal amount (or accreted
value, as the case may be) of the Refinanced Indebtedness plus
the amount of accrued and unpaid interest on the Refinanced
Indebtedness, any premium paid to holders of the Refinanced
Indebtedness and reasonable expenses (including underwriting
discounts) incurred in connection with the Incurrence of the
Refinanced Indebtedness;
72
(2) the obligor of Refinancing Indebtedness does not
include any Person (other than the Company, the Issuer or any
Subsidiary Note Guarantor) that is not an obligor of the
Refinanced Indebtedness;
(3) if the Refinanced Indebtedness was subordinated in
right of payment to the Notes, the Elan Note Guarantee or any
Subsidiary Note Guarantee, as the case may be, then such
Refinancing Indebtedness, by its terms, is subordinated in right
of payment to the Note, the Elan Note Guarantee or such
Subsidiary Note Guarantee, as the case may be, at least to the
same extent as the Refinanced Indebtedness;
(4) the Refinancing Indebtedness has a Stated Maturity
either (a) no earlier than the Refinanced Indebtedness or
(b) after the Stated Maturity of the Refinanced
Indebtedness; and
(5) the portion, if any, of the Refinancing Indebtedness
that is scheduled to mature on or prior to the Stated Maturity
of the Notes has a Weighted Average Life to Maturity at the time
such Refinancing Indebtedness is Incurred that is equal to or
greater than the Weighted Average Life to Maturity of the
portion of the Refinanced Indebtedness that is scheduled to
mature prior to the Stated Maturity of the Notes.
Registration Rights Agreement has the meaning
set forth under Principal, Maturity and
Interest Interest upon Redemption and Payment
Instructions.
Restricted Payment has the meaning set forth
under Certain Covenants Limitation
on Restricted Payments.
Restricted Subsidiary means any Subsidiary of
the Company which at the time of determination is not an
Unrestricted Subsidiary.
Revocation has the meaning set forth under
Certain Covenants Limitation on
Designation of Unrestricted Subsidiaries.
S&P has the meaning set forth under
Certain Covenants Covenant
Suspension.
Sale and Leaseback Transaction means any
direct or indirect arrangement with any Person or to which any
such Person is a party providing for the leasing to the Company
or a Restricted Subsidiary of any property, whether owned by the
Company or any Restricted Subsidiary at October 2, 2009 or
later acquired, which has been or is to be sold or transferred
by the Company or such Restricted Subsidiary to such Person or
to any other Person by whom funds have been or are to be
advanced on the security of such property.
Significant Subsidiary means any Restricted
Subsidiary (other than the Issuer) that would be a
significant subsidiary as defined in
Regulation S-X
promulgated pursuant to the Securities Act as such Regulation is
in effect on October 2, 2009.
Standard Securitization Undertakings means
representations, warranties, covenants, indemnities and
guarantees of performance entered into by the Company or any of
its Subsidiaries, which the Company has determined in good faith
to be customary in a Qualified Receivables Transaction
including, without limitation, those relating to the servicing
of the assets of a Receivables Subsidiary, it being understood
that any Receivables Repurchase Obligation shall be deemed to be
a Standard Securitization Undertaking.
Stated Maturity means, with respect to any
security, the date specified in such security as the fixed date
on which the final payment of principal of such security is due
and payable, including pursuant to any mandatory redemption
provision (but excluding any provision providing for the
repurchase of such security at the option of the holder thereof
upon the happening of any contingency unless such contingency
has occurred).
Subordinated Indebtedness means, with respect
to the Issuer, the Company or any Subsidiary Note Guarantor, any
Indebtedness which is expressly subordinated in right of payment
to the Notes, the Elan Note Guarantee or the relevant Subsidiary
Note Guarantee, as the case may be.
Subsidiary means, with respect to any Person,
any other Person of which such Person owns, directly or
indirectly, more than 50% of the voting power of the other
Persons outstanding Voting Stock.
73
Subsidiary Note Guarantee means any guarantee
of the Issuers obligations under the Notes and the
Indenture provided by a Restricted Subsidiary pursuant to the
Indenture until such time as such guarantee is released in
accordance with the Indenture.
Subsidiary Note Guarantor means any
Restricted Subsidiary that provides a Subsidiary Note Guarantee
pursuant to the Indenture until such time as its Subsidiary Note
Guarantee is released in accordance with the Indenture.
Surviving Entity has the meaning set forth
under Certain Covenants Limitation
on Merger, Consolidation and Sale of Assets.
Suspended Covenants has the meaning set forth
under Certain Covenants Covenant
Suspension.
Suspension Period means any period during
which the Company and its Restricted Subsidiaries are not
subject to the Suspended Covenants pursuant to Certain
Covenants Covenant Suspension.
Taxes has the meaning set forth under
Payment of Additional Amounts.
Taxing Jurisdiction has the meaning set forth
under Payment of Additional Amounts.
TIA means the Trust Indenture Act of
1939 (15 U.S.C.
Sections 77aaa-77bbbb)
as in effect on the date of the Indenture.
Treasury Rate has the meaning set forth under
Optional Redemption.
Unrestricted Subsidiary means (i) Elan
Science One Limited, Neotope Biosciences Limited and Elan
Science Three Limited, (ii) any other Subsidiary of the
Company Designated as such pursuant to Certain
Covenants Limitation on Designation of Unrestricted
Subsidiaries and (iii) any Subsidiary of an
Unrestricted Subsidiary.
U.S. Government Obligations means direct
obligations (or certificates representing an ownership interest
in such obligations) of the United States of America (including
any agency or instrumentality thereof) for the payment of which
the full faith and credit of the United States of America is
pledged and which are not callable or redeemable at the
issuers option.
Voting Stock means, with respect to any
Person, securities of any class of Capital Stock of such Person
entitling the holders thereof (whether at all times or only so
long as no senior class of stock has voting power by reason of
any contingency) to vote in the election of members of the Board
of Directors of such Person.
Weighted Average Life to Maturity means, when
applied to any Indebtedness at any date, the number of years
(calculated to the nearest one-twelfth) obtained by dividing:
(1) the then-outstanding aggregate principal amount or
liquidation preference, as the case may be, of such Indebtedness
into
(2) the sum of the products obtained by multiplying:
(a) the amount of each then-remaining installment, sinking
fund, serial maturity or other required payment of principal or
liquidation preference, as the case may be, including payment at
final maturity, in respect thereof, by
(b) the number of years (calculated to the nearest
one-twelfth) which will elapse between such date and the making
of such payment.
74
BOOK-ENTRY
General
The exchange Notes will be represented by one or more registered
global notes without interest coupons (the Global
Notes). The Global Notes will be deposited upon issuance
with the Trustee as custodian for The Depository
Trust Company (DTC), in New York, New York, and
registered in the name of DTC or its nominee for credit to an
account of a direct or indirect participant in DTC (including
the Euroclear System (Euroclear) or Clearstream
Banking, S.A. (Clearstream), as described below
under Depositary Procedures. So long as
DTC or its nominee is the registered owner or holder of any of
the notes, DTC or such nominee will be considered the sole owner
or holder of such Notes represented by the Global Notes for all
purposes of the indenture.
Except as set forth below, the Global Notes may be transferred,
in whole and not in part, only to another nominee of DTC or to a
successor of DTC or its nominee. Beneficial interests in the
Global Notes may not be exchanged for Notes in certificated form
except in the limited circumstances described below under
Exchange of Book-Entry Notes for Certificated
Notes.
Transfers of beneficial interests in the Global Notes will be
subject to the applicable rules and procedures of DTC and its
direct or indirect participants (including, if applicable, those
of Euroclear and Clearstream), which may change from time to
time.
Depositary
Procedures
The following description of the operations and procedures of
DTC, Euroclear and Clearstream are provided solely as a matter
of convenience. These operations and procedures are solely
within the control of the respective settlement systems and are
subject to changes by them. We take no responsibility for these
operations and procedures and urge investors to contact the
systems or their participants directly to discuss these matters.
DTC is a limited-purpose trust company created to hold
securities for its participating organizations (collectively,
the Participants) and facilitate the clearance and
settlement of transactions in those securities between
Participants through electronic book-entry changes in accounts
of its Participants. The Participants include securities brokers
and dealers (including the initial purchasers), banks, trust
companies, clearing corporations and certain other
organizations. Access to DTCs system is also available to
other entities such as banks, brokers, dealers and trust
companies that clear through or maintain a custodial
relationship with a Participant, either directly or indirectly
(collectively, the Indirect Participants). Persons
who are not Participants may beneficially own securities held by
or on behalf of DTC only through Participants or Indirect
Participants. DTC has no knowledge of the identity of beneficial
owners of securities held by or on behalf of DTC. DTCs
records reflect only the identity of Participants to whose
accounts securities are credited. The ownership interests and
transfer of ownership interests of each beneficial owner of each
security held by or on behalf of DTC are recorded on the records
of the Participants and Indirect Participants.
Pursuant to procedures established by DTC:
|
|
|
|
|
upon deposit of the Global Notes, DTC will credit the accounts
of Participants designated by the initial purchasers with
portions of the principal amount of the Global Notes; and
|
|
|
|
ownership of such interests in the Global Notes will be
maintained by DTC (with respect to the Participants) or by the
Participants and the Indirect Participants (with respect to
other owners of beneficial interests in the Global Notes).
|
Investors in the Global Notes may hold their interests therein
directly through DTC, if they are Participants in such system,
or indirectly through organizations (including Euroclear and
Clearstream) that are Participants or Indirect Participants in
such system. Euroclear and Clearstream will hold interests in
the Notes on behalf of their participants through
customers securities accounts in their respective names on
the books of their respective depositaries, which are Euroclear
Bank, S.A./N.V., as operator of Euroclear, and Citibank,
75
N.A., as operator of Clearstream. The depositaries, in turn,
will hold interests in the Notes in customers securities
accounts in the depositaries names on the books of DTC.
All interests in a Global Note, including those held through
Euroclear or Clearstream, will be subject to the procedures and
requirements of DTC. Those interests held through Euroclear or
Clearstream will also be subject to the procedures and
requirements of these systems. The laws of some states require
that certain persons take physical delivery of certificates
evidencing securities they own. Consequently, the ability to
transfer beneficial interests in a Global Note to such persons
will be limited to that extent. Because DTC can act only on
behalf of Participants, which in turn act on behalf of Indirect
Participants, the ability of beneficial owners of interests in a
Global Note to pledge such interests to persons or entities that
do not participate in the DTC system, or otherwise take actions
in respect of such interests, may be affected by the lack of a
physical certificate evidencing such interests. For certain
other restrictions on the transferability of the Notes, see
Exchange of Book-Entry Notes for Certificated
Notes.
Except as described below, owners of interests in the Global
Notes will not have Notes registered in their names, will not
receive physical delivery of Notes in certificated form and will
not be considered the registered owners or holders thereof under
the indenture governing the Notes for any purpose.
Payments in respect of the principal of and premium, if any, and
interest on a Global Note registered in the name of DTC or its
nominee will be payable by the Trustee (or the paying agent if
other than the Trustee) to DTC in its capacity as the registered
holder under the indenture related to the Notes. The Issuers and
the Trustee will treat the persons in whose names the Notes,
including the Global Notes, are registered as the owners thereof
for the purpose of receiving such payments and for any and all
other purposes whatsoever. Consequently, none of the Company,
the Trustee or any agent of the Issuers or the Trustee has or
will have any responsibility or liability for:
|
|
|
|
|
any aspect of DTCs records or any Participants or
Indirect Participants records relating to or payments made
on account of beneficial ownership interests in the Global
Notes, or for maintaining, supervising or reviewing any of
DTCs records or any Participants or Indirect
Participants records relating to the beneficial ownership
interests in the Global Notes; or
|
|
|
|
any other matter relating to the actions and practices of DTC or
any of its Participants or Indirect Participants.
|
DTC has advised us that its current practice, upon receipt of
any payment in respect of securities such as the Notes
(including principal and interest), is to credit the accounts of
the relevant Participants with the payment on the payment date
in amounts proportionate to their respective holdings in the
principal amount of the relevant security as shown on the
records of DTC, unless DTC has reason to believe it will not
receive payment on such payment date. Payments by the
Participants and the Indirect Participants to the beneficial
owners of Notes will be governed by standing instructions and
customary practices and will be the responsibility of the
Participants or the Indirect Participants and will not be the
responsibility of DTC, the Trustee or the Issuers. Neither we
nor the Trustee will be liable for any delay by DTC or any of
its Participants in identifying the beneficial owners of the
Notes, and we and the Trustee may conclusively rely on and will
be protected in relying on instructions from DTC or its nominee
for all purposes.
Except for trades involving only Euroclear and Clearstream
participants, interests in the Global Notes are expected to be
eligible to trade in DTCs
Same-Day
Funds Settlement System and secondary market trading activity in
such interests will therefore settle in immediately available
funds, subject in all cases to the rules and procedures of DTC
and its Participants.
Transfers between Participants in DTC will be effected in
accordance with DTCs procedures, and will be settled in
same-day
funds, and transfers between participants in Euroclear and
Clearstream will be effected in accordance with their respective
rules and operating procedures.
Cross-market transfers between Participants in DTC, on the one
hand, and Euroclear or Clearstream participants, on the other
hand, will be effected through DTC in accordance with DTCs
rules on behalf of Euroclear or Clearstream, as the case may be,
by their depositaries. Cross-market transactions will require
76
delivery of instructions to Euroclear or Clearstream, as the
case may be, by the counterparty in that system in accordance
with the rules and procedures and within the established
deadlines (Brussels time) of that system. Euroclear or
Clearstream, as the case may be, will, if the transaction meets
its settlement requirements, deliver instructions to its
respective depositaries to take action to effect final
settlement on its behalf by delivering or receiving interests in
the relevant Global Note in DTC, and making or receiving payment
in accordance with normal procedures for
same-day
funds settlement applicable to DTC. Euroclear and Clearstream
participants may not deliver instructions directly to the
depositaries for Euroclear or Clearstream.
Because of time zone differences, the securities account of a
Euroclear or Clearstream participant purchasing an interest in a
Global Note from a Participant in DTC will be credited and
reported to the relevant Euroclear or Clearstream participant,
during the securities settlement processing day (which must be a
business day for Euroclear and Clearstream) immediately
following the settlement date of DTC. DTC has advised us that
cash received in Euroclear or Clearstream as a result of sales
of interests in a Global Note by or through a Euroclear or
Clearstream participant to a Participant in DTC will be received
with value on the settlement date of DTC but will be available
in the relevant Euroclear or Clearstream cash account only as of
the business day for Euroclear or Clearstream following
DTCs settlement date.
DTC has advised us that it will take any action permitted to be
taken by a holder of Notes only at the direction of one or more
Participants to whose account with DTC interests in the Global
Notes are credited and only in respect of such portion of the
aggregate principal amount of the Notes as to which such
Participant or Participants has or have given such direction.
Although DTC, Euroclear and Clearstream have agreed to the
foregoing procedures to facilitate transfers of interests in the
Global Notes among participants in DTC, Euroclear and
Clearstream, they are under no obligation to perform or to
continue to perform such procedures, and the procedures may be
discontinued at any time. Neither we nor the Trustee will have
any responsibility for the performance by DTC, Euroclear or
Clearstream or their respective participants or indirect
participants of their respective obligations under the rules and
procedures governing their operations.
The information in this section concerning DTC, Euroclear and
Clearstream and their book-entry systems has been obtained from
sources that we believe to be reliable, but we take no
responsibility for the accuracy thereof.
Exchange
of Book-Entry Notes for Certificated Notes
The Global Notes are exchangeable for certificated Notes in
definitive, fully registered form without interest coupons
(Certificated Notes) only in the following limited
circumstances:
|
|
|
|
|
DTC notifies us that it is unwilling or unable to continue as
depositary for the Global Note or DTC ceases to be a clearing
agency registered under the Securities Exchange Act of 1934, as
amended, at a time when DTC is required to be so registered in
order to act as depositary, and in each case we fail to appoint
a successor depositary within 90 days of such notice,
|
|
|
|
we notify the Trustee in writing that the Global Note shall be
so exchangeable, or
|
|
|
|
if there shall have occurred and be continuing an Event of
Default with respect to the Notes.
|
In all cases, Certificated Notes delivered in exchange for any
Global Note or beneficial interests therein will be registered
in the names, and issued in any approved denominations,
requested by or on behalf of DTC (in accordance with its
customary procedures).
77
PLAN OF
DISTRIBUTION
Each broker-dealer that receives exchange Notes for its own
account pursuant to the exchange offer must acknowledge that it
will deliver a prospectus in connection with any resale of such
exchange Notes. This prospectus, as it may be amended or
supplemented from time to time, may be used by a broker-dealer
in connection with resales of exchange Notes received in
exchange for outstanding Notes where such outstanding Notes were
acquired by such broker-dealer as a result of market-making
activities or other trading activities. We have agreed that for
a period of 180 days after the date of acceptance of Notes
for exchange, we will make this prospectus, as amended or
supplemented, available to any broker-dealer for use in
connection with any such resale.
We will not receive any proceeds from any sale of exchange Notes
by broker-dealers. Exchange Notes received by broker-dealers for
their own account pursuant to the exchange offer may be sold
from time to time in one or more transactions in the
over-the-counter
market, in negotiated transactions, through the writing of
options on the exchange Notes or a combination of such methods
of resale, at market prices prevailing at the time of resale, at
prices related to such prevailing market prices or at negotiated
prices. Any such resale may be made directly to purchasers or to
or through brokers or dealers who may receive compensation in
the form of commissions or concessions from any such
broker-dealer
and/or the
purchasers of any such exchange Notes. Any broker-dealer that
resells exchange Notes that were received by it for its own
account pursuant to the exchange offer and any broker or dealer
that participates in a distribution of such exchange Notes may
be deemed to be an underwriter within the meaning of
the Securities Act and any profit of any such resale of exchange
Notes and any commissions or concessions received by any such
persons may be deemed to be underwriting compensation under the
Securities Act. The letter of transmittal states that, by
acknowledging that it will deliver and by delivering a
prospectus, a broker-dealer will not be deemed to admit that it
is an underwriter within the meaning of the
Securities Act. By acceptance of the exchange offer, each
broker-dealer that receives exchange Notes pursuant to the
exchange offer hereby agrees to notify us prior to using this
prospectus in connection with the sale or transfer of exchange
Notes, and acknowledges and agrees that, upon receipt of notice
from us of the happening of any event which makes any statement
in this prospectus untrue in any material respect or which
requires the making of any changes in this prospectus in order
to make the statements herein not misleading (which notice we
agree to deliver promptly to such broker-dealer), such
broker-dealer will suspend use of this prospectus until we have
amended or supplemented the prospectus to correct such
misstatement or omission and have furnished copies of the
amended or supplemented prospectus to such broker-dealer.
For a period of 180 days after the date of acceptance of
Notes for exchange, we will promptly upon request send
additional copies of this prospectus and any amendment or
supplement thereto to any broker-dealer that requests such
documents in the letter of transmittal. We have agreed to pay
all expenses incident to the exchange offer (including the
expenses of any one special counsel for the Holders of the
Notes) other than commissions or concessions of any brokers or
dealers and will indemnify Holders of the Notes participating in
the exchange offer (including any broker-dealers) against
certain liabilities, including liabilities under the Securities
Act.
78
CERTAIN
U.S. FEDERAL INCOME TAX CONSEQUENCES
The following is a general discussion of certain United States
federal income tax consequences of the exchange of an
outstanding Note for an exchange Note and the ownership and
disposition of an exchange Note acquired pursuant to the
exchange offer. Except where noted, the following discussion
addresses only Notes and exchange Notes held as capital assets
within the meaning of Section 1221 of the Internal Revenue
Code of 1986, as amended (the Code), and does not
deal with special situations, such as those of broker-dealers,
tax-exempt organizations, individual retirement accounts and
other tax deferred accounts, controlled foreign corporations,
passive foreign investment companies, holders that own 10% or
more of the total combined voting power of Elans
outstanding stock, financial institutions, insurance companies,
holders subject to the alternative minimum tax, certain
short-term holders of Notes, partnerships or other pass-through
entities (or investors in such entities), persons hedging their
exposure in the Notes or holding Notes as part of a hedging or
conversion transaction, a straddle or a constructive sale,
U.S. expatriates and United States Holders (as defined
below) whose functional currency is not the U.S. dollar.
Holders should be aware that the U.S. federal income tax
consequences may be materially different for investors described
in the prior sentence. In addition, the following does not
consider the effect of any applicable foreign, state, local or
other U.S. federal tax laws (such as estate or gift tax, or
the newly enacted Medicare tax on investment income).
The following discussion is based upon the provisions of the
Code and regulations, rulings and judicial decisions thereunder
as of the date hereof, and such authorities may be repealed,
revoked or modified (possibly with retroactive effect) so as to
result in U.S. federal income tax consequences different
from those discussed below. We have not and will not seek any
rulings from the Internal Revenue Service (IRS)
regarding the matters discussed below. There can be no assurance
that the IRS will not take positions concerning the tax
consequences of the purchase, ownership or disposition of the
Notes that are different from those discussed below.
As used herein, a United States Holder is a
beneficial owner of a Note that is, for U.S. federal income
tax purposes: (i) an individual who is a citizen or
resident of the United States, (ii) a corporation, or any
other entity treated as a corporation for U.S. federal
income tax purposes, that was created or organized in or under
the laws of the United States, any state thereof or the District
of Columbia, (iii) an estate the income of which is subject
to U.S. federal income taxation regardless of its source,
or (iv) a trust if (A) a United States court is able
to exercise primary supervision over the administration of the
trust and one or more United States persons have the authority
to control all substantial decisions of the trust, or
(B) the trust was in existence on August 20, 1996, was
treated as a domestic trust and has elected to be treated as a
U.S. person.
A
Non-United
States Holder is a beneficial owner of a Note that is, for
U.S. federal income tax purposes, an individual,
corporation, estate or trust that is not a United States Holder.
If any entity taxable as a partnership for U.S. federal
income tax purposes holds Notes, the U.S. federal income
tax treatment of a partner in the partnership will generally
depend upon the status of the partner and the activities of the
partnership. If you are a partner of a partnership holding the
Notes, you should consult your own tax advisor regarding the tax
consequences of the acquisition, ownership and disposition of
the Notes.
Exchange
of Notes
The exchange of an outstanding Note for an exchange Note
pursuant to the exchange offer will not be a taxable event for
U.S. federal income tax purposes. Consequently, (i) no
gain or loss will be recognized by a holder upon receipt of an
exchange Note, (ii) the holding period of the exchange Note
will include the holding period of the outstanding Note
immediately before the exchange and (iii) the tax basis of
the exchange Note will be the same as the tax basis of the
outstanding Note immediately before the exchange.
Effect of
Certain Contingencies
In certain circumstances, we may be obligated to pay amounts in
excess of stated interest or principal on the Notes. Our
obligation to pay such excess amounts may implicate the
provisions of the Treasury regulations
79
relating to contingent payment debt instruments.
Under these regulations, however, one or more contingencies will
not cause a debt instrument to be treated as a contingent
payment debt instrument if, as of the issue date, each such
contingency is remote or is considered to be
incidental. We believe and intend to take the
position that the foregoing contingencies should be treated as
remote
and/or
incidental. Our position is binding on a holder, unless the
holder discloses in the proper manner to the IRS that it is
taking a different position. However, this determination is
inherently factual and we can give you no assurance that our
position would be sustained if challenged by the IRS. A
successful challenge of this position by the IRS could affect
the timing and amount of a holders income and could cause
the gain from the sale or other disposition (including a
retirement or redemption) of a Note to be treated as ordinary
income, rather than capital gain. This disclosure assumes that
the Notes will not be considered contingent payment debt
instruments. Holders are urged to consult their own tax advisors
regarding the potential application to the Notes of the
contingent payment debt regulations and the consequences thereof.
United
States Holders
Stated
Interest
A United States Holder generally will be required to include in
its gross income (as ordinary interest income) the stated
interest on an exchange Note at the time such interest accrues
or is received, in accordance with the United States
Holders method of accounting for U.S. federal income
tax purposes.
Original
Issue Discount
The exchange Notes will be treated as having OID for
U.S. federal income tax purposes because the outstanding
notes were issued with OID. Subject to the rules described below
under Acquisition Premium and
Amortizable Bond Premium, a United
States Holder (whether a cash or accrual method taxpayer) will
be required to include in gross income (as ordinary income) OID
as it accrues on a constant yield to maturity basis, before the
receipt of cash payments attributable to this income. The amount
of OID includible in gross income for a taxable year will be the
sum of the daily portions of OID with respect to the Note for
each day during that taxable year on which the United States
Holder holds the Note. The daily portion is determined by
allocating to each day in an accrual period a pro
rata portion of the OID allocable to that accrual period.
Accrual periods may be any length and may vary in length over
the term of a Note, so long as no accrual period is longer than
one year and each scheduled payment of principal or interest
occurs on the first or last day of an accrual period. The OID
allocable to any accrual period will equal (a) the product
of the adjusted issue price of the Note as of the
beginning of such period and the Notes yield to maturity
(determined on the basis of compounding at the close of each
accrual period and properly adjusted for the length of the
accrual period) less (b) the stated interest allocable to
the accrual period. The adjusted issue price of a
Note as of the beginning of any accrual period will equal its
issue price, increased by previously accrued OID. A Notes
yield to maturity is the discount rate that causes the present
value on the issue date of all payments on the note to equal the
issue price.
A United States Holder will not be required to recognize any
additional income upon the receipt of any payment on the Notes
that is attributable to previously accrued OID.
Market
Discount
A United States Holder who purchased an outstanding Note at a
market discount will generally be required to treat any gain
recognized on the sale, exchange, retirement or other taxable
disposition of the exchange Note received in exchange therefor
as ordinary income to the extent of the accrued market discount
(during the periods in which the holder held the outstanding
Note and exchange Note) that has not been previously included in
income. Market discount is generally defined as the amount by
which a United States Holders purchase price for a Note is
less than the Notes adjusted issue price (as described
above) on the date of purchase, subject to a statutory de
minimis exception. In general, market discount accrues on a
ratable basis over the remaining term of the Note unless a
United States Holder makes an irrevocable election to accrue
market discount on a constant yield to maturity basis.
80
Acquisition
Premium
If a United States Holder acquired the outstanding Note at a
cost less than or equal to the stated principal amount, but
greater than the Notes adjusted issue price on the
acquisition date, the United States Holder will be treated as
acquiring the outstanding Note at an acquisition
premium. Unless an election is made, the United States
Holder generally will reduce the amount of OID otherwise
includible in gross income for an accrual period by an amount
equal to the amount of OID otherwise includible in gross income
multiplied by a fraction, the numerator of which is the excess
of the United States Holders initial tax basis in the Note
over the Notes adjusted issue price on the acquisition
date and the denominator of which is the excess of the stated
principal amount over the Notes adjusted issue price on
the acquisition date. Alternatively, the United States Holder
may elect to compute OID accruals by treating the acquisition of
the Note as a purchase at original issuance and applying the
constant yield method described above.
Amortizable
Bond Premium
A United States Holder who purchased an outstanding Note for an
amount in excess of its principal amount will be considered to
have purchased the outstanding Note at a premium. A United
States Holder may elect to amortize premium on a constant yield
method; provided that, while, as in this case, the Notes
may be called by the Issuer at a premium, a United States
Holders amortization of premium may be deferred or
disallowed. The amount amortized in any year will be treated as
a reduction of the United States Holders stated interest
income from the exchange Note. A United States Holder who elects
to amortize the premium on a Note must reduce its tax basis in
the Note by the amount of the premium amortized in any year. A
United States Holder that acquired the Notes at premium will not
be required to include any OID as income.
An election to amortize bond premium applies to all taxable debt
obligations then owned and thereafter acquired by the United
States Holder and may be revoked only with the consent of the
IRS. Bond premium on a Note held by a United States Holder who
does not make such an election will decrease the capital gain or
increase the capital loss otherwise recognized on the
disposition of the Note.
Sale,
Exchange, Redemption, Retirement or Other Taxable Disposition of
the Notes
Except as described above under Market
Discount, a United States Holder generally will recognize
capital gain or loss on the sale, exchange, redemption,
retirement or other taxable disposition of a Note in an amount
equal to the difference between the amount of cash plus the fair
market value of any property received (other than any such
amount attributable to accrued stated interest, which will be
taxable as ordinary income to the extent not previously included
in income), and the United States Holders adjusted tax
basis in the Note. A United States Holders adjusted tax
basis in a Note will, in general, be the United States
Holders cost thereof, increased by any OID (net of any
acquisition premium) previously includible in income by the
United States Holder and reduced by the amount of any
amortizable bond premium previously taken into account with
respect to the Note.
Any capital gain or loss recognized by a United States Holder on
the sale, exchange, redemption, retirement or other taxable
disposition of a Note that such United States Holder has held
for more than one year generally will be long-term capital gain
or loss. For non-corporate holders, certain preferential tax
rates may apply to gain recognized as long-term capital gain.
The deductibility of capital losses is subject to certain
limitations. Any gain or loss realized by a United States Holder
on the sale, exchange, redemption, retirement or other
disposition of a Note generally will be treated as
U.S. source gain or loss, as the case may be.
Information
Reporting and Backup Withholding
Information returns may be filed with the IRS in connection with
payments of interest (including accrual of OID) on the Notes and
the proceeds from a sale or other disposition (including a
retirement or redemption) of the Notes unless the United States
Holder of the Notes establishes an exemption from the
information reporting rules. A United States Holder of Notes
that does not establish such an exemption may be subject to
U.S. backup withholding tax (currently at a rate of 28%) on
these payments if the holder fails to provide its taxpayer
identification number or to certify its exemption from backup
withholding.
81
Backup withholding is not an additional tax. Any amounts
withheld under the backup withholding rules from a payment to a
United States Holder of the Notes will be allowed as a refund or
a credit against such holders U.S. federal income tax
liability; provided that the required information is
timely furnished to the IRS.
Non-United
States Holders
Interest
and Disposition
In general (and subject to the discussion below under
Information Reporting and Backup Withholding), a
Non-United
States Holder will not be subject to U.S. federal income or
withholding tax with respect to payments of interest on (which,
for purposes of this discussion, includes OID), or gain upon the
sale, exchange, redemption, retirement or other taxable
disposition of, Notes, unless:
|
|
|
|
|
the interest or gain is effectively connected with the conduct
by the
Non-United
States Holder of a trade or business in the United
States; or
|
|
|
|
in the case of gain upon the disposition of Notes, the
Non-United
States Holder is an individual who is present in the
U.S. for 183 days or more in the taxable year and
certain other conditions are met.
|
A Non-United
States Holder described in the first bullet point above will
generally be subject to regular U.S. federal income tax on
such effectively connected interest or gain in the same manner
as if it were realized by a United States Holder (unless an
applicable income tax treaty provides otherwise). In addition, a
corporate
Non-United
States Holder may be subject to a branch profits tax on its
effectively connected earnings and profits attributable to such
interest or gain at a rate of 30% (or such lower rate as is
provided by an applicable income tax treaty). A
Non-U.S. Holder
described in the second bullet point above will be subject to a
30% U.S. federal income tax on the gain derived from the
sale or other taxable disposition, which may be offset by
certain U.S. source capital losses.
Backup
Withholding and Information Reporting
Backup withholding (currently at a rate of 28%) and related
information reporting is generally not required if an
appropriate certification of
non-U.S. status
is provided or an exemption is otherwise established. Backup
withholding is not an additional tax. Any amounts withheld under
the backup withholding rules from a payment to a holder of the
Notes will be allowed as a refund or a credit against such
holders U.S. federal income tax liability;
provided that the required information is timely
furnished to the IRS.
Non-United
States Holders should consult their own tax advisors concerning
the application of the backup withholding and related
information reporting rules.
82
IRELAND
TAXATION
The following is a summary based on the laws and practices
currently in force in Ireland regarding the tax position of
investors beneficially owning their exchange Notes and should be
treated with appropriate caution. Particular rules may apply to
certain classes of taxpayers holding exchange Notes. It does not
purport to be a complete description of all of the tax
consequences that may be relevant to a decision to subscribe
for, buy, hold, sell, redeem, exchange or dispose of the
exchange Notes and does not constitute tax or legal advice.
Prospective investors in the exchange Notes should consult their
professional advisers on the tax implications of the purchase,
holding, redemption or sale of the exchange Notes and the
receipt of interest thereon under the laws of their country of
residence, citizenship or domicile.
Withholding
Tax
In general, tax at the standard rate of income tax (currently
20 per cent), is required to be withheld from payments of
Irish source interest. However, an exemption from withholding on
interest payments exists under Section 64 of the Taxes
Consolidation Act, 1997 (the 1997 Act) for certain
securities (quoted Eurobonds) issued by a body
corporate (such as the Issuers) which are interest bearing and
quoted on a recognised stock exchange (which would include the
Irish Stock Exchange).
Any interest paid on such quoted Eurobonds can be paid free of
withholding tax provided:
(a) the person by or through whom the payment is made is
not in Ireland; or
(b) the payment is made by or through a person in Ireland,
and either:
(i) the quoted Eurobond is held in a clearing system
recognised by the Irish Revenue Commissioners (Euroclear and
Clearstream, Luxembourg are so recognised), or
(ii) the person who is the beneficial owner of the quoted
Eurobond and who is beneficially entitled to the interest is not
resident in Ireland and has made a declaration to a relevant
person (such as an Irish paying agent) in the prescribed form.
So long as the exchange Notes are quoted on a recognised stock
exchange and are held in Euroclear
and/or
Clearstream, Luxembourg, interest on the exchange Notes can be
paid by the Issuers and any paying agent acting on behalf of the
Issuers without any withholding or deduction for or on account
of Irish income tax.
If, for any reason, the quoted Eurobond exemption referred to
above does not or ceases to apply, an Issuer can still pay
interest on the exchange Notes free of withholding tax provided
it is a qualifying company (within the meaning of
Section 110 of the 1997 Act) and provided the interest is
paid to a person resident in a Relevant Territory
(i.e. a member state of the European Union (other than
Ireland) or a country with which Ireland has signed a double
taxation agreement). For this purpose, residence is determined
by reference to the law of the country in which the recipient
claims to be resident. This exemption from withholding tax will
not apply, however, if the interest is paid to a company in
connection with a trade or business carried on by it through a
branch or agency located in Ireland.
In certain circumstances, Irish tax will be required to be
withheld at the standard rate from interest on any quoted
Eurobond, where such interest is collected by a bank or other
agent in Ireland on behalf of any noteholder who is Irish
resident.
Taxation
of Noteholders
Notwithstanding that a noteholder may receive interest on the
exchange Notes free of withholding tax, the noteholder may still
be liable to pay Irish tax on the income. Interest paid on the
exchange Notes may have an Irish source and therefore be within
the charge to Irish tax on income and potentially other Irish
charges. Ireland operates a self assessment system in respect of
tax on income and any person, including a person who is neither
resident nor ordinarily resident in Ireland, with Irish source
income comes within its scope.
83
However, interest on the exchange Notes will be exempt from
Irish income tax if the recipient of the interest is resident in
a Relevant Territory provided either (i) the exchange Notes
are quoted Eurobonds and are exempt from withholding tax as set
out above (ii) in the event of the exchange Notes not being
or ceasing to be quoted Eurobonds exempt from withholding tax,
if the Issuer paying the interest is a qualifying company within
the meaning of Section 110 of the 1997 Act, or
(iii) if the Issuer paying the interest has ceased to be a
qualifying company within the meaning of Section 110 of the
1997 Act, the recipient of the interest is a company and the
Relevant Territory in questions imposes a tax that generally
applies to interest receivable in that jurisdiction by companies
from sources outside their jurisdiction.
Notwithstanding these exemptions from income tax, a corporate
recipient that carries on a trade in Ireland through a branch or
agency in respect of which the exchange Notes are held or
attributed, may have a liability to Irish corporation tax on the
interest.
Interest on the exchange Notes which does not fall within the
above exemptions may be liable to Irish income tax.
Capital
Gains Tax
A holder of exchange Notes will be subject to Irish tax on
capital gains on a disposal of exchange Notes unless such holder
is neither resident nor ordinarily resident in Ireland and does
not carry on a trade in Ireland through a branch or agency in
respect of which the exchange Notes are used or held.
Exchange
Offer
On the basis that the exchange Notes will constitute substitute
evidence of the indebtedness originally represented by the
outstanding Notes and no other consideration will be received by
noteholders in respect of the exchange, the exchange of the
Notes will not be considered a disposal for the purposes of
Irish capital gains tax or corporation tax and, accordingly, no
charge to either tax would arise on the exchange.
Capital
Acquisitions Tax
A gift or inheritance comprising of exchange Notes will be
within the charge to capital acquisitions tax if either
(i) the disponer or the donee/successor in relation to the
gift or inheritance is resident or ordinarily resident in
Ireland (or, in certain circumstances, if the disponer is
domiciled in Ireland irrespective of his residence or that of
the donee/successor) on the relevant date or (ii) if the
exchange Notes are regarded as property situate in Ireland.
Registered notes are generally regarded as situate where the
principal register of noteholders is maintained or is required
to be maintained, but the exchange Notes may be regarded as
situated in Ireland regardless of the location of the register
as they secure a debt due by an Irish resident debtor and they
may be secured over Irish property. Accordingly, if such
exchange Notes are comprised in a gift or inheritance, the gift
or inheritance may be within the charge to tax regardless of the
residence status of the disponer or the donee/successor.
Stamp
Duty
No stamp duty or similar tax is imposed in Ireland on the issue,
transfer or redemption of the exchange Notes whether they are
represented by global notes or definitive notes (on the basis of
an exemption provided for in Section 85(2)(c) to the Stamp
Duties Consolidation Act, 1999 provided the money raised on the
issue of the exchange Notes is used in the course of the
Issuers business).
EU
Savings Directive
The Council of the European Union has adopted a directive
regarding the taxation of interest income known as the
European Union Directive on the Taxation of Savings Income
(Directive 2003/48/EC).
Ireland has implemented the directive into national law. Any
Irish paying agent making an interest payment on behalf of the
Issuer to an individual, and certain residual entities defined
in the 1997 Act, resident in another EU Member State and certain
associated and dependent territories of a Member State will have
to
84
provide details of the payment to the Irish Revenue
Commissioners who in turn will provide such information to the
competent authorities of the state or territory of residence of
the individual or residual entity concerned.
In November 2008 the European Commission proposed that a number
of changes be made to the directive following a report on its
operation since adoption. If any of these proposed changes are
adopted they are likely to broaden the scope of the directive.
85
LEGAL
MATTERS
Certain legal matters will be passed upon for us and Elan by
Cahill Gordon & Reindel
llp, with respect
to matters of U.S. law, and A&L Goodbody, with respect
to matters of Irish law.
EXPERTS
The consolidated financial statements and the related financial
statement schedule of Elan Corporation, plc as of
December 31, 2010 and 2009, and for each of the years in
the three-year period ended December 31, 2010, and
managements assessment of the effectiveness of internal
control over financial reporting as of December 31, 2010
have been incorporated by reference herein in reliance upon the
reports of KPMG, independent registered public accounting firm,
incorporated by reference herein, and upon the authority of said
firm as experts in accounting and auditing.
86
$200,000,000
Elan Finance public limited
company
Elan Finance Corp.
Exchange Offer
for up to
$200,000,000 Aggregate
Principal
Amount of 8.75% Senior
Notes due 2016
PROSPECTUS
,
2011
We have not authorized any dealer, salesperson or other person
to give any information or represent anything not contained in
this prospectus. You must not rely on unauthorized information.
This prospectus is not an offer to sell or buy any securities in
any jurisdiction where it is unlawful. The information in this
prospectus is current as
of ,
2011.
PART II
INFORMATION
NOT REQUIRED IN PROSPECTUS
|
|
Item 20.
|
Indemnification
of Directors and Officers.
|
Elan
Corporation, plc
Except to the extent indicated below, there is no charter
provision, by-law, contract, arrangement or statute under which
any director or officer of Elan is insured or indemnified in any
manner against any liability which he or she may incur in his or
her capacity as such.
Paragraph 115 of the Articles of Association of Elan
provides as follows:
115. Every Director and other officer of the Company (other
than an auditor) shall be indemnified out of the assets of the
Company against any cost, expense, liability or other matter
incurred by him in defending any proceedings, whether civil or
criminal, in relation to his acts while acting in such office in
which judgment is given in his favour or in which he is
acquitted or in connection with any application in which relief
is granted to him by the Court under the Acts.
Section 200 of the Irish Companies Act of 1963 (as amended)
provides as follows:
(1) Subject as hereinafter provided, any provision whether
contained in the articles of a company or in any contract with a
company or otherwise for exempting any officer of the company or
any person employed by the company as auditor from, or
indemnifying him against, any liability which by virtue of any
rule of law would otherwise attach to him in respect of any
negligence, default, breach of duty or breach of trust of which
he may be guilty in relation to the company shall be void, so,
however, that:
(a) nothing in this section shall operate to deprive any
person of any exemption or right to be indemnified in respect of
anything done or omitted to be done by him while any such
provision was in force; and
(b) notwithstanding anything in this section, a company
may, in pursuance of any such provision as aforesaid, indemnify
any such officer or auditor against any liability incurred by
him in defending proceedings, whether civil or criminal, in
which judgment is given in his favour or in which he is
acquitted, or in connection with any application under
section 391 of the Company Act, 1963, or section 42 of
the Companies (Amendment) Act, 1983, in which relief is granted
to him by the court.
(2) Notwithstanding subsection (1), a company may purchase
and maintain for any of its officers or auditors insurance in
respect of any liability referred to in that subsection.
(3) Notwithstanding any provision contained in an
enactment, the articles of a company or otherwise, a director
may be counted in the quorum and may vote on any resolution to
purchase or maintain any insurance under which the director may
benefit.
(4) Any directors and officers insurance
purchased or maintained by a company before the date on which
the amendments made to this section by the Companies (Auditing
and Accounting) Act 2003 came into operation is as valid and
effective as it would have been if those amendments had been in
operation when that insurance was purchased or maintained.
(5) In this section a reference to an officer or auditor
includes any former or current officer or auditor of the
company, as the case may be.
Elan has granted contractual indemnities to its directors, its
secretary and a number of members of its management
(Indemnified Persons). Under these contractual
indemnities, the Indemnified Persons will be indemnified by Elan
against certain liabilities, including any liabilities arising
out of anything done or not done by the Indemnified Persons in
the context of any offering for the subscription or purchase of
Elans securities. These contractual indemnities will
remain in effect for as long as the Indemnified Persons are
subject to any possible claim of a type covered by the
indemnities. Certain matters are, however, excluded
II-1
from these contractual indemnities, including any event based on
any dishonest or fraudulent act or omission or willful
misconduct by or on behalf of the Indemnified Persons. In the
case of Elans directors and secretary, their indemnities
will only have effect so long as the indemnity complies with
Irish law, including in particular Section 200 of the Irish
Companies Act, 1963 (as described above).
Elan maintains a standard form of directors and
officers liability insurance policy, which provides
coverage to its directors and officers for certain liabilities.
Elan
Finance public limited company
Except to the extent indicated below, there is no charter
provision, by-law, contract, arrangement or statute under which
any director or officer of Elan Finance public limited company
is insured or indemnified in any manner against any liability
which he or she may incur in his or her capacity as such.
Paragraph 39 of the Articles of Association of Elan Finance
public limited company provides as follows:
Subject to the Acts, every director, managing director, agent,
auditor, secretary and other officer for the time being of the
company shall be indemnified out of the assets of the company
against any liability incurred by him in defending any
proceedings, whether civil or criminal, in relation to his acts
while acting in such office, in which judgment is given in his
favour or in which he is acquitted or in connection with any
application under section 391 of the Act in which relief is
granted to him by the court. Regulation 138 of Part I
of Table A will not apply.
Section 200 of the Irish Companies Act of 1963 (as amended)
provides as follows:
(1) Subject as hereinafter provided, any provision whether
contained in the articles of a company or in any contract with a
company or otherwise for exempting any officer of the company or
any person employed by the company as auditor from, or
indemnifying him against, any liability which by virtue of any
rule of law would otherwise attach to him in respect of any
negligence, default, breach of duty or breach of trust of which
he may be guilty in relation to the company shall be void, so,
however, that:
(a) nothing in this section shall operate to deprive any
person of any exemption or right to be indemnified in respect of
anything done or omitted to be done by him while any such
provision was in force; and
(b) notwithstanding anything in this section, a company
may, in pursuance of any such provision as aforesaid, indemnify
any such officer or auditor against any liability incurred by
him in defending proceedings, whether civil or criminal, in
which judgment is given in his favour or in which he is
acquitted, or in connection with any application under
section 391 of the Company Act, 1963, or section 42 of
the Companies (Amendment) Act, 1983, in which relief is granted
to him by the court.
(2) Notwithstanding subsection (1), a company may purchase
and maintain for any of its officers or auditors insurance in
respect of any liability referred to in that subsection.
(3) Notwithstanding any provision contained in an
enactment, the articles of a company or otherwise, a director
may be counted in the quorum and may vote on any resolution to
purchase or maintain any insurance under which the director may
benefit.
(4) Any directors and officers insurance
purchased or maintained by a company before the date on which
the amendments made to this section by the Companies (Auditing
and Accounting) Act 2003 came into operation is as valid and
effective as it would have been if those amendments had been in
operation when that insurance was purchased or maintained.
(5) In this section a reference to an officer or auditor
includes any former or current officer or auditor of the
company, as the case may be.
II-2
Elan
Finance Corp.
Section 145 of the Delaware General Corporation Law
provides that a corporation may indemnify any person who was or
is a party or is threatened to be made a party to any
threatened, pending or completed action, suit or proceeding,
whether civil, criminal, administrative or investigative (other
than an action by or in the right of the corporation) by reason
of the fact that he is or was a director, officer, employee or
agent of the corporation, or is or was serving at the request of
the corporation as a director, officer, employee or agent of
another corporation, partnership, joint venture, trust or other
enterprise, against expenses (including attorneys fees),
judgments, fines and amounts paid in settlement actually and
reasonably incurred by him in connection with such action, suit
or proceeding if the person acted in good faith and in a manner
the person reasonably believed to be in or not opposed to the
best interest of the corporation, and, with respect to any
criminal action or proceeding, had no reasonable cause to
believe his conduct was unlawful; and further that a corporation
may indemnify such person against expenses (including
attorneys fees) actually and reasonably incurred by such
person in connection with the defense or settlement of action or
suit by or in the right of the corporation, if the person acted
in good faith and in a manner the person reasonably believed to
be in or not opposed to the best interests of the corporation,
except that no indemnification shall be made in respect of any
claim, issue or matter as to which such person shall have been
adjudged to be liable to the corporation unless and only to the
extent that the Court of Chancery or the court in which such
action or suit was brought shall determine upon application
that, despite the adjudication of liability but in view of all
the circumstances of the case, such person is fairly and
reasonably entitled to indemnity for such expenses which the
Court of Chancery or such other court shall deem proper. To the
extent that a present or former director or officer of a
corporation has been successful on the merits or otherwise in
defense of any such action described in this paragraph, suit or
proceeding, or in defense of any claim, issue or matter therein,
such person shall be indemnified against expenses (including
attorneys fees) actually and reasonably incurred by such
person in connection therewith.
Section 102(b)(7) of the Delaware General Corporation Law
allows a corporation to include in its certificate of
incorporation a provision to eliminate or limit the personal
liability of a director of a corporation to the corporation or
to any of its stockholders for monetary damages for a breach of
fiduciary duty as a director, except in the case where the
director (i) breaches his duty of loyalty to the
corporation or its stockholders, (ii) fails to act in good
faith, engages in intentional misconduct or knowingly violates a
law, (iii) authorizes the unlawful payment of a dividend or
approves a stock purchase or redemption in violation of
Section 174 of the Delaware General Corporation Law or
(iv) obtains an improper personal benefit. The
registrants Amended and Restated Certificate of
Incorporation includes a provision which eliminates
directors personal liability to the fullest extent
permitted under the Delaware General Corporation Law.
Elan Finance Corp.s By-Laws (the By-Laws)
provide that the Elan Finance Corp. shall indemnify, hold
harmless and advance expenses to each person (and, where
applicable, whether the person died testate or intestate, the
personal representative of such person, the estate of such
person and such persons legatees and heirs) who is or has
served as director of or officer of Elan Finance Corp. or any
other enterprise at the request of the Corporation, who was or
is made a party or is threatened to be made a party to or is
involved in any action, suit or proceeding, whether civil,
criminal, administrative or investigative (a
proceeding), by reason of the fact that he or she,
or a person of whom he or she is the legal representative, is or
was a director or officer of Elan Finance Corp. or is or was
serving at the request of Elan Finance Corp. as a director,
officer, employee or agent of another corporation or of a
partnership, joint venture, trust or other enterprise, including
service with respect to employee benefit plans, whether the
basis of such proceeding is alleged action in an official
capacity as a director, officer, employee or agent or in any
other capacity while serving as a director, officer, employee or
agent. Such indemnification and holding harmless covers all
recoverable expense, liability and loss (including, without
limitation, attorneys fees, judgments, fines, ERISA excise
taxes or penalties and amounts paid or to be paid in settlement)
incurred or suffered by such person in connection therewith and
such indemnification continues as to a person who has ceased to
be an officer, director, employee or agent and shall inure to
the benefit of his or her heirs, executors and administrators.
Elan Finance Corp. shall indemnify any such person seeking
indemnification in connection with a proceeding (or part
thereof) initiated by such person only if such proceeding (or
part thereof) was authorized by the Board of Directors of Elan
Finance Corp. The right to indemnification includes the right to
be paid by Elan Finance Corp. the expenses incurred
II-3
in defending any such proceeding in advance of its final
disposition; provided, however, that, if the
Delaware General Corporation Law requires, the payment of such
expenses incurred by a director or officer of Elan Finance Corp.
in his or her capacity as a director or officer of Elan Finance
Corp. (and not in any other capacity in which service was
rendered by such person while a director or officer, including,
without limitation, service to an employee benefit plan) in
advance of the final disposition of a proceeding, will be made
only upon delivery to Elan Finance Corp. of an undertaking, by
or on behalf of such director or officer, to repay all amounts
so advanced if it shall ultimately be determined that such
director or officer is not entitled to be indemnified under the
By-Laws or otherwise.
Section 145 of the Delaware General Corporation Law further
provides that a corporation shall have power to purchase and
maintain insurance on behalf of any person who is or was a
director, officer, employee or agent of the corporation, or is
or was serving at the request of the corporation as a director,
officer, employee or agent of another corporation, partnership,
joint venture, trust or other enterprise against any liability
asserted against such person and incurred by such person in any
such capacity, or arising out of such persons status as
such, whether or not the corporation would otherwise have the
power to indemnify such person against such liability under
Section 145.
II-4
|
|
|
|
|
Exhibit
|
|
|
No.
|
|
Description
|
|
|
3
|
.1
|
|
Memorandum and Articles of Association of Elan Corporation, plc
(incorporated by reference to Exhibit 1.1 of the Annual
Report on
Form 20-F
of Elan Corporation, plc filed with the Commission on
February 24, 2011).
|
|
3
|
.2
|
|
Memorandum and Articles of Association of Elan Finance Public
Limited Company (incorporated by reference to Exhibit 3.2
of the Registration Statement on
Form F-4
of Elan Corporation, plc (SEC File
No. 333-128234)
filed with the Commission on September 9, 2005).
|
|
3
|
.3
|
|
Certificate of Incorporation of Elan Finance Corp. (incorporated
by reference to Exhibit 3.3 of the Registration Statement
on
Form F-4
of Elan Corporation, plc (SEC File
No. 333-128234)
filed with the Commission on September 9, 2005).
|
|
3
|
.4
|
|
By-Laws of Elan Finance Corp. (incorporated by reference to
Exhibit 3.4 of the Registration Statement on
Form F-4
of Elan Corporation, plc (SEC File
No. 333-128234)
filed with the Commission on September 9, 2005).
|
|
4
|
.1
|
|
Indenture dated as of August 17, 2010, among Elan Finance
public limited company, Elan Finance Corp., Elan Corporation,
plc, the Subsidiary Note Guarantors party thereto and The Bank
of New York Mellon, as Trustee (incorporated by reference to
Exhibit 99.1 of the Report of Foreign Issuer on
Form 6-K
of Elan Corporation, plc (SEC File
No. 001-13896)
filed with the Commission on December 13, 2010).
|
|
4
|
.2
|
|
Form of 8.75% Senior Note due 2016 (incorporated by
reference to Exhibit A of the Indenture attached as
Exhibit 4.1 hereto).
|
|
4
|
.3
|
|
Registration Rights Agreement dated August 17, 2010 among
Elan Finance public limited company, Elan Finance Corp., Elan
Corporation, plc, certain Subsidiary Guarantors and Morgan
Stanley & Co. Incorporated, Citigroup Global Markets
Inc. and J & E Davy (incorporated by reference to
Exhibit 99.2 of the Report of Foreign Issuer on
Form 6-K
of Elan Corporation, plc filed with the Commission on
December 13, 2010).
|
|
5
|
.1
|
|
Opinion of A&L Goodbody regarding legality as to Irish law.
|
|
5
|
.2
|
|
Opinion of A&L Goodbody regarding legality as to English
law.
|
|
5
|
.3
|
|
Opinion of Cahill Gordon & Reindel
llp regarding
legality.
|
|
5
|
.4
|
|
Opinion of Casner & Edwards, LLP regarding legality.
|
|
5
|
.5
|
|
Opinion of Conyers Dill & Pearman Limited regarding
legality.
|
|
5
|
.6
|
|
Opinion of NautaDutilh N.V. regarding legality.
|
|
12
|
.1
|
|
Ratio of Earnings to Fixed Charges.
|
|
21
|
.1
|
|
Subsidiaries of Elan Corporation, plc (incorporated by reference
to Exhibit 8.1 of the Annual Report on
Form 20-F
of Elan Corporation, plc filed with the Commission on
February 24, 2011).
|
|
23
|
.1
|
|
Consent of A&L Goodbody (included in Exhibit 5.1).
|
|
23
|
.2
|
|
Consent of A&L Goodbody (included in Exhibit 5.2).
|
|
23
|
.3
|
|
Consent of Cahill Gordon & Reindel
llp (included in
Exhibit 5.3).
|
|
23
|
.4
|
|
Consent of Casner & Edwards, LLP regarding legality
(included in Exhibit 5.4).
|
|
23
|
.5
|
|
Consent of Conyers Dill & Pearman Limited (included in
Exhibit 5.5).
|
|
23
|
.6
|
|
Consent of NautaDutilh N.V. (included in Exhibit 5.6).
|
|
23
|
.7
|
|
Consent of Independent Registered Public Accounting Firm, KPMG.
|
|
24
|
.1
|
|
Powers of Attorney are included in the signature pages of this
registration statement.*
|
|
25
|
.1
|
|
Statement of Eligibility and Qualification under the
Trust Indenture Act of 1939 on
Form T-1
of The Bank of New York Mellon, as Trustee under the 2016
Indenture issued August 2010.
|
|
99
|
.1
|
|
Form of Letter of Transmittal.
|
|
99
|
.2
|
|
Form of Notice of Guaranteed Delivery.
|
|
99
|
.3
|
|
Form of Letter to Clients.
|
|
99
|
.4
|
|
Form of Letter to Brokers, Dealers, Commercial Banks,
Trust Companies and Other Nominees.
|
II-5
(a) The undersigned registrants hereby undertake:
(1) To file, during any period in which offers or sales are
being made, a post-effective amendment to this registration
statement:
(i) To include any prospectus required by
section 10(a)(3) of the Securities Act of 1933;
(ii) To reflect in the prospectus any facts or events
arising after the effective date of the registration statement
(or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change
in the information set forth in the registration statement.
Notwithstanding the foregoing, any increase or decrease in
volume of securities offered (if the total dollar value of
securities offered would not exceed that which was registered)
and any deviation from the low or high end of the estimated
maximum offering range may be reflected in the form of
prospectus filed with the Commission pursuant to
Rule 424(b) if, in the aggregate, the changes in volume and
price represent no more than 20% change in the maximum aggregate
offering price set forth in the Calculation of
Registration Fee table in the effective registration
statement; and
(iii) To include any material information with respect to
the plan of distribution not previously disclosed in the
registration statement or any material change to such
information in the registration statement;
provided, however, that paragraphs (a)(1)(i) and
(a)(1)(ii) of this section do not apply if the registration
statement is on
Form S-3,
Form S-8
or
Form F-3,
and the information required to be included in a post-effective
amendment by those paragraphs is contained in periodic reports
filed with or furnished to the Commission by the registrants
pursuant to section 13 or section 15(d) of the
Securities Exchange Act of 1934 that are incorporated by
reference in the registration statement.
(2) That, for the purpose of determining any liability
under the Securities Act of 1933, each such post-effective
amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of
such securities at that time shall be deemed to be the initial
bona fide offering thereof.
(3) To remove from registration by means of a
post-effective amendment any of the securities being registered
which remain unsold at the termination of the offering.
(b) The undersigned registrants hereby undertake that, for
purposes of determining any liability under the Securities Act,
each filing of the registrants annual report pursuant to
Section 13(a) or Section 15(d) of the Exchange Act
(and, where applicable, each filing of an employee benefit
plans annual report pursuant to Section 15(d) of the
Exchange Act), that is incorporated by reference in this
registration statement shall be deemed to be a new registration
statement relating to the securities offered herein, and the
offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
(c) Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to directors, officers
and controlling persons of the registrants under the foregoing
provisions, or otherwise, the registrants have been advised that
in the opinion of the SEC such indemnification is against public
policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that claim for indemnification
against such liabilities (other than the payment by the
registrants of expenses incurred or paid by a director, officer
or controlling person of the registrants in the successful
defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the
securities being registered, the registrants will, unless in the
opinion of its counsel the matter has been settled by
controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is
against public policy as expressed in the Securities Act and
will be governed by the final adjudication of such issue.
(d) The undersigned registrants hereby undertake
(i) to respond to requests for information that are
incorporated by reference into the prospectus pursuant to
Items 4, 10(b), 11 or 13 of
Form F-4,
within one
II-6
business day of receipt of such request, and to send the
incorporated documents by first class mail or other equally
prompt means; and (ii) to arrange or provide for a facility
in the United States for the purpose of responding to such
requests. The undertaking in subparagraph (i) above include
information contained in documents filed subsequent to the
effective date of this registration statement through the date
of responding to the request.
(e) The undersigned registrants hereby undertake to supply
by means of a post-effective amendment all information
concerning a transaction and the company being acquired involved
therein, that was not the subject of and included in the
registration statement when it became effective.
II-7
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
Registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized in Dublin, Ireland, on the 22nd day of June,
2011.
ELAN FINANCE PUBLIC LIMITED COMPANY
ELAN HOLDINGS LIMITED
ELAN MANAGEMENT LIMITED
ELAN PHARMA INTERNATIONAL LIMITED
ELAN TRANSDERMAL LIMITED
THE INSTITUTE OF BIOPHARMACEUTICS,
LIMITED
KEAVY FINANCE LIMITED
CRIMAGUA LIMITED
ORCHARDBROOK LIMITED
|
|
|
|
By:
|
/s/ Shane
M. Cooke
Name: Shane
M. Cooke
Title: Director
|
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Shane
M. Cooke
(Shane
M. Cooke)
|
|
Director
|
|
June 22, 2011
|
|
|
|
|
|
*
(William
F. Daniel)
|
|
Director
|
|
June 22, 2011
|
|
|
|
|
|
*
(Mary
Sheahan)
|
|
Director
|
|
June 22, 2011
|
|
|
|
|
|
|
|
* By:
|
|
/s/ Shane
M. Cooke
Shane
M. Cooke
Attorney-in-Fact
|
|
|
|
|
II-8
Pursuant to the requirements of the Securities Act of 1933, the
Registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized in Dublin, Ireland, on the 22nd day of June 2011.
ELAN SCIENCE FOUR LIMITED
|
|
|
|
By:
|
/s/ Nigel
Clerkin
Name: Nigel
Clerkin
Title: Director
|
KNOW ALL PERSONS BY THESE PRESENTS, that Nigel Clerkin whose
signature appears below constitutes and appoints William F.
Daniel and Shane Cooke, and each of them, as attorneys-in-fact
and agents, each with the power of substitution, for him and in
his name, place and stead in any and all capacities, in
connection with this Registration Statement, including to sign,
in the name and on behalf of the undersigned, this Registration
Statement and any and all amendments thereto (including
post-effective amendments) and to file the same, with all
exhibits thereto, and other documents in connection therewith,
with the Securities and Exchange Commission, granting unto such
attorneys-in-fact and agents full power and authority to do and
perform each and every act and thing requisite and necessary to
be done in and about the premises, as fully to all intents and
purposes as he might or could do in person, hereby ratifying and
confirming all that said attorneys-in-fact and agents, or his
substitute or substitutes, may lawfully do or cause to be done
by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Nigel
Clerkin
(Nigel
Clerkin)
|
|
Director
|
|
June 22, 2011
|
|
|
|
|
|
*
(William
F. Daniel)
|
|
Director
|
|
June 22, 2011
|
|
|
|
|
|
|
|
*By:
|
|
/s/ Shane
M. Cooke
Shane
M. CookeAttorney-in-Fact
|
|
|
|
|
II-9
Pursuant to the requirements of the Securities Act of 1933, the
Registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized in Dublin, Ireland, on the 22nd day of June,
2011.
ELAN CORPORATION, PLC
|
|
|
|
By:
|
/s/ Shane
M. Cooke
Name: Shane
M. Cooke
Title: Executive Vice President, Head of
Elan
Drug
Technologies
|
KNOW ALL PERSONS BY THESE PRESENTS, that Grainne McAleese whose
signature appears below constitutes and appoints William F.
Daniel and Shane Cooke, and each of them, as attorneys-in-fact
and agents, each with the power of substitution, for her and in
her name, place and stead in any and all capacities, in
connection with this Registration Statement, including to sign,
in the name and on behalf of the undersigned, this Registration
Statement and any and all amendments thereto (including
post-effective amendments) and to file the same, with all
exhibits thereto, and other documents in connection therewith,
with the Securities and Exchange Commission, granting unto such
attorneys-in-fact and agents full power and authority to do and
perform each and every act and thing requisite and necessary to
be done in and about the premises, as fully to all intents and
purposes as she might or could do in person, hereby ratifying
and confirming all that said attorneys-in-fact and agents, or
her substitute or substitutes, may lawfully do or cause to be
done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
*
(Robert
A. Ingram)
|
|
Chairman of the Board
|
|
June 22, 2011
|
|
|
|
|
|
*
(G.
Kelly Martin)
|
|
Chief Executive Officer and Director (Principal Executive
Officer)
|
|
June 22, 2011
|
|
|
|
|
|
/s/ Shane
M. Cooke
(Shane
M. Cooke)
|
|
Executive Vice President and Director, Head of Elan Drug
Technologies
|
|
June 22, 2011
|
|
|
|
|
|
*
(Nigel
Clerkin)
|
|
Executive Vice President and Chief Financial Officer (Principal
Financial Officer)
|
|
June 22, 2011
|
|
|
|
|
|
*
(Lars
Ekman, M.D. Ph.D)
|
|
Director
|
|
June 22, 2011
|
|
|
|
|
|
/s/ Grainne
McAleese
(Grainne
McAleese)
|
|
Vice President, Finance and Group Controller (Principal
Accounting Officer)
|
|
June 22, 2011
|
|
|
|
|
|
*
(Gary
Kennedy)
|
|
Director
|
|
June 22, 2011
|
II-10
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
(Patrick
Kennedy)
|
|
Director
|
|
|
|
|
|
|
|
*
(Giles
Kerr)
|
|
Director
|
|
June 22, 2011
|
|
|
|
|
|
(Kieran
McGowan)
|
|
Director
|
|
|
|
|
|
|
|
*
(Kyran
McLaughlin)
|
|
Director
|
|
June 22, 2011
|
|
|
|
|
|
*
(Donal
OConnor)
|
|
Director
|
|
June 22, 2011
|
|
|
|
|
|
*
(Richard
Pilnik)
|
|
Director
|
|
June 22, 2011
|
|
|
|
|
|
*
(Dennis
J. Selkoe)
|
|
Director
|
|
June 22, 2011
|
|
|
|
|
|
|
|
* By:
|
|
/s/ Shane
M. Cooke
Shane
M. Cooke
Attorney-in-Fact
|
|
|
|
|
II-11
Pursuant to the requirements of the Securities Act of 1933, the
Registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized in South San Francisco, California on the
22nd day of June, 2011.
ELAN FINANCE CORP.
|
|
|
|
By:
|
/s/ John
L. Donahue
Name: John
L. Donahue
Title: Vice President
|
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
*
(Johannes
Roebers)
|
|
President, Chief Executive Officer, Assistant Secretary and
Director
|
|
June 22, 2011
|
|
|
|
|
|
*
(Sandy
A. Alipio)
|
|
Treasurer and Chief Financial Officer
|
|
June 22, 2011
|
|
|
|
|
|
/s/ John
L. Donahue
(John
L. Donahue)
|
|
Vice President, Secretary and Director
|
|
June 22, 2011
|
|
|
|
|
|
*
(Douglas
Love)
|
|
Vice President and Director
|
|
June 22, 2011
|
|
|
|
|
|
|
|
*By:
|
|
/s/ Shane
M.
Cooke Shane
M. CookeAttorney-in-Fact
|
|
|
|
|
II-12
Pursuant to the requirements of the Securities Act of 1933, the
Registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized in Dublin, Ireland, on the 22nd day of June,
2011.
ELAN PHARMA LIMITED
MEADWAY PHARMACEUTICALS LTD
THE LIPOSOME COMPANY LIMITED
|
|
|
|
By:
|
/s/ Shane
M. Cooke
Name: Shane
M. Cooke
Title: Director
|
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
*
(William
F. Daniel)
|
|
Director
|
|
June 22, 2011
|
|
|
|
|
|
/s/ Shane
M. Cooke
(Shane
Cooke)
|
|
Director
|
|
June 22, 2011
|
|
|
|
|
|
*
(Mary
Sheahan)
|
|
Director
|
|
June 22, 2011
|
|
|
|
|
|
|
|
*By:
|
|
/s/ Shane
M.
Cooke Shane
M. CookeAttorney-in-Fact
|
|
|
|
|
II-13
Pursuant to the requirements of the Securities Act of 1933, the
Registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized in South San Francisco, California on the
22nd day of June, 2011.
ATHENA NEUROSCIENCES, INC.
|
|
|
|
By:
|
/s/ John
L. Donahue
Name: John
L. Donahue
Title: Assistant
Secretary
|
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
*
(G.
Kelly Martin)
|
|
President and Chief Executive Officer
|
|
June 22, 2011
|
|
|
|
|
|
*
(Sandy
A. Alipio)
|
|
Treasurer and Chief Financial Officer
|
|
June 22, 2011
|
|
|
|
|
|
*
(Johannes
Roebers)
|
|
Vice President, Secretary and Director
|
|
June 22, 2011
|
|
|
|
|
|
*
(Kathleen
Martorano)
|
|
Director
|
|
June 22, 2011
|
|
|
|
|
|
*
(Douglas
Love)
|
|
Vice President and Director
|
|
June 22, 2011
|
|
|
|
|
|
|
|
By:
|
|
/s/ Shane
M. Cooke
Shane
M. Cooke
Attorney-in-Fact
|
|
|
|
|
II-14
Pursuant to the requirements of the Securities Act of 1933, the
Registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized in South San Francisco, California on the
22th day of June, 2011.
ELAN DRUG DELIVERY, INC.
|
|
|
|
By:
|
/s/ John
L. Donahue
Name: John
L. Donahue
Title: Assistant
Secretary
|
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
*
(James
L. Botkin)
|
|
President and Chief Executive Officer and Director
|
|
June 22, 2011
|
|
|
|
|
|
*
(Nancy
Neill)
|
|
Treasurer, Chief Financial Officer, Secretary and Director
|
|
June 22, 2011
|
|
|
|
|
|
|
|
By:
|
|
/s/ Shane
M. Cooke
Shane
M. Cooke
Attorney-in-Fact
|
|
|
|
|
II-15
Pursuant to the requirements of the Securities Act of 1933, the
Registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized in South San Francisco, California, on the
22nd day of June, 2011.
ELAN HOLDINGS, INC.
|
|
|
|
By:
|
/s/ John
L. Donahue
Name: John
L. Donahue
Title: Assistant
Secretary
|
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
*
(James
L. Botkin)
|
|
President and Chief Executive Officer and Director
|
|
June 22, 2011
|
|
|
|
|
|
*
(Nancy
Neill)
|
|
Treasurer, Chief Financial Officer and Director
|
|
June 22, 2011
|
|
|
|
|
|
|
|
By:
|
|
/s/ Shane
M. Cooke
Shane
M. Cooke
Attorney-in-Fact
|
|
|
|
|
II-16
Pursuant to the requirements of the Securities Act of 1933, the
Registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized in South San Francisco, California, on the
22nd day of June, 2011.
ELAN PHARMACEUTICALS, INC.
|
|
|
|
By:
|
/s/ John
L. Donahue
Name: John
L. Donahue
Title: Assistant
Secretary
|
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
*
(G.
Kelly Martin)
|
|
President and Chief Executive Officer
|
|
June 22, 2011
|
|
|
|
|
|
*
(Sandy
A. Alipio)
|
|
Treasurer and Chief Financial Officer
|
|
June 22, 2011
|
|
|
|
|
|
*
(Johannes
Roebers)
|
|
Vice President, Secretary and Director
|
|
June 22, 2011
|
|
|
|
|
|
*
(Douglas
Love)
|
|
Vice President and Director
|
|
June 22, 2011
|
|
|
|
|
|
|
|
*By:
|
|
/s/ Shane
M. Cooke
Shane
M. CookeAttorney-in-Fact
|
|
|
|
|
II-17
Pursuant to the requirements of the Securities Act of 1933, the
Registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized in Dublin, Ireland, on the 22nd day of June,
2011.
ELAN INTERNATIONAL INSURANCE LTD.
ELAN INTERNATIONAL SERVICES LTD.
NEURALAB LIMITED
|
|
|
|
By:
|
/s/ Shane
M. Cooke
Name: Shane
M. Cooke
Title: Attorney-in-Fact
|
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
*
(Kevin
Insley)
|
|
Director
|
|
June 22, 2011
|
|
|
|
|
|
(Karen
S. Kim)
|
|
Director
|
|
|
|
|
|
|
|
*
(David
G. Carrick)
|
|
Director
|
|
June 22, 2011
|
|
|
|
|
|
|
|
*By:
|
|
/s/ Shane
M. Cooke
Shane
M. Cooke
Attorney-in-Fact
|
|
|
|
|
II-18
Pursuant to the requirements of the Securities Act of 1933, the
Registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly
authorized in Amsterdam, on the 22nd day of June, 2011.
MONKSLAND HOLDINGS B.V.
|
|
|
|
By:
|
/s/ Shane
M. Cooke
Name: Shane
M. Cooke
Title: Attorney-in-Fact
|
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons
in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ ANT
Management (Netherlands) B.V.
(ANT
Management (Netherlands) B.V.)
|
|
Managing director
|
|
June 22, 2011
|
|
|
|
|
|
/s/ Pieter
Bosse
(Pieter
Bosse)
|
|
Managing director
|
|
June 22, 2011
|
|
|
|
|
|
*
(William
F. Daniel)
|
|
Managing director
|
|
June 22, 2011
|
|
|
|
|
|
*
(Wim
Kok)
|
|
Managing director
|
|
June 22, 2011
|
|
|
|
|
|
|
|
*By:
|
|
/s/ Shane
M. Cooke
Shane
M. Cooke
Attorney-in-Fact
|
|
|
|
|
II-19
EXHIBIT INDEX
|
|
|
Exhibit No.
|
|
Description
|
|
3.1
|
|
Memorandum and Articles of Association of Elan Corporation, plc
(incorporated by reference to Exhibit 1.1 of the Annual Report
on Form 20-F of Elan Corporation, plc filed with the Commission
on February 24, 2011).
|
3.2
|
|
Memorandum and Articles of Association of Elan Finance Public
Limited Company (incorporated by reference to Exhibit 3.2 of the
Registration Statement on Form F-4 of Elan Corporation, plc (SEC
File No. 333-128234) filed with the Commission on September 9,
2005).
|
3.3
|
|
Certificate of Incorporation of Elan Finance Corp. (incorporated
by reference to Exhibit 3.3 of the Registration Statement on
Form F-4 of Elan Corporation, plc (SEC File No. 333-128234)
filed with the Commission on September 9, 2005).
|
3.4
|
|
By-Laws of Elan Finance Corp. (incorporated by reference to
Exhibit 3.4 of the Registration Statement on Form F-4 of Elan
Corporation, plc (SEC File No. 333-128234) filed with the
Commission on September 9, 2005).
|
4.1
|
|
Indenture dated as of August 17, 2010, among Elan Finance public
limited company, Elan Finance Corp., Elan Corporation, plc, the
Subsidiary Note Guarantors party thereto and The Bank of New
York Mellon, as Trustee (incorporated by reference to Exhibit
99.1 of the Report of Foreign Issuer on Form 6-K of Elan
Corporation, plc (SEC File No. 001-13896) filed with the
Commission on December 13, 2010).
|
4.2
|
|
Form of 8.75% Senior Note due 2016 (incorporated by
reference to Exhibit A of the Indenture attached as Exhibit 4.1
hereto).
|
4.3
|
|
Registration Rights Agreement dated August 17, 2010 among Elan
Finance public limited company, Elan Finance Corp., Elan
Corporation, plc, certain Subsidiary Guarantors and Morgan
Stanley & Co. Incorporated, Citigroup Global Markets Inc.
and J & E Davy (incorporated by reference to Exhibit 99.2
of the Report of Foreign Issuer on Form 6-K of Elan Corporation,
plc filed with the Commission on December 13, 2010).
|
5.1
|
|
Opinion of A&L Goodbody regarding legality as to Irish law.
|
5.2
|
|
Opinion of A&L Goodbody regarding legality as to English
law.
|
5.3
|
|
Opinion of Cahill Gordon & Reindel
llp regarding
legality.
|
5.4
|
|
Opinion of Casner & Edwards, LLP regarding legality.
|
5.5
|
|
Opinion of Conyers Dill & Pearman Limited regarding
legality.
|
5.6
|
|
Opinion of NautaDutilh N.V. regarding legality.
|
12.1
|
|
Ratio of Earnings to Fixed Charges.
|
21.1
|
|
Subsidiaries of Elan Corporation, plc (incorporated by reference
to Exhibit 8.1 of the Annual Report on Form 20-F of Elan
Corporation, plc filed with the Commission on February 24, 2011).
|
23.1
|
|
Consent of A&L Goodbody (included in Exhibit 5.1).
|
23.2
|
|
Consent of A&L Goodbody (included in Exhibit 5.2).
|
23.3
|
|
Consent of Cahill Gordon & Reindel
llp (included in
Exhibit 5.3).
|
23.4
|
|
Consent of Casner & Edwards, LLP regarding legality
(included in Exhibit 5.4).
|
23.5
|
|
Consent of Conyers Dill & Pearman Limited (included in
Exhibit 5.5).
|
23.6
|
|
Consent of NautaDutilh N.V. (included in Exhibit 5.6).
|
23.7
|
|
Consent of Independent Registered Public Accounting Firm, KPMG.
|
24.1
|
|
Powers of Attorney are included in the signature pages of this
registration statement.*
|
25.1
|
|
Statement of Eligibility and Qualification under the Trust
Indenture Act of 1939 on Form T-1 of The Bank of New York
Mellon, as Trustee under the 2016 Indenture issued August 2010.
|
99.1
|
|
Form of Letter of Transmittal.
|
99.2
|
|
Form of Notice of Guaranteed Delivery.
|
99.3
|
|
Form of Letter to Clients.
|
99.4
|
|
Form of Letter to Brokers, Dealers, Commercial Banks, Trust
Companies and Other Nominees.
|